Profil

Delanaye Pierre

Département des sciences cliniques

Département de pharmacie > Chimie médicale

See author's contact details
ORCID
0000-0002-1480-5761
Main Referenced Co-authors
Cavalier, Etienne  (371)
Krzesinski, Jean-Marie  (213)
Chapelle, Jean-Paul  (73)
Mariat, Christophe (59)
Pottel, Hans  (59)
Main Referenced Keywords
Nephrology (36); Humans (35); glomerular filtration rate (29); creatinine (19); Creatinine (18);
Main Referenced Disciplines
Urology & nephrology (477)
Laboratory medicine & medical technology (262)
Endocrinology, metabolism & nutrition (32)
Anesthesia & intensive care (22)
General & internal medicine (18)

Publications (total 679)

The most downloaded
7929 downloads
Delanaye, P., Cavalier, E., Maillard, N., Krzesinski, J.-M., Mariat, C., Cristol, J.-P., & Pieroni, L. (2010). La creatinine : d'hier a aujourd'hui. Annales de Biologie Clinique, 68 (5), 531-43. doi:10.1684/abc.2010.0479 https://hdl.handle.net/2268/73824

The most cited

485 citations (Scopus®)

Schaeffner, E., Ebert, N., DELANAYE, P., Frei, U., Gaedeke, J., Jakob, O., Kuhlmann, K., Schuchardt, M., Tolle, M., Ziebig, R., van der Giet, M., & Martus, P. (2012). Two novel equations to estimate kidney function in persons aged 70 years or older. Annals of Internal Medicine, 157 (7), 471-481. doi:10.7326/0003-4819-157-7-201210020-00003 https://hdl.handle.net/2268/147070

Navez, M., Pinto Coelho, T., El Karouni Walid, ERPICUM, P., Vandermeulen, M., Lagny, M.-G., CHERAMY-BIEN, J.-P., Gilbo, N., Malisoux, C., GUARIN, C., Thierry, G., Delanaye, P., Cavalier, E., Jouret, F., & Detry, O. (25 April 2024). Development of a model of simultaneous normothermic perfusion of kidney grafts in the pig [Paper presentation]. BVN-SBN Annual Scientific Meeting 2024, Vilvoorde, Belgium.
Peer reviewed

Delanaye, P. (25 April 2024). Genre et fonction rénale : n’y a-t-il vraiment aucune différence ? [Paper presentation]. 40ème colloque Romand de Néphrologie : « La Néphrologie a-t-elle un genre ? ».

Delanaye, P. (04 April 2024). Estimating GFR : facts and fiction [Paper presentation]. Nephrology Grand Rounds (virtual), Ottawa, Canada.

Stevens, K. I., Mallamaci, F., Ortiz, A., Bover, J., Delanaye, P., Torra, R., & Cozzolino, M. (April 2024). 'The forgotten sex': gender disparities in kidney disease. Clinical Kidney Journal, 17 (4), 102. doi:10.1093/ckj/sfad102
Peer Reviewed verified by ORBi

Nkoy, A. B., Matoka, T. T., Bukabau, J. B., Sumaili, E. K., Labarque, V., van den Heuvel, L. P., Levtchenko, E., Cavalier, E., Delanaye, P., Ekulu, P. M., & Pottel, H. (2024). Estimated glomerular filtration rate: applicability of creatinine-based equations in African children. Pediatric Nephrology. doi:10.1007/s00467-024-06349-x
Peer Reviewed verified by ORBi

Fu, E. L., Levey, A. S., Coresh, J., Grams, M. E., Faucon, A.-L., Elinder, C.-G., Dekker, F. W., Delanaye, P., Inker, L. A., & Carrero, J.-J. (27 March 2024). Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care. Nephrology Dialysis Transplantation, 39 (4), 694 - 706. doi:10.1093/ndt/gfad219
Peer Reviewed verified by ORBi

Navez, M., Pinto Coelho, T., El Karouni Walid, ERPICUM, P., Vandermeulen, M., Lagny, M.-G., CHERAMY-BIEN, J.-P., Malisoux, C., GUARIN, C., Thierry, G., Delanaye, P., Cavalier, E., Gilbo, N., Jouret, F., & Detry, O. (15 March 2024). Development of a model of simultaneous normothermic perfusion of kidney grafts in the pig [Paper presentation]. Congrès Société Belge de Transplantation, Bruxelles, Belgium.
Peer reviewed

Pottel, H., Delanaye, P., & Cavalier, E. (01 March 2024). Exploring Renal Function Assessment: Creatinine, Cystatin C, and Estimated Glomerular Filtration Rate Focused on the European Kidney Function Consortium Equation. Annals of Laboratory Medicine, 44 (2), 135 - 143. doi:10.3343/alm.2023.0237
Peer reviewed

Nyman, U., Björk, J., Delanaye, P., Lahens, A., Pottel, H., Vidal-Petiot, E., & Flamant, M. (26 February 2024). Rescaling creatinine makes GFR estimation equations generally applicable across populations - validation results for the Lund-Malmö equation in a French cohort of sub-Saharan ancestry. Clinical Chemistry and Laboratory Medicine, 62 (3), 421 - 427. doi:10.1515/cclm-2023-0496
Peer Reviewed verified by ORBi

Floyd, L., & Delanaye, P. (February 2024). Testing the waters on home-based albuminuria screening to enhance the detection and management of CKD. Clinical Kidney Journal, 17 (2), 031. doi:10.1093/ckj/sfae031
Peer Reviewed verified by ORBi

Delanaye, P., & Pottel, H. (February 2024). Estimating GFR: The Devil Is in the Details [letter to the editor]. American Journal of Kidney Diseases, 83 (2), 268. doi:10.1053/j.ajkd.2023.09.016
Peer Reviewed verified by ORBi

Cirillo, A., Résimont, G., Jouret, F., Vidal-Petiot, E., Flamant, M., Delanaye, P., & De Tullio, P. (31 January 2024). How can metabolomics help the follow-up management of kidney transplantation recipients? An untargeted based-metabolomics multiplatform study [Paper presentation]. Metabolomics in Life Science, Umea, Sweden.

Mohamed, A. A. A., Bökenkamp, A., Cavalier, E., Delanaye, P., Ebert, N., & van Londen, M. (2024). Diverse protocols for measuring glomerular filtration rate using iohexol clearance. Nephrology Dialysis Transplantation. doi:10.1093/ndt/gfae006
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Stehlé, T., & Pottel, H. (2024). Glomerular filtration rate estimation in adults: myths and promises. Nephron journals, 1-7. doi:10.1159/000536243
Peer Reviewed verified by ORBi

Delanaye, P., & Pottel, H. (2024). Estimating Glomerular Filtration Rate in China: Is the European Kidney Function Consortium (EKFC) Equation the Solution? Nephron journals, 148 (2), 74 - 77. doi:10.1159/000531314
Peer Reviewed verified by ORBi

Delanaye, P., Rule, A. D., Schaeffner, E., Cavalier, E., Shi, J., Hoofnagle, A. N., Nyman, U., Björk, J., & Pottel, H. (2023). Performance of the European Kidney Function Consortium (EKFC) creatinine-based equation in United States cohorts. Kidney International. doi:10.1016/j.kint.2023.11.024
Peer Reviewed verified by ORBi

Scheen, A., & Delanaye, P. (December 2023). Le médicament du mois. La finérénone (Kerendia®), une nouvelle arme contre la maladie rénale chronique du patient avec diabète de type 2. Revue Médicale de Liège, 78 (12), 725-732.
Editorial Reviewed verified by ORBi

Delanaye, P., Pottel, H., Cavalier, E., Flamant, M., Stehlé, T., & Mariat, C. (2023). Diagnostic standard: assessing glomerular filtration rate. Nephrology Dialysis Transplantation. doi:10.1093/ndt/gfad241
Peer Reviewed verified by ORBi

Cavalier, E., Farre Segura, J., LUKAS, P., GENDEBIEN, A.-S., Peeters, S., Massonnet, P., Le Goff, C., Bouquegneau, A., Souberbielle, J.-C., Delatour, V., & Delanaye, P. (2023). Unveiling a new era with liquid chromatography coupled with mass spectrometry to enhance parathyroid hormone measurement in patients with chronic kidney disease. Kidney International. doi:10.1016/j.kint.2023.09.033
Peer Reviewed verified by ORBi

Pottel, H., Nyman, U., Björk, J., Berg, U., Bökenkamp, A., Dubourg, L. D., Lemoine, S., Goffin, K., Grubb, A., Hansson, M., Larsson, A., Littmann, K., Åsling-Monemi, K., Adeli, K., Cavalier, E., & Delanaye, P. (2023). Extending the cystatin C based EKFC-equation to children - validation results from Europe. Pediatric Nephrology. doi:10.1007/s00467-023-06192-6
Peer Reviewed verified by ORBi

Cavalier, E., Makris, K., Portakal, O., Nikler, A., Datta, P., Zima, T., Delanaye, P., & EFLM Task Group on CKD. (02 October 2023). Assessing the status of European laboratories in evaluating biomarkers for chronic kidney diseases (CKD) and recommendations for improvement: insights from the 2022 EFLM Task Group on CKD survey. Clinical Chemistry and Laboratory Medicine, 0 (0). doi:10.1515/cclm-2023-0987
Peer Reviewed verified by ORBi

Delanaye, P. (23 August 2023). Troubles minéraux associés à la maladie rénale chronique [Paper presentation]. Ier congrès de Société congolaise de Néphrologie, Kinshasa, Congo - Kinshasa.

Delanaye, P. (22 August 2023). Progression de la maladie rénale chronique : apport du blocage du système rénine angiotensine versus inhibiteurs SGLT2 [Paper presentation]. IIème cours international de Néphrologie, Dialyse et Transplantation, Kinshasa, Congo - Kinshasa.

Delanaye, P. (22 August 2023). Prise en charge des complications de la maladie rénale chronique : anémie, acidose métabolique et hyperparathyroidie [Paper presentation]. IIème cours international de Néphrologie, Dialyse et Transplantation, Kinshasa, Congo - Kinshasa.

Adebayo, O. C., Nkoy, A. B., van den Heuvel, L. P., Labarque, V., Levtchenko, E., Delanaye, P., & Pottel, H. (August 2023). Glomerular hyperfiltration: part 2-clinical significance in children. Pediatric Nephrology, 38 (8), 2529 - 2547. doi:10.1007/s00467-022-05826-5
Peer Reviewed verified by ORBi

Pottel, H., Adebayo, O. C., Nkoy, A. B., & Delanaye, P. (August 2023). Glomerular hyperfiltration: part 1 - defining the threshold - is the sky the limit? Pediatric Nephrology, 38 (8), 2523 - 2527. doi:10.1007/s00467-022-05827-4
Peer Reviewed verified by ORBi

Diévart, F., Darmon, P., Halimi, J.-M., Hadjadj, S., Angoulvant, D., Prévost, G., Delanaye, P., & Boivin, J.-M. (17 July 2023). Quand et comment utiliser les inhibiteurs de la SGLT2 ou gliflozines en pratique clinique ? Un consensus proposé par la Société francophone du diabète (SFD), la Société française de cardiologie (SFC), le Collège national des cardiologues français (CNCF) et la Société francophone de néphrologie, dialyse et transplantation (SFNDT). Néphrologie et Thérapeutique, 19 (4), 1 - 27. doi:10.1684/ndt.2023.25
Peer Reviewed verified by ORBi

Fu, E., Levey, A., Faucon, A.-L., Delanaye, P., Inker, L., & Carrero, J. J. (June 2023). #4506 ACCURACY OF NOVEL GFR ESTIMATING EQUATIONS BASED ON CREATININE, CYSTATIN C OR BOTH IN ROUTINE CARE. Nephrology Dialysis Transplantation, 38 (Supplement_1). doi:10.1093/ndt/gfad063c_4506
Peer Reviewed verified by ORBi

van Londen, M., Bökenkamp, A., Cavalier, E., Delanaye, P., & Ebert, N. (June 2023). #4179 DIFFERENCES IN PROTOCOLS FOR MEASURING GLOMERULAR FILTRATION RATE USING IOHEXOL. Nephrology Dialysis Transplantation, 38 (Supplement_1). doi:10.1093/ndt/gfad063d_4179
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Pottel, H., & Stehlé, T. (15 March 2023). New and old GFR equations: a European perspective. Clinical Kidney Journal, 16 (9), 1375-1383. doi:10.1093/ckj/sfad039
Peer Reviewed verified by ORBi

Oliva-Damaso, N., Tangri, N., Delanaye, P., & Glassock, R. J. (17 February 2023). Bridging the gap of referral to nephrology care. Nature Reviews Nephrology, 19, 275-276. doi:10.1038/s41581-023-00693-1
Peer Reviewed verified by ORBi

Stehlé, T., Vidal-Petiot, E., Flamant, M., & Delanaye, P. (01 February 2023). Actualités et perspectives dans l’estimation du débit de filtration glomérulaire. Néphrologie et Thérapeutique, 19 (1), 13 - 22. doi:10.1684/ndt.2023.11
Peer Reviewed verified by ORBi

Delanaye, P., Schaeffner, E., Cozzolino, M., Langlois, M., Plebani, M., Ozben, T., & Cavalier, E. (27 January 2023). The new, race-free, Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) equation to estimate glomerular filtration rate: is it applicable in Europe? A position statement by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Clinical Chemistry and Laboratory Medicine, 61 (1), 44 - 47. doi:10.1515/cclm-2022-0928
Peer Reviewed verified by ORBi

Résimont, G., Cavalier, E., & Delanaye, P. (27 January 2023). Response to "About the estimation of albuminuria based on proteinuria results". Clinical Chemistry and Laboratory Medicine, 61 (1), 3 - e4. doi:10.1515/cclm-2022-0879
Peer Reviewed verified by ORBi

Pottel, H., Björk, J., Rule, A. D., Ebert, N., Eriksen, B. O., Dubourg, L., Vidal-Petiot, E., Grubb, A., Hansson, M., Lamb, E. J., Littmann, K., Mariat, C., Melsom, T., Schaeffner, E., Sundin, P.-O., Åkesson, A., Larsson, A., Cavalier, E., Bukabau, J. B., ... Delanaye, P. (26 January 2023). Cystatin C-Based Equation to Estimate GFR without the Inclusion of Race and Sex. New England Journal of Medicine, 388 (4), 333 - 343. doi:10.1056/NEJMoa2203769
Peer Reviewed verified by ORBi

Delanaye, P. (24 January 2023). Frailty in dialysis patients. Relevance and pitfalls [Paper presentation]. 8th Clinical Update Virtual Symposium.

Delanaye, P., Vidal-Petiot, E., Björk, J., Ebert, N., Eriksen, B. O., Dubourg, L., Grubb, A., Hansson, M., Littmann, K., Mariat, C., Melsom, T., Schaeffner, E., Sundin, P.-O., Bökenkamp, A., Berg, U. B., Åsling-Monemi, K., Åkesson, A., Larsson, A., Cavalier, E., ... Flamant, M. (23 January 2023). Performance of creatinine-based equations to estimate glomerular filtration rate in White and Black populations in Europe, Brazil and Africa. Nephrology Dialysis Transplantation, 38 (1), 106 - 118. doi:10.1093/ndt/gfac241
Peer Reviewed verified by ORBi

Delanaye, P., & Mariat, C. (2023). Réflexions sur les scores et les définitions de l’insuffisance rénale aiguë. Revue Francophone des Laboratoires, 555, 26-31.

Delanaye, P. (2023). GFR in current clinical guidelines [Paper presentation]. Kidney Week, Phidelphia, United States - Pennsylvania.
Editorial reviewed

Delanaye, P. (2023). Lower GFR and ageing: distinguish physiological and disease-related [Paper presentation]. Congress of the European Renal Association.

Delanaye, P. (2023). eGFR measurements in clinical practice [Paper presentation]. Congress of the European Renal Association.

Delanaye, P. (2023). Performance of the European Kidney Function Consortium (EKFC) creatinine-based equation in American cohorts [Poster presentation]. Kidney Week, Phidelphia, United States - Pennsylvania.
Peer reviewed

Delanaye, P., Lanot, A., Bouquegneau, A., Warling, X., Radermacher, L., Masset, C., Krzesinski, J.-M., Moranne, O., & Cavalier, E. (January 2023). Monitoring 25-OH and 1,25-OH vitamin D levels in hemodialysis patients after starting therapy: Does it make sense? Clinica Chimica Acta, 539, 50-54. doi:10.1016/j.cca.2022.11.032
Peer Reviewed verified by ORBi

Delanaye, P. (2023). DFG pour qui ? et comment ? [Paper presentation]. 19ème Congrès National de Néphrologie. Société Marocaine de Néphrologie.

Delanaye, P., & Scheen, A. (January 2023). EMPA-KIDNEY : l’empagliflozine dans la maladie rénale chronique. Revue Médicale de Liège, 78 (1), 24 - 28.
Editorial Reviewed verified by ORBi

VIEUJEAN, S., GILLARD, R., Delanaye, P., Seidel, L., Bequet, E., Salée, C., Meuwis, M.-A., Massot, C., Pierre, N., Meunier, P., Cavalier, E., & Louis, E. (2023). Matrix gla protein, a potential marker of tissue remodelling and physiological ageing of the gut in crohn’s disease. Scandinavian Journal of Gastroenterology, 1-8. doi:10.1080/00365521.2023.2286913
Peer Reviewed verified by ORBi

Delanaye, P., Masson, I., Maillard, N., Pottel, H., & Mariat, C. (01 December 2022). The New 2021 CKD-EPI Equation Without Race in a European Cohort of Renal Transplanted Patients. Transplantation, 106 (12), 2443 - 2447. doi:10.1097/TP.0000000000004234
Peer Reviewed verified by ORBi

TIV, H., Vandelaer, A., Delanaye, P., Forte, F., & Bouquegneau, A. (December 2022). Piège diagnostique : neurotoxicité au lithium avec lithémie normale. Néphrologie et Thérapeutique, 18 (7), 650 - 654. doi:10.1016/j.nephro.2022.07.398
Peer Reviewed verified by ORBi

Farre Segura, J., Le Goff, C., LUKAS, P., Cobraiville, G., Fillet, M., Servais, A.-C., Delanaye, P., & Cavalier, E. (03 November 2022). Validation of an LC-MS/MS Method Using Solid-Phase Extraction for the Quantification of 1-84 Parathyroid Hormone: Toward a Candidate Reference Measurement Procedure. Clinical Chemistry, 68 (11), 1399-1409. doi:10.1093/clinchem/hvac135
Peer Reviewed verified by ORBi

Nateghi Haredasht, F., Antonatou, M., Cavalier, E., Delanaye, P., Pottel, H., & Makris, K. (November 2022). The effect of different consensus definitions on diagnosing acute kidney injury events and their association with in-hospital mortality. Journal of Nephrology, 35 (8), 2087-2095. doi:10.1007/s40620-022-01323-y
Peer Reviewed verified by ORBi

Oliva-Damaso, N., Delanaye, P., Oliva-Damaso, E., Payan, J., & Glassock, R. J. (November 2022). Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease. Clinical Kidney Journal, 15 (11), 1996-2005. doi:10.1093/ckj/sfac104
Peer Reviewed verified by ORBi

Zingano, C. P., Escott, G. M., Rocha, B. M., Porgere, I. F., Moro, C. C., Delanaye, P., & Silveiro, S. P. (29 October 2022). 2009 CKD-EPI glomerular filtration rate estimation in Black individuals outside the United States: a systematic review and meta-analysis. Clinical Kidney Journal, 16 (2), 322-330. doi:10.1093/ckj/sfac238
Peer Reviewed verified by ORBi

Ebert, N., Pottel, H., Giet, M. V. D., Kuhlmann, M. K., Delanaye, P., & Schaeffner, E. (14 October 2022). The Impact of the New CKD-EPI Equation on GFR Estimation in the Elderly. Deutsches Ärzteblatt International, 119 (41), 694 - 695. doi:10.3238/arztebl.m2022.0258
Peer reviewed

Pottel, H., Björk, J., Delanaye, P., & Nyman, U. (September 2022). Evaluation of the creatinine-based chronic kidney disease in children (under 25 years) equation in healthy children and adolescents. Pediatric Nephrology, 37 (9), 2213-2216. doi:10.1007/s00467-022-05429-0
Peer Reviewed verified by ORBi

Pottel, H., Cavalier, E., Björk, J., Nyman, U., Grubb, A., Ebert, N., Schaeffner, E., Eriksen, B. O., Melsom, T., Lamb, E. J., Mariat, C., Dubourg, L., Hansson, M., Littmann, K., Sundin, P.-O., Åkesson, A., Larsson, A., Rule, A., & Delanaye, P. (03 August 2022). Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function. Clinical Kidney Journal, 15 (12), 2258-2265. doi:10.1093/ckj/sfac182
Peer Reviewed verified by ORBi

Massonnet, P., Peeters, S., Grifnee, E., Demeuse, J., Huyghebaert, L., Farre Segura, J., Delanaye, P., Le Goff, C., & Cavalier, E. (August 2022). Iohexol quantitation and possible degradation kinetics in human urine using mass spectrometry coupled to liquid chromatography (LC) [Poster presentation]. International Mass Spectrometry Conference (IMSC) 2022, Maastricht, Netherlands.
Peer reviewed

Delanaye, P., Pottel, H., & Melsom, T. (18 July 2022). Physiology of the Aging Kidney: We Know Where We Are Going, but We Don't Know How… Clinical Journal of the American Society of Nephrology, 17 (8), 1107-1109. doi:10.2215/CJN.06880622
Editorial reviewed

Résimont, G., VRANKEN, L., Pottel, H., JOURET, F., KRZESINSKI, J.-M., CAVALIER, E., & DELANAYE, P. (27 June 2022). Estimating urine albumin to creatinine ratio from protein to creatinine ratio using same day measurement: validation of equations. Clinical Chemistry and Laboratory Medicine, 60 (7), 1064-1072. doi:10.1515/cclm-2022-0049
Peer Reviewed verified by ORBi

Cirillo, A., Résimont, G., Delanaye, P., Emmanuelle Vidal-Petiot, Martin Flamant, Jouret, F., & De Tullio, P. (19 June 2022). Application of metabolomics to the evaluation of kidney function and kidney transplantation [Poster presentation]. Metabolomics Society.

DELANAYE, P. (26 May 2022). Débit de filtration glomérulaire : comment mesurer et estimer correctement ? [Paper presentation]. Eméritat du Professeur Nazaire Nseka Mangani, Kinshsa, Kinshasa, Congo - Kinshasa.

DELANAYE, P., Björk, J., Courbebaisse, M., Couzi, L., Ebert, N., Eriksen, B. O., Dalton, R. N., Dubourg, L., Gaillard, F., Garrouste, C., Grubb, A., Jacquemont, L., Hansson, M., Kamar, N., Lamb, E. J., Legendre, C., Littmann, K., Mariat, C., Melsom, T., ... Nyman, U. (May 2022). Performance of creatinine-based equations to estimate glomerular filtration rate with a methodology adapted to the context of drug dosage adjustment. British Journal of Clinical Pharmacology, 88 (5), 2118-2127. doi:10.1111/bcp.15132
Peer Reviewed verified by ORBi

DELANAYE, P., Bjork, J., Vidal-Petiot, E., Ebert, N., Odvar Eriksen, B., Dubourg, L., Grubb, A., Hansson, M., Lamb, E., Littman, K., Mariat, C., Melsom, T., Schaeffner, E., Sundin, P.-O., Bokenkamp, A., Berg, U., Asling-Monemi, K., Åkesson, A., Larsson, A., ... Flamant, M. (May 2022). Performance of Creatinine-Based Equations to Estimate Glomerular Filtration Rate in White and Black Subjects From Europe, Brazil and Africa. Nephrology Dialysis Transplantation, 37 (Supplement_3), 385. doi:10.1093/ndt/gfac069.018
Peer Reviewed verified by ORBi

BOUQUEGNEAU, A., MALAISE, O., SEIDEL, L., BONVOISIN, C., WEEKERS, L., JOURET, F., CAVALIER, E., & DELANAYE, P. (May 2022). Bone Mineral Density, Bone Micro-Architecture Evolution After Kidney Transplantation: A Prospective Cohort Study. Nephrology Dialysis Transplantation, 37 (Supplement_3). doi:10.1093/ndt/gfac073.006
Peer Reviewed verified by ORBi

DELANAYE, P., Masson, I., Maillard, N., Pottel, H., & Mariat, C. (May 2022). Estimating GFR in Renal Transplanted Patients With Equations Based on Creatinine (With or Without Race Variable) and/or Cystatin C. Nephrology Dialysis Transplantation, 37 (Supplement_3). doi:10.1093/ndt/gfac069.014
Peer Reviewed verified by ORBi

Farre Segura, J., COBRAIVILLE, G., LUKAS, P., LE GOFF, C., Servais, A.-C., Fillet, M., DELANAYE, P., & CAVALIER, E. (11 April 2022). Development and validation of a candidate reference method for 1-84 PTH by LC-MS/MS [Poster presentation]. EuroMedLab 2021 Munich, Munich, Germany.

Nyman, U., Björk, J., Berg, U., Bökenkamp, A., Dubourg, L., Goffin, K., Grubb, A., Hansson, M., Larsson, A., Littmann, K., Åsling-Monemi, K., Pottel, H., & Delanaye, P. (26 March 2022). The Modified CKiD Study Estimated GFR Equations for Children and Young Adults Under 25 Years of Age: Performance in a European Multicenter Cohort. American Journal of Kidney Diseases, 80 (6), 807 - 810. doi:10.1053/j.ajkd.2022.02.018
Peer Reviewed verified by ORBi

DELANAYE, P. (15 March 2022). Mesures et estimations du débit de filtration glomérulaire [Paper presentation]. Réunion de Néphrologie Hôpital Necker, Paris, virtuel, France.

DELANAYE, P. (2022). Mesures et estimations du DFG pour un usage clinique en 2022 [Paper presentation]. IX symposium Reins & Médicaments, Liège, Belgium.

DELANAYE, P., Pottel, H., & Glassock, R. J. (10 March 2022). Americentrism in estimation of glomerular filtration rate equations. Kidney International, 101 (5), 856 - 858. doi:10.1016/j.kint.2022.02.022
Peer Reviewed verified by ORBi

Guillo, L., DELANAYE, P., Flamant, M., Figueres, L., Karam, S., Lemoine, S., Benezech, A., Pelletier, A.-L., Amiot, A., Caron, B., Stefanescu, C., Boschetti, G., Bouguen, G., Rahier, J.-F., Gornet, J.-M., Hugot, J.-P., Bonnet, J., Vuitton, L., Nachury, M., ... Peyrin-Biroulet, L. (March 2022). Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus. Digestive and Liver Disease, 54 (3), 309-315. doi:10.1016/j.dld.2021.11.008
Peer Reviewed verified by ORBi

SCHEEN, A., & DELANAYE, P. (March 2022). Acute renal injury events in diabetic patients treated with SGLT2 inhibitors: A comprehensive review with a special reference to RAAS blockers. Diabetes and Metabolism, 48 (2), 101315. doi:10.1016/j.diabet.2021.101315
Peer Reviewed verified by ORBi

VALDES SOCIN, H. G., SCHEEN, A., JOURET, F., GROSCH, S., & DELANAYE, P. (March 2022). De la découverte de la phlorizine (une histoire belge) aux inhibiteurs des SGLT2. Revue Médicale de Liège, 77 (3), 175-180.
Editorial Reviewed verified by ORBi

DELANAYE, P. (15 February 2022). What should we know about the last eGFR equation without race? [Paper presentation]. UZA Seminars Nephrology.

Schulz, C., Messikh, Z., Reboul, P., Cariou, S., Ahmadpoor, P., Pambrun, E., Prelipcean, C., Garo, F., Prouvot, J., DELANAYE, P., & Moranne, O. (14 January 2022). Characteristics of outpatients referred for a first consultation with a nephrologist: impact of different guidelines. Journal of Nephrology, 35 (5), 1375-1385. doi:10.1007/s40620-021-01204-w
Peer Reviewed verified by ORBi

Flamant, M., Delanaye, P., Vidal-Petiot, E., & Pottel, H. (2022). Performances des nouvelles formules d’estimation du DFG dérivées de la créatininémie dans des populations européennes, africaines et brésiliennes. Néphrologie et Thérapeutique, 18 (5), 05.
Peer Reviewed verified by ORBi

DELANAYE, P., Gaillard, F., van der Weijden, J., Mjøen, G., Ferhman-Ekholm, I., Dubourg, L., Ebert, N., Schaeffner, E., Åkerfeldt, T., Goffin, K., Couzi, L., Garrouste, C., Rostaing, L., Courbebaisse, M., Legendre, C., Hourmant, M., Kamar, N., Cavalier, E., WEEKERS, L., ... van Londen, M. (2022). Age-adapted percentiles of measured glomerular filtration in healthy individuals: extrapolation to living kidney donors over 65 years. Clinical Chemistry and Laboratory Medicine, 60 (3), 401-407. doi:10.1515/cclm-2021-1011
Peer Reviewed verified by ORBi

Faucon, A.-L., Flamant, M., DELANAYE, P., Lambert, O., Essig, M., Peraldi, M.-N., Tabibzadeh, N., Haymann, J.-P., Stengel, B., Geri, G., & Vidal-Petiot, E. (2022). Estimating Extracellular Fluid Volume in Healthy Individuals: Evaluation of Existing Formulae and Development of a New Equation. Kidney International Reports, 7 (4), 810-822. doi:10.1016/j.ekir.2022.01.1057
Peer Reviewed verified by ORBi

VIEUJEAN, S., DELANAYE, P., SEIDEL, L., CAVALIER, E., Pierre, N., & LOUIS, E. (2022). Matrix Gla Protein, a potential marker of tissue remodelling and physiological ageing of the gut in Crohn's disease [Paper presentation]. Belgian Week of Gastroenterology 2022.
Peer reviewed

VIEUJEAN, S., DELANAYE, P., SEIDEL, L., CAVALIER, E., Pierre, N., & LOUIS, E. (01 January 2022). P168 Matrix Gla protein, a potential marker of tissue remodelling and physiological ageing of the gut in Crohn’s Disease [Poster presentation]. European Crohn's and Colitis Organisation 2022. doi:10.1093/ecco-jcc/jjab232.296
Peer reviewed

Delanaye, P. (2022). CKD diagnosis in the aging population [Paper presentation]. 54th Annual Meeting Swiss Society of Nephrology.

Delanaye, P., Masson, I., Maillard, N., Pottel, H., & Mariat, C. (2022). Performance de la nouvelle équation CKD-EPI (sans la variable ethnique) en transplantation rénale. Néphrologie et Thérapeutique, 18 (5), 06.
Peer Reviewed verified by ORBi

Delanaye, P., & De Seigneux, S. (2022). Finérénone : une nouvelle avancée sur le chemin de la néphroprotection. Revue Médicale Suisse, 18 (792), 1534-1538. doi:10.53738/revmed.2022.18.792.1534
Peer Reviewed verified by ORBi

Delanaye, P. (2022). Screening for kidney diseases in the camp: which tools for the best efficiency? Laboratory Medicine for Mobile Societies in our Area [Paper presentation]. Second AFCB-EFLM conference.

Delanaye, P., & Cavalier, E. (2022). Impact des nouvelles équations EKFC et CKD-EPI (sans facteur ethnique) sur la prévalence de la maladie rénale chronique. Néphrologie et Thérapeutique, 18 (5), 20.
Peer Reviewed verified by ORBi

SALMON, A., Delanaye, P., & WEEKERS, L. (2022). La variation de la créatinine sérique au cours de la première année post-transplantationa-t-elle une influence sur le devenir du greffon rénal ? Néphrologie et Thérapeutique, 18 (5), 07.
Peer Reviewed verified by ORBi

Delanaye, P. (2022). Suivi rénal des MICI [Paper presentation]. VII congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT).

Scheen, A., & Delanaye, P. (2022). Inhibiteurs des SGLT2 et bloqueurs du système rénine-angiotensine. Similitudes, différences et complémentarité. Revue Médicale de Liège, 77 (1), 18 - 24.
Editorial Reviewed verified by ORBi

Massonnet, P., Peeters, S., Grifnée, E., Demeuse, J., Huyghebaert, L., Dubrowski, T., Dufour, P., Farre Segura, J., Delanaye, P., Le Goff, C., & Cavalier, E. (2022). QUANTIFICATION AND POSSIBLE DEGRADATION KINETICS OF IOHEXOL IN HUMAN FLUIDS USING MASS SPECTROMETRY COUPLED TO LIQUID CHROMATOGRAPHY [Paper presentation]. RBSLM Congress.
Peer reviewed

DELANAYE, P., DUBOIS, B., CAVALIER, E., & JOURET, F. (2022). Vignette diagnostique de l’étudiant : approche diagnostique de la maladie rénale chronique. Revue Médicale de Liège, 7 (4), 249-252.
Editorial Reviewed verified by ORBi

Cavalier, E., LUKAS, P., & DELANAYE, P. (2022). Analytical evaluation of the Nittobo Medical tartrate resistant acid phosphatase isoform 5b (TRACP-5b) EIA and comparison with IDS iSYS in different clinically defined populations. Clinical Chemistry and Laboratory Medicine, 60 (3), 394-400. doi:10.1515/cclm-2021-1190
Peer Reviewed verified by ORBi

Pottel, H., Goffin, K., De Waele, L., Levtchenko, E., & DELANAYE, P. (2022). 51Cr-EDTA plasma clearance in children. One, two, or multiple samples? Medicine, 101 (3), 28608. doi:10.1097/MD.0000000000028608
Peer Reviewed verified by ORBi

MALAISE, O., SEIDEL, L., BONVOISIN, C., WEEKERS, L., JOURET, F., MALAISE, M., CAVALIER, E., DELANAYE, P., & BOUQUEGNEAU, A. (2022). BONE MINERAL DENSITY AND BONE MICRO-ARCHITECTURE EVOLUTION AFTER KIDNEY TRANSPLANTATION: 3-MONTHS RESULTS OF A PROSPECTIVE COHORT STUDY. Osteoporosis International.
Peer Reviewed verified by ORBi

DELANAYE, P. (2022). What should we know about the last eGFR equations without "race"? [Paper presentation]. Belgian Society Of Nephrology.

Résimont, G., Cavalier, E., Radermecker, R., & Delanaye, P. (2022). Albuminuria in diabetic patients: How to measure it?-a narrative review. Journal of Laboratory and Precision Medicine, 7, 4-4. doi:10.21037/jlpm-21-58
Peer Reviewed verified by ORBi

ROUSSEAU, A.-F., KELLENS, I., DELANAYE, P., Bruyère, O., Misset, B., & Croisier, J.-L. (January 2022). Experimental Approach of Quadriceps Strength Measurement: Implications for Assessments in Critically Ill Survivors. Diagnostics, 12 (1), 202. doi:10.3390/diagnostics12010202
Peer Reviewed verified by ORBi

SCHEEN, A., & DELANAYE, P. (January 2022). Understanding the protective effects of SGLT2 inhibitors in type 2 diabetes patients with chronic kidney disease. Expert Review of Endocrinology and Metabolism, 17 (1), 35-46. doi:10.1080/17446651.2022.2014322
Peer Reviewed verified by ORBi

DELANAYE, P., Cavalier, E., & Bouquegneau, A. (2022). The ideal drug dosage adaptation through estimated glomerular filtration rate in obese patients? Measuring GFR is the key. British Journal of Clinical Pharmacology. doi:10.1111/bcp.15255
Peer Reviewed verified by ORBi

Luyckx, V. A., Rule, A. D., Tuttle, K. R., DELANAYE, P., Liapis, H., Gandjour, A., Romagnani, P., & Anders, H.-J. (08 December 2021). Nephron overload as a therapeutic target to maximize kidney lifespan. Nature Reviews Nephrology, 18 (3), 171-183. doi:10.1038/s41581-021-00510-7
Peer Reviewed verified by ORBi

DELANAYE, P. (07 December 2021). Mesure du débit de filtration glomérulaire [Paper presentation]. Séminaire Service de Biochimie et Biologie Moléculaire, UM Pathologies rénales et osseuses, Lyon, France.

DELANAYE, P. (07 December 2021). Estimation du débit de filtration glomérulaire [Paper presentation]. Séminaire Service de Biochimie et Biologie Moléculaire, UM Pathologies rénales et osseuses, Lyon, France.

DELANAYE, P., Wissing, K. M., & SCHEEN, A. (December 2021). Sodium–glucose cotransporter 2 inhibitors: renal outcomes according to baseline albuminuria. Clinical Kidney Journal, 14 (12), 2463-2471. doi:10.1093/ckj/sfab096
Peer Reviewed verified by ORBi

Gaillard, F., Courbebaisse, M., Dubourg, L., Couzi, L., Garrouste, C., Rostaing, L., Hourmant, M., Kamar, N., Mariat, C., & DELANAYE, P. (07 October 2021). Age-adapted percentiles for older candidates to living kidney donors [Paper presentation]. VI congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT), Toulouse, France.

DELANAYE, P. (07 October 2021). Performance des équations d’estimation du DFG basées sur la créatinine dans le contexte de l’adaptation posologique [Paper presentation]. VI congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT), Toulouse, France.

Malisoux, C., KOCH, J.-N., MEURISSE, N., Lagny, M., VANDERMEULEN, M., HONORE, P., JOURET, F., DELANAYE, P., & DETRY, O. (August 2021). Perioperative risk factors of acute kidney injury post liver transplantation: a monocentric retrospective cohort study of 260 patients. Transplant International, 34 (S1 POS315), 312.
Peer Reviewed verified by ORBi

Lambermont, B., HUART, J., Chase, J. G., & Delanaye, P. (01 July 2021). Is Mortality Rate of Ventilated Patients With Coronavirus Disease 2019 So High? Critical Care Medicine, 49 (7), 738 - e739. doi:10.1097/CCM.0000000000004986
Peer Reviewed verified by ORBi

Pottel, H., & DELANAYE, P. (July 2021). Development and validation of a modified full age spectrum creatinine-based equation to estimate glomerular filtration rate [letter to the editor]. Annals of Internal Medicine, 174 (7), 1038. doi:10.7326/L21-0248

ROUSSEAU, A.-F., MINGUET, P., COLSON, C., KELLENS, I., Chaabane, S., DELANAYE, P., Cavalier, E., Chase, J. G., LAMBERMONT, B., & Misset, B. (July 2021). Post-intensive care syndrome after a critical COVID-19: cohort study from a Belgian follow-up clinic. Annals of Intensive Care, 11 (1), 118. doi:10.1186/s13613-021-00910-9
Peer Reviewed verified by ORBi

DELANAYE, P. (07 June 2021). Pearls in CKJ [Paper presentation]. LVIII Congress of ERA-EDTA.

DELANAYE, P. (2021). Accurate assessement of kidney function : for whom, when, and how [Paper presentation]. 26ème édition du symposium belge de Dialyse (Fresenius Medical Care), Jodoigne, Belgium.

Chazot, R., Botelho-Nevers, E., Mariat, C., Frésard, A., Cavalier, E., Lucht, F., Delanaye, P., Maillard, N., & Gagneux-Brunon, A. (03 March 2021). Cystatin C and Urine Albumin to Creatinine Ratio Predict 5-Year Mortality and Cardiovascular Events in People Living With HIV. Journal of Infectious Diseases, 223 (5), 885 - 892. doi:10.1093/infdis/jiaa433
Peer Reviewed verified by ORBi

Gaillard, F., Jacquemont, L., Lazareth, H., Albano, L., Barrou, B., Bouvier, N., Buchler, M., Titeca-Beauport, D., Couzi, L., Delahousse, M., Ducloux, D., Etienne, I., Frimat, L., Garrouste, C., Glotz, D., Grimbert, P., Hazzan, M., Hertig, A., Hourmant, M., ... Mariat, C. (March 2021). Living kidney donor evaluation for all candidates with normal estimated GFR for age. Transplant International, 34 (3), 1123-1133. doi:10.1111/tri.13870
Peer Reviewed verified by ORBi

BOUQUEGNEAU, A., ERPICUM, P., GROSCH, S., HABRAN, L., HOUGRAND, O., HUART, J., KRZESINSKI, J.-M., Misset, B., Hayette, M.-P., DELVENNE, P., BOVY, C., Kylies, D., huber, T. B., Puelles, V. G., DELANAYE, P., & Jouret, F. (2021). COVID-19-associated nephropathy includes tubular necrosis and capillarycongestion, with evidence of SARS-CoV-2 in the nephron. Kidney International. doi:10.34067/KID.0006992020
Peer Reviewed verified by ORBi

Pottel, H., Bjork, J., Courbebaisse, M., Couzi, L., Ebert, N., Eriksen, B.-O., Dalton, N., Dubourg, L., Gaillard, F., Garrouste, C., Grubb, A., Jacquement, L., Hansson, M., Kamar, N., Lamb, E., Legendre, C., Littmann, K., Mariat, C., Melsom, T., ... DELANAYE, P. (February 2021). Development and validation of a modified full age spectrum creatinine-based equation to estimate glomerular filtration rate. A cross-sectional analysis of pooled data. Annals of Internal Medicine, 174 (2), 183-191. doi:10.7326/M20-4366
Peer Reviewed verified by ORBi

HUART, J., BOUQUEGNEAU, A., Lutteri, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., BOVY, C., Krzesinski, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., Mariat, C., CAVALIER, E., Burtey, S., Jouret, F., & DELANAYE, P. (23 January 2021). Proteinuria in COVID‑19: prevalence, characterization and prognostic role. Journal of Nephrology, 34 (3), 355-364. doi:10.1007/s40620-020-00931-w
Peer Reviewed verified by ORBi

DELANAYE, P., & CAVALIER, E. (2021). Arguments for an age-adapted definition of chronic kidney disease. Portuguese Journal of nephrology and hypertension, 35 (4), 261-262.
Peer reviewed

Lambermont, B., ROUSSEAU, A.-F., Seidel, L., THYS, M., CAVALLERI, J., DELANAYE, P., Chase, J. G., Gillet, P., & Misset, B. (2021). Outcome Improvement Between the First Two Waves of the Coronavirus Disease 2019 Pandemic in a Single Tertiary-Care Hospital in Belgium. Critical Care Explorations, 3 (5), 0438. doi:10.1097/CCE.0000000000000438
Peer Reviewed verified by ORBi

LAMBERMONT, B., SEIDEL, L., THYS, M., CAVALLERI, J., DELANAYE, P., CANIVET, J.-L., KISOKA, G., LAYIOS, N., LEDOUX, D., MASSION, P., MORIMONT, P., Parzibut, G., PIRET, S., ROBINET, S., ROUSSEAU, A.-F., WIESEN, P., Chase, J. G., MEURIS, C., Moutschen, M., & Misset, B. (2021). Comparison of Covid-19 patient management and outcome in a tertiary care center during the first and second waves of the pandemic. Annals of Intensive Care, Suppl 1, 86.
Peer Reviewed verified by ORBi

Scheen, A.* , & Delanaye, P.*. (2021). Inhibiteurs des SGLT2: focus sur le rein et la néphroprotection. Revue Médicale Suisse, 17 (747), 1397-1403.
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Delanaye, P., & Scheen, A. (2021). Epidemiology of acute kidney injury adverse events with SGLT2 inhibitors: A meta-analysis of observational cohort studies. Diabetes Epidemiology and Management, 3, 100021. doi:10.1016/j.deman.2021.100021
Peer Reviewed verified by ORBi

DELANAYE, P. (2021). Assessment of kidney function and diagnosis of chronic kidney disease.

Pottel, H., Schaeffner, E., Ebert, N., van der Giet, M., & DELANAYE, P. (2021). Iohexol plasma clearance for measuring glomerular filtration rate: effect of different ways to calculate the area under the curve. BMC Nephrology, 22 (1), 166. doi:10.1186/s12882-021-02376-0
Peer Reviewed verified by ORBi

Résimont, G., Piéroni, L., Bigot‑Corbel, E., CAVALIER, E., & DELANAYE, P. (2021). Urinary strips for protein assays: easy to do but difficult to interpret! Journal of Nephrology, 34 (3), 411-432. doi:10.1007/s40620-020-00735-y
Peer Reviewed verified by ORBi

Cavalier, E., Fraser, C. G., Bhattoa, H. P., Heijboer, A. C., Makris, K., Ulmer, C. Z., Vesper, H. W., Vasikaran, S., LUKAS, P., DELANAYE, P., Carobene, A., & On Behalf Of The Ifcc-Iof Committee For Bone Metabolism. (January 2021). Analytical Performance Specifications for 25-Hydroxyvitamin D Examinations. Nutrients, 13 (2). doi:10.3390/nu13020431
Peer Reviewed verified by ORBi

DELANAYE, P., HUART, J., BOUQUEGNEAU, A., & JOURET, F. (2021). Long-term effects of COVID-19 on kidney function [letter to the editor]. The Lancet, 397 (10287), 1807. doi:10.1016/S0140-6736(21)00881-3

Résimont, G., VRANKEN, L., CAVALIER, E., & DELANAYE, P. (2021). Estimation d’un ratio Albumine/Créatinine urinaire à partir d’un ratio Protéine/Créatinine urinaire au départ de mesures réalisées sur un même échantillon : validation d’équations [Paper presentation]. VI congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT), Toulouse, France.

Pottel, H., Delay, A., Maillard, N., Mariat, C., & DELANAYE, P. (2021). 20-year longitudinal follow-up of measured and estimated glomerular filtration rate in kidney transplant patients. Clinical Kidney Journal, 14 (3), 909-916. doi:10.1093/ckj/sfaa034
Peer Reviewed verified by ORBi

Delay, A., Moranne, O., Fafin, C., Mariat, C., Alamartine, E., DELANAYE, P., & Maillard, N. (2021). Relationship between decline in estimated or measured glomerular filtration rate and 16-year postrenal outcome. Clinical Kidney Journal, 14 (6), 1665-1672. doi:10.1093/ckj/sfaa203
Peer Reviewed verified by ORBi

DELANAYE, P., & Scheen, A. (2021). The diuretic effects of SGLT2 inhibitors: A comprehensive review of their specificities and their role in renal protection. Diabetes & metabolism, 47 (6), 101285. doi:10.1016/j.diabet.2021.101285
Peer reviewed

DELANAYE, P., Melsom, T., CAVALIER, E., Pottel, H., Eriksen, B., & Dubourg, L. (2021). Iohexol plasma clearance: impact of weighing the syringe. Kidney International Reports, 6 (9), 2478-2480. doi:10.1016/j.ekir.2021.05.038
Peer Reviewed verified by ORBi

DELANAYE, P., KRZESINSKI, F., DUBOIS, B., DELCOUR, A., Robinet, S., PIETTE, C., KRZESINSKI, J.-M., & LANCELLOTTI, P. (2021). A simple modification of dialysate potassium: its impact on plasma potassium concentrations and the electrocardiogram. Clinical Kidney Journal, 14 (1), 390-397. doi:10.1093/ckj/sfz157
Peer Reviewed verified by ORBi

Lambermont, B., Seidel, L., THYS, M., CAVALLERI, J., Delanaye, P., Canivet, J.-L., KISOKA, G., Layios, N., & Misset, B. (2021). Comparison of Covid‐19 patient management and outcome in a tertiary care center during the first and second waves of the pandemic. Annals of Intensive Care.
Peer Reviewed verified by ORBi

DELANAYE, P., & Mariat, C. (2021). Comparing multiple-biomarker panels for estimating GFR with estimating equations without coefficient distinguishing black individuals from persons of other groups [letter to the editor]. American Journal of Kidney Diseases, 77 (5), 823-824. doi:10.1053/j.ajkd.2020.12.016
Peer Reviewed verified by ORBi

DELANAYE, P., Vidal-Petiot, Stehlé, T., Dubourg, Gaillard, F., Sterner, G., White, C., Lemoine, S., Audard, V., Prié, D., CAVALIER, E., Courbebaisse, M., Pottel, H., & Flamant, M. (2021). Comparison of plasma clearance with early-compartment correction equations and urinary clearance in high GFR ranges. Kidney International Reports, 6 (6), 1622-1628. doi:10.1016/j.ekir.2021.03.886
Peer Reviewed verified by ORBi

DELANAYE, P., Mariat, C., Cavalier, E., Glassock, R. J., Gemenne, F., & Pottel, H. (2021). The « race » correction in estimating glomerular filtration rate: an European point of view. Current Opinion in Nephrology and Hypertension, 30 (6), 525-530. doi:10.1097/MNH.0000000000000739
Peer Reviewed verified by ORBi

BOUQUEGNEAU, A., HUART, J., LUTTERI, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., ROUSSEAU, A.-F., BOVY, C., KRZESINSKI, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., DARCIS, G., CAVALIER, E., JOURET, F., & DELANAYE, P. (2021). Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. Journal of Nephrology, 34 (4), 967-969. doi:10.1007/s40620-021-01075-1
Peer Reviewed verified by ORBi

Bjork, J., Nyman, U., Larsson, A., DELANAYE, P., & Pottel, H. (2021). Estimation of the glomerular filtration rate in children and young adults by means of the CKD-EPI equation with age-adjusted creatinine values. Kidney International, 99 (4), 940-947. doi:10.1016/j.kint.2020.10.017
Peer Reviewed verified by ORBi

DELANAYE, P., & Mariat, C. (2021). Adherence to therapy: burden, complexity, and perception. Kidney International Reports, 6 (1), 5-6. doi:10.1016/j.ekir.2020.11.005
Peer Reviewed verified by ORBi

Scheen, A., & DELANAYE, P. (2021). Inhibiteurs des SGLT2 chez les patients avec insuffisance rénale chronique : des essais contrôlés aux recommandations internationales et perspectives en pratique clinique. Revue Médicale de Liège, 76 (3), 186-194.
Peer reviewed

Delanaye, P. (20 November 2020). Renal function in the geriatric patient [Paper presentation]. Annual meeting of the Royal Belgian Society of Laboratory Medicine and joint meeting with the Belgian Society for Gerontology and Geriatrics, E-meeting, Belgium.

DELANAYE, P. (22 October 2020). Epidémiologie et diagnostic de la maladie rénale chronqiue [Paper presentation]. Forum des savoirs, Module Sciences et Avenir. Pourquoi prendre soin de ses reins ?, Liège, Belgium.

Pelaez, A., Dinic, M., Roche, F., Barthélémy, J., Alamartine, E., Cavalier, E., DELANAYE, P., Maillard, N., & Mariat, C. (October 2020). Cystatine C, inflammation et dysfonctionnement autonomique: un "ménage à trois" caché? [Poster presentation]. Société Française de Néphrologie (SFNDT), E-congrès, France.

DELANAYE, P. (October 2020). Estimating or measuring glomerular filtration rate in the critically ill patients for the determination of drug dosage [Paper presentation]. XVIII réunion de la société hellénique de biologie clinique et de biochimie, Athènes, Greece.

Cavalier, E., DELANAYE, P., & Delanghe, J. (Eds.). (2020). Bone markers and CKD-MBD. Elsevier.

DELANAYE, P. (2020). Kidney function. In K. Finkel, M. Perazella, ... E. Cohen, Onco-Nephrology. Philadelphia, United States: Elsevier. doi:10.1016/B978-0-323-54945-5.00010-2
Peer reviewed

DELANAYE, P., & Pottel, H. (2020). The authors reply [letter to the editor]. Kidney International Reports, 5 (10), 1843. doi:10.1016/j.ekir.2020.07.022
Peer Reviewed verified by ORBi

Glassock, R., DELANAYE, P., & Rule, A. (January 2020). Should the definition of CKD be changed to include age-adapted GFR criteria? YES. Kidney International, 97 (1), 34-37. doi:10.1016/j.kint.2019.08.033
Peer Reviewed verified by ORBi

Lambermont, B., Ernst, M., Demaret, P., Boccar, S., Gurdebeke, C., Cedric, V. B., Quinonez, M., Dubois, C., Lemineur, T., Njambou, T., Akando, B., Wertz, D., Higny, J., DELANAYE, P., & Misset, B. (2020). Predictors of Mortality and Effect of Drug Therapies in Mechanically Ventilated Patients With Coronavirus Disease 2019: A Multicenter Cohort Study. Critical Care Explorations, 2 (12), 0305. doi:10.1097/CCE.0000000000000305
Peer Reviewed verified by ORBi

ERPICUM, P., GROSCH, S., BOUQUEGNEAU, A., HUART, J., Résimont, G., BOVY, C., HABRAN, L., Delvenne, P., KRZESINSKI, J.-M., BURTEY, S., DELANAYE, P., & Jouret, F. (2020). Atteintes rénales de la COVID-19. Revue Médicale de Liège. Supplément, 75 (supplément 1), 109-S114.
Peer reviewed

DELANAYE, P., BOUQUEGNEAU, A., Moranne, O., & Cavalier, E. (2020). Comment estimer la filtration glomérulaire dans le contexte de l’adaptation posologique de médicaments ? Revue Médicale Suisse, 16 (703), 1489-1493.
Peer Reviewed verified by ORBi

CAVALIER, E., LUKAS, P., Warling, X., Moonen, M., Smelten, N., & DELANAYE, P. (2020). The percentage of non-oxidized PTH concentration remains stable over a period of 1 year in hemodialyzed patients. Clinica Chimica Acta, 506, 107-109. doi:10.1016/j.cca.2020.03.025
Peer Reviewed verified by ORBi

De Broe, M., & DELANAYE, P. (2020). How to interpret an estimated glomerular filtration rate (eGFR) in 2020? Kidney International, 98 (5), 1090-1092. doi:10.1016/j.kint.2020.07.015
Peer Reviewed verified by ORBi

Bjork, J., Nyman, U., DELANAYE, P., Grubb, A., Larsson, A., VRANKEN, L., Akesson, A., & Pottel, H. (2020). A novel method for creatinine adjustment makes the revised Lund-Malmö GFR estimating equation applicable in children. Scandinavian Journal of Clinical and Laboratory Investigation, 80 (6), 456-463. doi:10.1080/00365513.2020.1774641
Peer Reviewed verified by ORBi

Rule, A. D., Jager, K. J., Van Den Brand, J. A. J. G., & Delanaye, P. (2020). Authors' reply [letter to the editor]. Journal of the American Society of Nephrology, 31 (2), 448-449. doi:10.1681/ASN.2019111188

BOVY, C., DELANAYE, P., JOURET, F., & KRZESINSKI, J.-M. (2020). Nouveautés thérapeutiques en Néphrologie : 10 ans d'avancées. Revue Médicale de Liège, 75 (5-6), 336-343.
Peer reviewed

DELANAYE, P., Dubourg, L., Flamant, M., Yayo, E., Bukabau, J., Vidal-Petiot, E., Lemoine, S., CAVALIER, E., Schaeffner, E., Monnet, D., Sumaili, E., Ebert, N., & Pottel, H. (2020). Comparison of early-compartment correction equations for GFR measurements. Kidney International Reports, 5 (7), 1079-1081. doi:10.1016/j.ekir.2020.04.015
Peer Reviewed verified by ORBi

DELANAYE, P., & Pottel, H. (2020). Estimating glomerular filtration rate in African American individuals [letter to the editor]. JAMA Internal Medicine, 180 (11), 1549. doi:10.1001/jamainternmed.2020.2352
Peer Reviewed verified by ORBi

Bjork, J., Nyman, U., Courbebaisse, M., Couzi, L., Dalton, N., Dubourg, L., Ebert, N., Eriksen, B., Gaillard, F., Garrouste, C., Grubb, A., Hansson, M., Jacquemont, L., Jones, I., Kamar, N., Lamb, E., Legendre, C., Littmann, K., Mariat, C., ... Pottel, H. (2020). Prospects for improved glomerular filtration rate estimation based on creatinine-results from a transnational multicentre study. Clinical Kidney Journal, 13 (4), 674-683. doi:10.1093/ckj/sfaa039
Peer Reviewed verified by ORBi

DELANAYE, P., MEURISSE, N., WEEKERS, L., & KRZESINSKI, J.-M. (17 December 2019). Transplantation rénale à partir d’un donneur vivant: un bénéfice pour le receveur, au prix d’un risque mesuré pour le donneur [Paper presentation]. Enseignement Post-Universitaire, Liège, Belgium.

Agarwal, R., & DELANAYE, P. (December 2019). Glomerular filtration rate: when to measure and in which patients? Nephrology Dialysis Transplantation, 34 (12), 2001-2007. doi:10.1093/ndt/gfy363
Peer Reviewed verified by ORBi

De Maré, A., Verhulst, A., CAVALIER, E., DELANAYE, P., Behets, G. J., Meijers, B., Kuypers, D., D'Haese, P., & Evenepoel, P. (December 2019). Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease. Journal of Clinical Medicine, 8 (12), 2027. doi:10.3390/jcm8122027
Peer Reviewed verified by ORBi

DELANAYE, P. (2019). AVK et calcifications vasculaires (y compris la calciphylaxie) [Paper presentation]. MRC 2019 Anticoagulation en néphrologie, Mechelen, Belgium.

DELANAYE, P. (04 October 2019). Quoi de neuf en dialyse? [Paper presentation]. IV réunion de la société francophone de néphrologie dialyse et transplantation, Nancy, France.

DELANAYE, P., VRANKEN, L., Schoneveld, L., LAMBERMONT, B., & CAVALIER, E. (2019). Prévalence de l’atteinte rénale aigue chez le patient hospitalisé en fonction du critère de variation de la créatinine utilisée. Néphrologie et Thérapeutique.
Peer Reviewed verified by ORBi

DELANAYE, P., VRANKEN, L., Pottel, H., & CAVALIER, E. (2019). Impact du choix de l’équation basée sur la créatinine sur la classification de la maladie rénale chronique dans une base de données de laboratoire. Néphrologie et Thérapeutique.
Peer Reviewed verified by ORBi

Cavalier, E., Souberbielle, J.-C., & Delanaye, P. (2019). PTH determination in hemodialyzed patients—A laboratory perspective. Seminars in Dialysis. doi:10.1111/sdi.12844
Peer Reviewed verified by ORBi

Ion, V., Le Goff, C., Cavalier, E., Delanaye, P., Servais, A.-C., Muntean, D.-L., & Fillet, M. (August 2019). Determination of iohexol by capillary blood microsampling and UHPLC-MS/MS. Journal of Pharmaceutical Analysis, 9 (4), 259-265. doi:10.1016/j.jpha.2019.06.003
Peer Reviewed verified by ORBi

CASTIGLIONE, V., Pottel, H., Lieske, J. C., LUKAS, P., CAVALIER, E., DELANAYE, P., & Rule, A. (2019). Evaluation of inactive Matrix-Gla-Protein (MGP) as a biomarker for incident and recurrent kidney stones. Journal of Nephrology. doi:10.1007/s40620-019-00623-0
Peer Reviewed verified by ORBi

Senterre, Y., Fombellida, K., CAVALIER, E., PAQUOT, N., & DELANAYE, P. (May 2019). Are variations of glycated hemoglobin given by the freestyle device accurate? [Poster presentation]. XXIII IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, Barcelone, Spain.

Gaillard, F., Courbebaisse, M., Kamar, N., Rostaing, L., Jacquemont, L., Hourmant, M., Del Bello, A., Couzi, L., Merville, P., Malvezzi, P., Janbon, B., Moulin, B., Maillard, N., Dubourg, L., Lemoine, S., Garrouste, C., Pottel, H., Legendre, C., DELANAYE, P., & Mariat, C. (April 2019). Impact of estimation versus direct measurement of predonation glomerular filtration rate on the eligibility of potential living kidney donors. Kidney International, 95 (4), 896-904. doi:10.1016/j.kint.2018.11.029
Peer Reviewed verified by ORBi

DELANAYE, P., Bataille, S., Quinonez, K., Buckinx, F., Warling, X., KRZESINSKI, J.-M., Pottel, H., Burtey, S., Bruyère, O., & CAVALIER, E. (25 January 2019). Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis. Journal of Renal Nutrition, 29 (6), 511-520. doi:10.1053/j.jrn.2018.11.010
Peer Reviewed verified by ORBi

masson, G., VRANKEN, L., KRZESINSKI, J.-M., Pottel, H., CAVALIER, E., & DELANAYE, P. (2019). Impact of the creatinine-based equations used on the chronic kidney disease classification in a large laboratory database. Nephrology Dialysis Transplantation.
Peer Reviewed verified by ORBi

Delanaye, P., Bataille, P., Quinonez, K., Buckinx, F., Warling, X., KRZESINSKI, J.-M., Pottel, H., Burtey, S., Bruyère, O., & CAVALIER, E. (2019). Myostatin and insulin growth factor 1 are biomarkers of muscle strength, muscle mass, and mortality in hemodialysis patients. Osteoporosis International, 30 (S2), 270.
Peer Reviewed verified by ORBi

Pottel, H., Björk, J., Bökenkamp, A., Berg, U., Asling-Monemi, K., Selistre, L., Dubourg, L., Hansson, M., Littmann, K., Jones, I., Sjöström, P., Nyman, U., & DELANAYE, P. (2019). Estimating glomerular filtration rate at the transition from pediatric to adult care. Kidney International, 95 (5), 1234-1243. doi:10.1016/j.kint.2018.12.020
Peer Reviewed verified by ORBi

STOJKOVIC, V., Delanaye, P., COLLARD, G., FERRANTE, N., Le Goff, C., Lutteri, L., & Cavalier, E. (2019). Estimated glomerular filtration rate using a point of care measure of creatinine in patients with iohexol determinate GFR. Clinica Chimica Acta, 499, 123-127. doi:10.1016/j.cca.2019.08.032
Peer Reviewed verified by ORBi

Bukabau, J., Yayo, E., Gnionsahé, A., Monnet, D., Pottel, H., CAVALIER, E., Nkodila, A., Makula, Mokoli, V., Lepira, F., Nseka, M., KRZESINSKI, J.-M., Sumaili, E., & DELANAYE, P. (2019). Performance of creatinine- or cystatin C-based equations to estimate glomerular filtration rate in sub-Saharan African populations. Kidney International, 95 (5), 1181-1189. doi:10.1016/j.kint.2018.11.045
Peer Reviewed verified by ORBi

DELANAYE, P., & SCHEEN, A. (2019). Preventing and treating kidney disease in patients with type 2 diabetes. Expert Opinion on Pharmacotherapy, 20 (3), 277-294. doi:10.1080/14656566.2018.1551362
Peer Reviewed verified by ORBi

Björk, J., Nyman, U., Berg, U., Delanaye, P., Dubourg, L., Goffin, K., Grubb, A., Hansson, M., Littmann, K., Åsling-Monemi, K., Bökenkamp, A., & Pottel, H. (2019). Validation of standardized creatinine and cystatin C GFR estimating equations in a large multicentre European cohort of children. Pediatric Nephrology, 34 (6), 1087-1098. doi:10.1007/s00467-018-4185-y
Peer Reviewed verified by ORBi

DELANAYE, P. (2019). Too much nephrology? The CKD epidemic is real and concerning. A CON view. Nephrology Dialysis Transplantation, 34 (4), 581-584. doi:10.1093/ndt/gfy331
Peer Reviewed verified by ORBi

DELANAYE, P., Jager, K., Bokenkamp, A., Christensson, A., Dubourg, L., Eriksen, B., Gaillard, F., Gambaro, G., van der Giet, M., Glassock, R., Indridason, O., van Londen, M., Mariat, C., Melsom, T., Moranne, O., Nordin, G., Palsson, R., Pottel, H., Rule, A., ... van den Brand, J. (2019). Chronic Kidney Disease: call for an age-adapted definition. Journal of the American Society of Nephrology, 30 (10), 1785-1805. doi:10.1681/ASN.2019030238
Peer Reviewed verified by ORBi

DELANAYE, P., KRZESINSKI, F., DUBOIS, B., LANCELLOTTI, P., & KRZESINSKI, J.-M. (2019). Modification of potassium in dialysate: impact on per-dialytic plasma potassium concentrations and electrocardiograms. Nephrology Dialysis Transplantation.
Peer Reviewed verified by ORBi

Cavalier, E., Sagou Yayo, E., Attoungbre-Hauhouot, M.-L., Konan, J.-L., Yao-Yapo, C., Monnet, D., Gnionsahe, A., Souberbielle, J.-C., & DELANAYE, P. (2019). Vitamin D, bone alkaline phosphatase and parathyroid hormone in healthy subjects and haemodialysed patients from West Africa: impact of reference ranges and parathyroid hormone generation assays on the KDIGO guidelines. Clinical Kidney Journal, 12 (2), 288-293. doi:10.1093/ckj/sfy074
Peer Reviewed verified by ORBi

Pallet, N., Bastard, J., Claeyssens, S., Fellahi, S., DELANAYE, P., Piéroni, L., & Causse, E. (2019). Typage des protéinuries : comment, pourquoi et pour qui ? Annales de Biologie Clinique, 77 (1), 13-25. doi:10.1684/abc.2018.1401
Peer Reviewed verified by ORBi

BOUQUEGNEAU, A., Evenepoel, P., PAQUOT, F., MALAISE, O., CAVALIER, E., & DELANAYE, P. (2019). Sclerostin within the chronic kidney disease spectrum. Clinica Chimica Acta, 502, 84-90. doi:10.1016/j.cca.2019.12.008
Peer Reviewed verified by ORBi

DELANAYE, P., & Pottel, H. (2019). New equation to estimate glomerular filtration rate in China: a reference issue [letter to the editor]. Kidney International, 96 (2), 521. doi:10.1016/j.kint.2019.02.044
Peer Reviewed verified by ORBi

DELANAYE, P. (2019). Which method to measure GFR and in which clinical conditions? [Paper presentation]. LVI Congress of ERA-EDTA, Budapest, Hungary.

Castiglione, V., DELANAYE, P., LUKAS, P., & CAVALIER, E. (19 October 2018). Matrix-Gla-Protein: un nouveau marqueur de lithiase urinaire? [Paper presentation]. 23e Confrontations Clinico-Biologiques sur la Lithiase Urinaire, Paris, France.

DELANAYE, P. (2018). Nephrology and Clinical Chemistry: friends for life! In P. DELANAYE, Nephrology and Clinical Chemistry (pp. 1-3). AME Publiqhing Company.
Peer reviewed

DELANAYE, P. (Ed.). (2018). Nephrology and Clinical Chemistry. AME Publishing Company.

Résimont, G., GADISSEUR, R., LUTTERI, L., KRZESINSKI, J.-M., CAVALIER, E., & DELANAYE, P. (October 2018). Comment j'explore...Une protéinurie. Revue Médicale de Liège, 73 (10), 519-525.
Peer reviewed

Yayo, E., Aye, M., Yao, C., Gnionsahe, A., Attoungbre, M.-L., Cavalier, E., Pottel, H., Monnet, D., & DELANAYE, P. (July 2018). Measured (and estimated) glomerular filtration rate: reference values in West Africa. Nephrology Dialysis Transplantation, 33 (7), 1176-1180. doi:10.1093/ndt/gfx244
Peer Reviewed verified by ORBi

DELANAYE, P. (06 June 2018). Comment apprécier et suivre la MRC chez l’enfant et le sujet âgé [Paper presentation]. Prise en charge précoce de la maladie rénale chronique, « Optimiser les périodes de transition au cours de l’IRC », Montpelllier, France.

DELANAYE, P. (27 May 2018). Controvery: Too much nephrology? The CKD epidemics is overstated [Paper presentation]. LV Congress of ERA-EDTA, Copenhagen, Denmark.

VALDES SOCIN, H. G., BETEA, D., Daly, A., DELANAYE, P., Souberbielle, J.-C., Beckers, A., & CAVALIER, E. (May 2018). hCG as a diagnostic test to differentiate between parathyroid carcinoma, primary benign hyperparathyroidism and secondary hyperparathyroidism [Poster presentation]. 20th European Congress of Endocrinology.

Cavalier, E., Salse, M., Dupuy, A.-M., Bargnoux, A.-S., WATAR, F., Souberbielle, J.-C., DELANAYE, P., & Cristol, J.-P. (April 2018). Establishment of reference values in a healthy population and interpretation of serum PTH concentrations in hemodialyzed patients according to the KDIGO Guidelines using the Lumipulse(R) G whole PTH (3rd generation) assay. Clinical Biochemistry, 54, 119-122. doi:10.1016/j.clinbiochem.2018.02.019
Peer Reviewed verified by ORBi

DELANAYE, P. (April 2018). Estimation et mesure du débit de filtration glomérulaire : en quête de précision. Néphrologie et Thérapeutique, 14 (Suppl 1), 59-S66. doi:10.1016/j.nephro.2018.02.005
Peer Reviewed verified by ORBi

DELANAYE, P. (22 March 2018). Formules d’estimation de la fonction rénale : Quand ça marche ? Quand ça ne marche pas ? [Paper presentation]. 7ème Congrès Maghrébin de Néphrologie, Marrakech, Morocco.

DELANAYE, P. (23 February 2018). Rein du sujet âgé [Paper presentation]. 3ème congrès de la Société Sénégalaise de Néphrologie, Dakar, Senegal.

DELANAYE, P. (23 February 2018). Vascularites à ANCA [Paper presentation]. 3ème congrès de la Société Sénégalaise de Néphrologie. Programmes FMC Glomérulopathies, Dakar, Senegal.

DELANAYE, P. (2018). Measurement and estimation of renal function [Paper presentation]. Actualités néphrologiques Jean Haburger, Hôpital Necker, Paris, France.

Delay, A., Moranne, O., Maillard, N., Alamartine, E., DELANAYE, P., & Mariat, C. (2018). Can early decline in estimated or measured GFR be used as a surrogate for a long-term renal transplant outcome? [Poster presentation]. LV Congress of ERA-EDTA, Copenhagen, Denmark.

Dinic, M., Maillard, N., DELANAYE, P., KRZESINSKI, J.-M., SAINT-REMY, A., CAVALIER, E., & Mariat, C. (2018). Association between matrix gla protein and aortic stiffness in kidney transplantation [Poster presentation]. LV Congress of ERA-EDTA, Copenhagen, Denmark.

Bataille, Y., Costerousse, O., Bertrand, O. F., Moranne, O., Pottel, H., & DELANAYE, P. (2018). One-year mortality of patients with ST-Elevation myocardial infarction: Prognostic impact of creatinine-based equations to estimate glomerular filtration rate. PLoS ONE, 13 (7), 0199773. doi:10.1371/journal.pone.0199773
Peer Reviewed verified by ORBi

Bukabau, J., Gnionsahé, A., Monnet, D., Pottel, H., CAVALIER, E., Makulo, J., Nseka, Sumaili, E., DELANAYE, P., & Yayo, E. (2018). Performance des équations basées sur la créatinine ou la cystatine C en Afrique sub-saharienne : intérêt de l’équation « Full Age Spectrum ». Néphrologie et Thérapeutique, 14 (5), 14.
Peer Reviewed verified by ORBi

Buckinx, F., Bruyère, O., Reginster, J.-Y., Charles, A., DELANAYE, P., & CAVALIER, E. (2018). Plasma Klotho and Mortality Risk Among Nursing Home Residents: Results From the SENIOR Cohort [letter to the editor]. Journal of the American Medical Directors Association, 19 (12), 1139-1140. doi:10.1016/j.jamda.2018.08.010
Peer Reviewed verified by ORBi

Bargnoux, A.-S., Kuster, N., CAVALIER, E., Piéroni, L., Souweine, J.-S., DELANAYE, P., & Cristol, J.-P. (2018). Serum creatinine: advantages and pitfalls. Journal of Laboratory and Precision Medicine. doi:10.21037/jlpm.2018.08.01

PAQUOT, F., DELANAYE, P., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Maillard, N., Pottel, H., Evenepoel, P., & CAVALIER, E. (2018). Variations of sclerostin with other bone biomarkers over a one-year period in hemodialysis patients [letter to the editor]. Clinica Chimica Acta, 486, 183-184. doi:10.1016/j.cca.2018.08.003
Peer Reviewed verified by ORBi

Résimont, G., GADISSEUR, R., DUBOIS, B., KRZESINSKI, J.-M., CAVALIER, E., & DELANAYE, P. (2018). Bandelette urinaire positive pour une recherche de protéinurie : correspondance avec un résultat quantitatif sur échantillon [Poster presentation]. III congrès de la Société francophone de néphrologie dialyse et transplantation, Lille, France.

Bataille, S., QUINONEZ, K., Buckinx, F., Warling, X., KRZESINSKI, J.-M., Pottel, H., Burtey, S., Bruyère, O., CAVALIER, E., & DELANAYE, P. (2018). La myostatine et l’IGF1 sont de bons biomarqueurs de la force musculaire chez les patients hémodialysés chroniques. Néphrologie et Thérapeutique, 14 (5), 4.
Peer Reviewed verified by ORBi

Bukabau, J., Sumaili, E., CAVALIER, E., Pottel, H., Kifakiou, B., Nkodila, A., Makulo, J., Mokoli, V., Zinga, C., Longo, A., Engole, Y., Nlandu, Y., Lepira, F., Nseka, N., KRZESINSKI, J.-M., & DELANAYE, P. (2018). Performance of glomerular filtration rate estimation equations in Congolese healthy adults: the inopportunity of the ethnic correction. PLoS ONE, 13 (3), 0193384. doi:10.1371/journal.pone.0193384
Peer Reviewed verified by ORBi

Bataille, S., QUINONEZ, K., KRZESINSKI, J.-M., Burtey, S., & DELANAYE, P. (2018). Myostatin: a new biomarker of muscle strength in hemodialysis patients [Poster presentation]. LV Congress of ERA-EDTA, Copenhagen, Denmark.

Flamant, M., DELANAYE, P., Pottel, H., Vidal-Petiot, E., Lemoine, S., CAVALIER, E., Schaeffner, E., Ebert, N., & Dubourg, L. (2018). Mesure du débit de filtration glomérulaire par prélèvement plasmatique unique : impact des différentes modelisations mathématiques [Poster presentation]. III congrès de la Société francophone de néphrologie dialyse et transplantation, Lille, France.

DELANAYE, P., KRZESINSKI, F., DUBOIS, B., DELCOUR, A., KRZESINSKI, J.-M., & LANCELLOTTI, P. (2018). Modification du potassium dans le bain de dialyse: impact sur les kaliémies per-dialytiques et les données electrocardiographiques [Poster presentation]. III congrès de la Société francophone de néphrologie dialyse et transplantation, Lille, France.

Gaillard, F., Courbebaisse, M., Kamar, N., Rostaing, L., Girerd, S., Flamant, M., Vidal-Petiot, E., Couzi, L., Malvezzi, P., Peraldi, M., Moulin, B., Gatault, P., Maillard, N., Dubourg, L., Garrouste, C., Legendre, C., DELANAYE, P., & Mariat, C. (2018). The impact of GFR evaluation technique on living kidney donation eligibility. Nephrology Dialysis Transplantation. doi:10.1093/ndt/gfy104.FO048
Peer Reviewed verified by ORBi

Gaillard, F., Courbebaisse, M., Kamar, M., Rostaing, L., Girerd, S., Flamant, M., Vidal-Petiot, E., Couzi, L., Malvezzi, P., Peraldi, M., Moulin B, Gatault, P., Dubourg, L., Garrouste, C., Legendre, C., DELANAYE, P., & Mariat, C. (2018). The impact of age on acceptable measured GFR for living kidney donation [Poster presentation]. LV Congress of ERA-EDTA, Copenhagen, Denmark.

Gaillard, F., Courbebaisse, M., Kamar, N., Rostaing, L., Del Bello, A., Girerd, S., Kessler, M., Flamant, M., Vidal-Petiot, E., Peraldi, M., Couzi, L., Merville, P., Malvezzi, P., Janbon, B., Moulin, B., Caillard, S., Gatault, P., BÜchler, M., Maillard, N., ... Mariat, C. (2018). THe age-calibrated measured glomerular filtration rate improves living kidney donation selection process. Kidney International, 94 (3), 616-624. doi:10.1016/j.kint.2018.05.016
Peer Reviewed verified by ORBi

Gaillard, F., Courbebaisse, M., Kamar, N., Rostaing, L., Girerd, S., Flamant, M., Moulin, B., Legendre, C., DELANAYE, P., & Mariat, C. (2018). Impact de la technique d’évaluation du DFG sur l’éligibilité au don des donneurs vivants de rein. Néphrologie et Thérapeutique, 14 (5), 4.
Peer Reviewed verified by ORBi

DELANAYE, P., Résimont, G., Bigot-Corbel, E., & CAVALIER, E. (2018). Protéinuries et bandelettes urinaires : une technique simple d’interprétation compliquée. Annales de Biologie Clinique, 76 (6), 617-626. doi:10.1684/abc.2018.1388
Peer Reviewed verified by ORBi

DELANAYE, P., QUINONEZ, K., Buckinx, F., KRZESINSKI, J.-M., & Bruyère, O. (2018). Hand grip strength measurement in haemodialysis patients: before or after the session? Clinical Kidney Journal, 11 (4), 555-558. doi:10.1093/ckj/sfx139
Peer Reviewed verified by ORBi

DELANAYE, P., Flamant, M., Dubourg, L., Vidal-Petiot, E., Lemoine, S., Cavalier, E., Schaeffner, E., Ebert, N., & Pottel, H. (2018). Single- versus multiple-sample method to measure glomerular filtration rate. Nephrology Dialysis Transplantation, 33 (10), 1778-1785. doi:10.1093/ndt/gfx345
Peer Reviewed verified by ORBi

Pottel, H., Dubourg, L., Goffin, K., & DELANAYE, P. (2018). Alternatives for the bedside Schwartz equation to estimate glomerular filtration rate in children. Advances in Chronic Kidney Disease, 25 (1), 57-66. doi:10.1053/j.ackd.2017.10.002
Peer Reviewed verified by ORBi

DELANAYE, P., PAQUOT, F., BOUQUEGNEAU, A., Blocki, F., Krzesinski, J.-M., Evenepoel, P., Pottel, H., & Cavalier, E. (2018). Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know. Nephrology Dialysis Transplantation, 33 (8), 1404-1410. doi:10.1093/ndt/gfx282
Peer Reviewed verified by ORBi

Gaillard, F., Courbebaisse, M., Kamar, N., Couzi, L., Gatault, P., Dubourg, L., Moulin, B., Legendre, C., DELANAYE, P., & Mariat, C. (2018). Impact de l’âge sur le niveau de DFG mesuré acceptable pour le don vivant de rein. Néphrologie et Thérapeutique, 14 (5), 05.
Peer Reviewed verified by ORBi

Mariat, C., DELANAYE, P., Bastard, J.-P., Résimont, G., CAVALIER, E., & Piéroni, L. (2018). Expression des résultats d’une protéinurie : le ratio protéines ou albumine sur créatinine urinaire. Annales de Biologie Clinique, 76 (6), 643-650. doi:10.1684/abc.2018.1394
Peer Reviewed verified by ORBi

CAVALIER, E., Salsé, M., Dupuy, A.-M., Bargnoux, A.-S., Souberbielle, J.-C., DELANAYE, P., & Cristol, J.-P. (2018). Lumipulse W-PTH 3rd generation assay: reference values in healthy population and classification of secondary hyperparathyroidism in CKD. Nephrology, Dialysis and Transplantation.

DELANAYE, P., Pottel, H., Flamant, M., Vidal-Petiot, E., Lemoine, S., CAVALIER, E., Schaeffner, E., Ebert, N., & Dubourg, L. (2018). Measurement of glomerular filtration rate by plasma iohexol clearance with different single-sample methods [Poster presentation]. LV Congress of ERA-EDTA, Copenhagen, Denmark.

DELANAYE, P., Bataille, Y., Costerousse, O., Bertrand, O., & Pottel, H. (2018). One-year mortality of patients with ST-elevation myocardial infarction: prognostic impact of creatinine-based equations to estimate glomerular filtration rate [Poster presentation]. LV Congress of ERA-EDTA, Copenhagen, Denmark.

Yayo, E., Bukabau, J., Gnionsahé, A., Monnet, D., Pottel, H., CAVALIER, E., Sumaili, E., DELANAYE, P., & Nseka, N. (2018). Mesure du DFG en population africaine par la clairance plasmatique de l’iohexol : comparaison des méthodes à prélèvement unique et prélèvements multiples [Poster presentation]. III congrès de la Société francophone de néphrologie dialyse et transplantation, Lille, France.

DELANAYE, P. (14 December 2017). The concept of frailty in patients on dialysis [Paper presentation]. State of the Art: clinical issues in dialysis treatment, Vilvoorde, Belgium.

DELANAYE, P. (07 December 2017). Estimation du débit de filtration glomérulaire [Paper presentation]. Soirées de biologie clinique du LHUB-ULB.

VALDES SOCIN, H. G., BETEA, D., Daly, A., DELANAYE, P., Souberbielle, J.-C., Beckers, A., & Cavalier, E. (December 2017). Paranéoplasic secretion in Parathyroid carcinoma : serum hCG as a tumor marker [Paper presentation]. Annual Congress of the Belgian Society of Internal Medicine, La hulpe, Belgium.

VALDES SOCIN, H. G., BETEA, D., Daly, A., DELANAYE, P., souberbielle, J.-C., BECKERS, A., & CAVALIER, E. (December 2017). Paraneoplastic secretion in parathyroid carcinoma: serum hCG as a tumor marker. Acta Clinica Belgica, 72 (2), 5.
Peer Reviewed verified by ORBi

DELANAYE, P. (24 November 2017). Débit de filtration glomérulaire : estimations et mesures [Paper presentation]. Conférences de Médecine, Centre Hospitalier Universitaire Brugmann, Service de Médecine.

Neuville, M., DELANAYE, P., & Jouret, F. (12 October 2017). Les patients polykystiques en hémodialyse chronique présentent une altération de la perception de soif [Poster presentation]. 2ème Congrès de la SFNDT, Nice, France.

DELANAYE, P. (13 June 2017). Acute renal failure: definition and detection [Paper presentation]. XXI IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, Athènes, Greece.

DELANAYE, P. (13 June 2017). GFR and drug dosage adaptation: are we still in the mist? [Paper presentation]. XXII IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, Athènes, Greece.

DELANAYE, P. (10 June 2017). Bone Markers and Vascular Calcification in CKD-MBD [Paper presentation]. Metabolic Bone Disease Satellite Meeting Euromedlab 2017, Athènes, Greece.

Neuville, M., JACQUES, J., DELANAYE, P., & Jouret, F. (04 June 2017). Patients with autosomal dominant polycystic kidney disease under chronic hemodialysis display thirst disturbance [Poster presentation]. 54th congress ERA-EDTA, Madrid, Spain.

Gagneux-Brunon, A., Bothelo-Nevers, E., DELANAYE, P., Lucht, F., Frésard, A., Cazorla, C., Guglielminotti, C., Fafin, C., Mariat, C., & Moranne, O. (June 2017). CKD-EPI equation: a suitable glomerular filtration rate estimate for drug dosing in HIV-infected patients. Médecine et Maladies Infectieuses, 47 (4), 266-270. doi:10.1016/j.medmal.2017.04.001
Peer Reviewed verified by ORBi

DELANAYE, P., Glassock, R., & De Broe, M. (June 2017). Epidemiology of chronic kidney disease: think (at least) twice! NDT Plus, 10 (3), 370-374.
Peer Reviewed verified by ORBi

Pottel, H., Dubourg, L., Schaeffner, E., Eriksen, B., Melsom, T., Lamb, E., Rule, A., Turner, S., Glassock, R., De Souza, V., Selistre, L., Goffin, K., Pauwels, S., Mariat, C., Flamant, M., Bevc, S., DELANAYE, P., & Ebert, N. (June 2017). The diagnostic value of rescaled renal biomarker serum creatinine and serum cystatin C and their relation with measured glomerular filtration rate. Clinica Chimica Acta, 471, 164-170. doi:10.1016/j.cca.2017.06.005
Peer Reviewed verified by ORBi

QUINONEZ, K., Buckinx, F., KRZESINSKI, J.-M., DELANAYE, P., & Bruyère, O. (18 March 2017). Mesure de la force de préhension chez le patient hémodialysé : quand l’effectuer ? [Paper presentation]. V congrès francophone Fragilité du sujet âgé & Prévention de la perte d’autonomie. Rencontres scientifiques sur la sarcopénie, Paris, France.

DELANAYE, P. (14 March 2017). Evaluation de la fonction rénale [Paper presentation]. AFRAN 2017, Yaoundé, Cameroon.

DELANAYE, P. (2017). Measuring and estimating GFR [Paper presentation]. GLEM Leuven, Leuven, Belgium.

Cavalier, E., LUKAS, P., BEKAERT, A.-C., CARLISI, I., Le Goff, C., DELANAYE, P., & Souberbielle, J.-C. (March 2017). Analytical and clinical validation of the new Abbot Architect 25(OH)D assay: fit for purpose? Clinical Chemistry and Laboratory Medicine, 55 (3), 378-384. doi:10.1515/cclm-2016-0566
Peer Reviewed verified by ORBi

CAVALIER, E., Reginster, J.-Y., & DELANAYE, P. (March 2017). Impact of the renal function on sclerostin determination: illustration with four different ELISA methods in patients undergoing GFR determination with Iohexol. Osteoporosis International, 28 Suppl 1, 629.
Peer Reviewed verified by ORBi

Pottel, H., Hoste, L., Yayo, E., & DELANAYE, P. (February 2017). Glomerular filtration rate in healthy living potential kidney donors: a meta-analysis supporting the construction of the the Full Age Spectrum equation. Nephron journals, 135 (2), 105-119. doi:10.1159/000450893
Peer Reviewed verified by ORBi

DELANAYE, P., Guerber, F., SCHEEN, A., Ellam, T., BOUQUEGNEAU, A., Guergour, D., Mariat, C., & Pottel, H. (February 2017). Discrepancies between the Cockcroft–Gault and Chronic Kidney Disease Epidemiology (CKD-EPI) Equations: Implications for Refining Drug Dosage Adjustment Strategies. Clinical Pharmacokinetics, 56 (2), 193-205. doi:10.1007/s40262-016-0434-z
Peer Reviewed verified by ORBi

Gregoire, E., Claisse, G., GUIOT, J., MORIMONT, P., KRZESINSKI, J.-M., Mariat, C., LAMBERMONT, B., CAVALIER, E., & DELANAYE, P. (13 January 2017). The added value of plasma or urinary NGAL concentrations in clinical practice [Poster presentation]. Reanimation 2017, Paris, France.

Glassock, R., Warnock, D., & DELANAYE, P. (2017). The global burden of chronic kidney disease: estimates, variability and pitfalls. Nature Reviews Nephrology, 13 (2), 104-114. doi:10.1038/nrneph.2016.163
Peer Reviewed verified by ORBi

yayo, E., Yao-Papo, E., Gnionsahé, A., Monnet, D., Pottel, H., CAVALIER, E., & DELANAYE, P. (2017). DFG en population saine africaine : comparaison des performances de 11 équations d’estimation à marquer unique ou combinés, avec et sans facteur ethnique. Néphrologie et Thérapeutique, 13 (5), 277.
Peer Reviewed verified by ORBi

DELANAYE, P., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Maillard, N., Pottel, H., & CAVALIER, E. (2017). Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients. Scientific Reports, 7 (1), 12623. doi:10.1038/s41598-017-12808-3
Peer Reviewed verified by ORBi

Pottel, H., DELANAYE, P., WEEKERS, L., Selistre, L., Goffin, K., Gheysens, O., & Dubourg, L. (2017). Age-dependent reference intervals for estimated and measured glomerular filtration rate. NDT Plus, 10 (4), 545-551.
Peer Reviewed verified by ORBi

Souberbielle, J.-C., Prie, D., Piketty, M.-L., Rothenbuhler, A., DELANAYE, P., Chanson, P., & Cavalier, E. (2017). Evaluation of a New Fully Automated Assay for Plasma Intact FGF23. Calcified Tissue International, 101 (5), 510-518. doi:10.1007/s00223-017-0307-y
Peer Reviewed verified by ORBi

QUINONEZ, K., Buckinx, F., KRZESINSKI, J.-M., Bruyère, O., & DELANAYE, P. (2017). Concept de fragilité chez le patient hémodialysé. Néphrologie et Thérapeutique, 13 (5), 296.
Peer Reviewed verified by ORBi

Flamant, M., Vidal-Petiot, E., Dubourg, L., Ebert, N., Lemoine, S., Schaeffner, E., Pottel, H., Cavalier, E., & DELANAYE, P. (2017). Mesure du débit de filtration glomérulaire par clairance plasmatique : comparaison d’une procédure à prélèvements multiples et à prélèvement unique [Poster presentation]. Deuxième congrès de la Société francophone de néphrologie, dialyse et transplantation (SFNDT), Nice, France.

DELANAYE, P., BOUQUEGNEAU, A., DUBOIS, B., SPRYNGER, M., Mariat, C., KRZESINSKI, J.-M., & Lancellotti, P. (2017). Fibrillation auriculaire et anticoagulation chez le patient hémodialysé : une décision difficile. Néphrologie et Thérapeutique. doi:10.1016/j.nephro.2016.09.002
Peer Reviewed verified by ORBi

Fusaro, M., Gallieni, M., Rizzo, M., Stucchi, A., DELANAYE, P., CAVALIER, E., Moyses, R., Jorgetti, V., Iervasi, G., Giannini, S., Fabris, F., Aghi, A., Sella, S., Galli, F., Viola, V., & Plebani, M. (2017). Vitamin K plasma levels determination in human health. Clinical Chemistry and Laboratory Medicine, 55 (6), 789-799. doi:10.1515/cclm-2016-0783
Peer Reviewed verified by ORBi

Bargnoux, A.-S., Pieroni, L., Cristol, J.-P., Kuster, N., DELANAYE, P., Carlier, M.-C., Fellahi, S., Boutten, A., Lombard, C., Gonzalez-Antuna, A., Delatour, V., & Cavalier, E. (2017). Multicenter Evaluation of Cystatin C Measurement after Assay Standardization. Clinical Chemistry, 63 (4), 833-841. doi:10.1373/clinchem.2016.264325
Peer Reviewed verified by ORBi

SCHLECK, M.-L., Souberbielle, J.-C., DELANAYE, P., Plebani, M., & Cavalier, E. (2017). Parathormone stability in hemodialyzed patients and healthy subjects: comparison on non-centrifuged EDTA and serum samples with second- and third-generation assays. Clinical Chemistry and Laboratory Medicine, 55 (8), 1152-1159. doi:10.1515/cclm-2016-0914
Peer Reviewed verified by ORBi

DELANAYE, P., QUINONEZ, K., Buckinx, F., Bruyère, O., & CAVALIER, E. (2017). Intérêt de nouveaux marqueurs biologiques dans l’évaluation de la sarcopénie en dialyse. Néphrologie et Thérapeutique, 13 (5), 269.
Peer Reviewed verified by ORBi

Ebert, N., Schaeffner, E., Pottel, H., CAVALIER, E., Dubourg, L., Flamant, M., & DELANAYE, P. (2017). Measuring Plasma Clearance for Exact Assessment of GFR: Multi versus Single Sampling [Poster presentation]. Renal Week, New Orleans, United States - Louisiana.

Maillard, N., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Pottel, H., CAVALIER, E., & DELANAYE, P. (2017). Les pentes d’évolution des CTX, de la phosphatase alkaline osseuse et du P1NP sont associées à celles de la PTH en hémodialyse chronique [Poster presentation]. Deuxième congrès de la Société francophone de néphrologie, dialyse et transplantation (SFNDT), Nice, France.

DELANAYE, P., Ebert, N., & Pottel, H. (2017). Newer GFR Estimating Equations Require Validation in Different Populations [letter to the editor]. American Journal of Kidney Diseases, 70 (4), 586. doi:10.1053/j.ajkd.2017.06.016
Peer Reviewed verified by ORBi

Gielen, E., Bergmann, P., Bruyère, O., Cavalier, E., DELANAYE, P., Goemaere, S., Kaufman, J.-M., Locquet, M., Reginster, J.-Y., Rozenberg, S., Vandenbroucke, A.-M., & Body, J.-J. (2017). Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone Club. Calcified Tissue International, 101 (2), 111-31. doi:10.1007/s00223-017-0266-3
Peer Reviewed verified by ORBi

WEEKERS, L., VANDERWECKENE, P., pottel, H., Castanares-Zapatero, D., BONVOISIN, C., HAMOIR, E., MAWEJA, S., Krzesinski, J.-M., DELANAYE, P., & Jouret, F. (2017). The closure of arteriovenous fistula in kidney transplant recipients is associated with an acceleration of kidney function decline. Nephrology Dialysis Transplantation. doi:10.1093/ndt/gfw351
Peer Reviewed verified by ORBi

Warnock, D., DELANAYE, P., & Glassock, R. (2017). Risks for All-Cause Mortality: Stratified by Age, Estimated Glomerular Filtration Rate and Albuminuria. Nephron journals, 136 (4), 292-297. doi:10.1159/000455197
Peer Reviewed verified by ORBi

Scheen, A., & DELANAYE, P. (2017). Effects of reducing blood pressure on renal outcomes in patients with type 2 diabetes: Focus on SGLT2 inhibitors and EMPA-REG OUTCOME. Diabetes and Metabolism, (epub ahead of print). doi:10.1016/j.diabet.2016.12.010
Peer Reviewed verified by ORBi

Scheen, A., & DELANAYE, P. (2017). Renal outcomes with dipeptidyl peptidase-4 inhibitors. Diabetes and Metabolism, 44 (2), 101-111. doi:10.1016/j.diabet.2017.07.011
Peer Reviewed verified by ORBi

DELANAYE, P., QUINONEZ, K., Buckinx, F., KRZESINSKI, J.-M., & Bruyère, O. (2017). Mesure de la force de préhension chez le patient dialysé: quand l'effectuer? Néphrologie et Thérapeutique, 13 (5), 296.
Peer Reviewed verified by ORBi

Dinic, M., Maillard, N., DELANAYE, P., KRZESINSKI, J.-M., SAINT-REMY, A., CAVALIER, E., & Mariat, C. (2017). Association entre les taux circulants de matrix-gla protein et rigidité artérielle en transplantation rénale. Néphrologie et Thérapeutique, 13 (5), 309.
Peer Reviewed verified by ORBi

Cavalier, E., Torres, P. U., DUBOIS, B., Smelten, N., Pottel, H., Krzesinski, J.-M., & DELANAYE, P. (2017). Impact of the type of dialysis membranes on the circulating concentration of markers of vitamin D metabolism. International Journal of Artificial Organs, 0. doi:10.5301/ijao.5000565
Peer Reviewed verified by ORBi

Bukabau, J., Sumaili, E., CAVALIER, E., Kayembe, P., Makulo, J., Mokoli, V., Kifakiou, B., Nkodila, A., Engole, Y., Lepira, F., Nseka, N., & DELANAYE, P. (2017). Performance des équations d’estimation du débit de filtration glomérulaire chez l’adulte sain en Afrique centrale (Congo Kinshasa) [Poster presentation]. Deuxième congrès de la Société francophone de néphrologie, dialyse et transplantation (SFNDT), Nice, France.

Pottel, H., Bataille, Y., Moranne, O., Bertrand, O., Costerousse, O., & DELANAYE, P. (2017). Impact pronostique d’une maladie rénale chronique lors de l’infacrtus aigu du myocarde : valeur prédictive de différentes équations basées sur la créatinine [Poster presentation]. Deuxième congrès de la Société francophone de néphrologie, dialyse et transplantation (SFNDT), Nice, France.

DELANAYE, P., Cavalier, E., & Pottel, H. (2017). Serum Creatinine: Not So Simple! Nephron journals, 136 (4), 302-308. doi:10.1159/000469669
Peer Reviewed verified by ORBi

Piéroni, L., Bargnoux, A., Cristol, J., CAVALIER, E., & DELANAYE, P. (2017). Did creatinine standardization give benefits to the evaluation of glomerular filtration rate? eJIFCC: Electronic journal of the International Federation of Clinical Chemistry and Laboratory Medicine, 28 (4), 251-257.
Peer Reviewed verified by ORBi

Dinic, M., Maillard, N., DELANAYE, P., KRZESINSKI, J.-M., SAINT-REMY, A., CAVALIER, E., & Mariat, C. (December 2016). Association entre taux circulants de matrix-gla protéine et rigidité artérielle en transplantation rénale [Paper presentation]. XVI réunion annuelle de la Société Francophone de Transplantation, Liège, Belgium.

Navaux, E., Gustot, T., Racape, J., & DELANAYE, P. (November 2016). Weak performance of glomerular filtration rate equations in stable lung/liver transplant recipients compared to 51Cr-EDTA clearance [Paper presentation]. ASN Kidney Week, Chicago, United States - Illinois.

Warnock, D., van den Brand, J., DELANAYE, P., Glassock, R., & Pottel, H. (November 2016). Comparisons of estimated GFR and Cockcroft Gault equations: calibration against relative risk for all-cause mortality [Poster presentation]. ASN Kidney Week, Chicago, United States - Illinois.

Pottel, H., Hoste, & DELANAYE, P. (November 2016). Glomerular filtration rate in healthy living potential kidney donors: a meta-analysis [Poster presentation]. ASN Kidney Week, Chicago, United States - Illinois.

Jouret, F., DELANAYE, P., VANDERWECKENE, P., & WEEKERS, J.-F. (November 2016). The closure of arteriovenous fistula is associated with a significant acceleration of eGFR decline in kidney transplant recipients [Poster presentation]. American society of Nephrology, Chicago, United States.

CAVALIER, E., & DELANAYE, P. (November 2016). Large variations between four methods for sclerotin determination in patients undergoing GFR measurement and in hemodialyzed patients before and after a single dialysis session [Poster presentation]. ASN Kidney Week, Chicago, United States - Illinois.

DELANAYE, P., & CAVALIER, E. (November 2016). Measurement of glomerular filtration rate by plasma iohexol clearance: single versus multiple samples method [Poster presentation]. ASN Kidney Week, Chicago, United States - Illinois.

DELANAYE, P. (15 October 2016). Is there a place for BTR markers in renal osteodystrophy? [Paper presentation]. Annual meeting of the Royal Belgian Society of Laboratory Medicine and joint meeting with the Belgian Bone club on Bone Turn-over and Bone Resorption Markers, Seraing, Belgium.

DELANAYE, P. (14 October 2016). How to measure renal function? [Paper presentation]. Annual meeting of the Royal Belgian Society of Laboratory Medicine and joint meeting with the Belgian Bone club on Bone Turn-over and Bone Resorption Markers, Seraing, Belgium.

DELANAYE, P., Melson, T., Ebert, N., Bäck, S.-E., Mariat, C., CAVALIER, E., Björk, J., Christensson, A., Nyman, U., Porrini, Remuzzi, G., Ruggenenti, P., Schaeffner, E., Soveri, I., Sterner, G., Odvar Eriksen, B., & Gaspari, F. (2016). Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 2: Why to measure glomerular filtration rate with iohexol? NDT Plus. doi:10.1093/ckj/sfw071
Peer Reviewed verified by ORBi

DELANAYE, P., Ebert, N., Melsom, T., Gaspari, F., Mariat, C., CAVALIER, E., Björk, J., Christensson, A., Nyman, U., Porrini, E., Remuzzi, G., Ruggenenti, P., Schaeffner, E., Soveri, I., Sterner, G., Odvar Eriksen, B., & Bäck, S.-E. (2016). Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1 : How to measure glomerular filtration rate with iohexol? NDT Plus. doi:10.1093/ckj/sfw070
Peer Reviewed verified by ORBi

Pieroni, L., Bargnoux, A. S., DELANAYE, P., Kuster, N., Carlier, M. C., Fellahi, S., Boutten, A., Lombard, C., Delatour, V., Cristol, P., & CAVALIER, E. (September 2016). La standardisation des dosages de cystatine C améliore l'estimation du DFG au stade 3: une étude multicentrique conduite par la société française de biologie clinique (SFBC) [Poster presentation]. Premier congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT), Strabsourg, France.

STOJKOVIC, V., SCHLECK, M.-L., CAVALIER, E., & DELANAYE, P. (September 2016). Evaluation du débit de filtration glomérulaire estimé à l'aide d'un dosage de créatinine par analyseur de biologie délocalisé (Point of Care) [Poster presentation]. Premier congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT), Strasbourg, France.

Yayo, E., Monnet, D., Attoungbré, M.-L., Gnionsahé, A., CAVALIER, E., Pottel, H., & DELANAYE, P. (September 2016). Valeurs de référence de débit de filtration glomérulaire en population noire-africaine. Néphrologie et Thérapeutique, 12 (5), 273.
Peer Reviewed verified by ORBi

DELANAYE, P., & CAVALIER, E. (September 2016). Mesure du débit de filtration glomérulaire par la clearance plasmatique de l'iohexol: comparaison d'une procédure à prélèvements multiples et à un prélèvement unique [Poster presentation]. Premier congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT), Strasbourg, France.

DELANAYE, P., & CAVALIER, E. (September 2016). Mesure du débit de filtration glomérulaire par la clearance plasmatique de l'iohexol: comparaison d'une procédure à prélèvements multiples & à un prélèvement unique [Poster presentation]. Premier congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT), Strasbourg, France.

Cavalier, E., Bergmann, P., Bruyère, O., DELANAYE, P., Durnez, A., Devogelaer, J.-P., Ferrari, S. L., Gielen, E., Goemaere, S., Kaufman, J.-M., Nzeusseu Toukap, A., Reginster, J.-Y., ROUSSEAU, A.-F., Rozenberg, S., Scheen, A., & Body, J.-J. (July 2016). The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club. Osteoporosis International, 27, 2181-2195. doi:10.1007/s00198-016-3561-3
Peer Reviewed verified by ORBi

DELANAYE, P. (June 2016). Vitamin D for the prevention of vascular calcification in normal renal function and CKD patients [Paper presentation]. III Seminario: Osteoporosi e Alterazioni del Metabolismo Minerale Osseo nella Malattia Renale Cronica, Padoue, Italy.

DELANAYE, P., & Glassock, R. (25 May 2016). Kidney-Failure Risk Projection for the Living Kidney-Donor candidate [letter to the editor]. New England Journal of Medicine, 374 (21), 2093-2095. doi:10.1056/NEJMc1603007
Peer Reviewed verified by ORBi

Ebert, N., DELANAYE, P., Shlipak, M., Jakob, O., Martus, P., Bartel, J., Gaedeke, J., van der Giet, M., Schuchardt, M., CAVALIER, E., & Schaeffner, E. (May 2016). Cystatin C standardization decreases assay variation and improves assessment of glomerular filtration rate. Clinica Chimica Acta, 456, 115-121. doi:10.1016/j.cca.2016.03.002
Peer Reviewed verified by ORBi

Jadoul, A., LOVINFOSSE, P., WEEKERS, L., DELANAYE, P., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (28 April 2016). The Uptake of 18F-FDG by Renal Allograft in Kidney Transplant Recipients is not Influenced by Renal Function [Paper presentation]. Annual Meeting of the BVN-SBN, Bruxelles, Belgium.

DELANAYE, P., CAVALIER, E., Fafin, C., DUBOIS, B., KRZESINSKI, J.-M., & Moranne, O. (2016). Efficiency of delivery observed treatment in hemodialysis patients: the example of the native vitamin D therapy. Journal of Nephrology, 29 (1), 99-103. doi:10.1007/s40620-015-0196-y
Peer Reviewed verified by ORBi

BOUQUEGNEAU, A., Salam, S., DELANAYE, P., Eastell, R., & Khwaja, A. (2016). Bone disease after kidney transplantation. Clinical Journal of the American Society of Nephrology, 11 (7), 1282-1296. doi:10.2215/CJN.11371015
Peer Reviewed verified by ORBi

PAQUOT, F., BOUQUEGNEAU, A., CAVALIER, E., & DELANAYE, P. (2016). Sclérostine & insuffisance rénale: que nous apprennent les différents méthodes de dosage? Néphrologie et Thérapeutique, 12 (5), 374.
Peer Reviewed verified by ORBi

BOUQUEGNEAU, A., Vidal-Petiot, E., Moranne, O., Mariat, C., Boffa, J., Vrtovsnik, F., SCHEEN, A., KRZESINSKI, J.-M., Flamant, M., & DELANAYE, P. (2016). Creatinine-based equations for the adjustment of drug dosage in an obese population. British Journal of Clinical Pharmacology, 81 (2), 349-361. doi:10.1111/bcp.12817
Peer Reviewed verified by ORBi

CAVALIER, E., LUKAS, P., BEKAERT, A.-C., PEETERS, S., LE GOFF, C., Yayo, E., DELANAYE, P., & Souberbielle, J.-C. (2016). Analytical and clinical evaluation of the new Fujirebio Lumipulse G non-competitive assay for 25(OH)-vitamin D and three immunoassays for 25(OH)D in healthy subjects, osteoporotic patients, third trimester pregnant women, healthy African subjects, hemodialyzed and intensive care patients. Clinical Chemistry and Laboratory Medicine. doi:10.1515/cclm-2015-0923
Peer Reviewed verified by ORBi

ROUSSEAU, A.-F., Damas, P., DELANAYE, P., & Cavalier, E. (2016). Bone markers during acute burn care: Relevance to clinical practice? Burns: Journal of the International Society for Burn Injuries. doi:10.1016/j.burns.2016.07.020
Peer Reviewed verified by ORBi

Sagou Yayo, E., Aye, E., Konan, J., Emième, A., Attoungbré, M., Gnionsahé, A., CAVALIER, E., Monnet, D., & DELANAYE, P. (2016). Inadéquation du facteur ethnique pour l’estimation du débit de filtration glomérulaire en population générale noire-africaine : résultats en Côte d’Ivoire. Néphrologie et Thérapeutique, 12 (6), 454-459. doi:10.1016/j.nephro.2016.03.006
Peer Reviewed verified by ORBi

Nyssen, L., DELANAYE, P., Le Goff, C., PEETERS, S., & Cavalier, E. (2016). A simple LC-MS method for the determination of iohexol and iothalamate in serum, using ioversol as an internal standard. Clinica Chimica Acta, 463, 96-102. doi:10.1016/j.cca.2016.10.021
Peer Reviewed verified by ORBi

Jadoul, A., LOVINFOSSE, P., WEEKERS, L., DELANAYE, P., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (2016). The Uptake of 18F-FDG by Renal Allograft in Kidney Transplant Recipients Is Not Influenced by Renal Function. Clinical Nuclear Medicine, 41 (9), 683-7. doi:10.1097/RLU.0000000000001298
Peer Reviewed verified by ORBi

JOURET, F., CAVALIER, E., & DELANAYE, P. (2016). Concordance between iothalamate and iohexol plasma clearances [Poster presentation]. LIII Congress of ERA-EDTA, Vienna, Austria.

DELANAYE, P., Glassock, R., Pottel, H., & Rule, A. (2016). An age-calibrated definition of chronic kidney disease: Rationale and benefits. Clinical Biochemist. Reviews, 37 (1).
Peer Reviewed verified by ORBi

DELANAYE, P., LE GOFF, C., JOURET, F., & CAVALIER, E. (2016). Concordance between Iothalamate and Iohexol Plasma Clearance [letter to the editor]. American Journal of Kidney Diseases, 68 (2), 329-330. doi:10.1053/j.ajkd.2016.01.007
Peer Reviewed verified by ORBi

DELANAYE, P., Flamant, M., CAVALIER, E., Guerber, F., Valloton, T., Moranne, O., Pottel, H., Boffa, J., & Mariat, C. (2016). Adaptation posologique des médicaments et fonction rénale : Quel(s) estimateur(s) faut-il choisir? Néphrologie et Thérapeutique, 12 (1), 18-31. doi:10.1016/j.nephro.2015.07.472
Peer Reviewed verified by ORBi

JADOUL, A., LOVINFOSSE, P., WEEKERS, L., DELANAYE, P., KRZESINSKI, J.-M., HUSTINX, R., & JOURET, F. (2016). The uptake of 18F-FDG by renal allograft in kidney transplant recipients is not influenced by renal function [Poster presentation]. LIII Congress of ERA-EDTA, Vienna, Austria.

Souberbielle, J.-C., Massart, C., Brailly-Tabard, S., Cormier, C., CAVALIER, E., DELANAYE, P., & Chanson, P. (2016). Serum PTH reference values established by an automated third-generation assay in Vitamin D-replete subjects with normal renal function: Consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients. European Journal of Endocrinology, 174 (3), 315-323. doi:10.1530/EJE-15-0595
Peer Reviewed verified by ORBi

Ebert, N., DELANAYE, P., Shlipak, M., Jakob, O., Martus, P., Gaedek, J., Schurchardt, M., van der Giet, M., Bartel, J., CAVALIER, E., & Schaeffner, E. (2016). Cystatin C standardization decreases assay variation and improves assessment of GFR [Poster presentation]. LIII Congress of ERA-EDTA, Vienna, Austria.

Mariat, C., Pottel, H., & DELANAYE, P. (2016). Drug dosing in chronic kidney disease: is the Cockcroft-Gault formula always the best estimation of renal function to prevent overexposure? [Poster presentation]. LIII Congress of ERA-EDTA, Vienna, Austria.

Bargnoux, A.-S., Kuster, N., Delatour, V., DELANAYE, P., Gonzalez-Antuna, A., Cristol, J.-P., Piéroni, L., & CAVALIER, E. (2016). Reference Method and Reference Material Are Necessary Tools to Reveal the Variability of Cystatin C Assays [letter to the editor]. Archives of Pathology and Laboratory Medicine, 140 (2), 117-118. doi:10.5858/arpa.2015-0198-LE
Peer Reviewed verified by ORBi

Pottel, H., Hoste, L., Dubourg, L., Ebert, N., Schaeffner, E., Eriksen, Melsom, T., Lamb, E., Rule, A., Turner, S., Glassock, R., De Souza, V., Selistre, L., Mariat, C., Martens, F., & DELANAYE, P. (2016). An estimated glomerular filtration rate equation for the full age spectrum. Nephrology Dialysis Transplantation, 31 (5), 798-806. doi:10.1093/ndt/gfv454
Peer Reviewed verified by ORBi

DELANAYE, P. (2016). AVK en hémodialyse-Rôle, attentes et conséquences cardio vasculaires [Paper presentation]. Hyperphosphatémie et troubles minéraux osseux : actualités et perspectives, Cabourg, France.

Glassock, R., DELANAYE, P., & El-Nahas, M. (2016). Managing Chronic Kidney Disease in Older People--Reply [letter to the editor]. JAMA: Journal of the American Medical Association, 315 (3). doi:10.1001/jama.2015.15999
Peer Reviewed verified by ORBi

ROUSSEAU, A.-F., SOUBERBIELLE, J.-C., DELANAYE, P., Damas, P., & Cavalier, E. (2016). Fibroblast growth factor 23 in acute burn patients: Novel insights from an intact-form assay. Burns: Journal of the International Society for Burn Injuries. doi:10.1016/j.burns.2016.01.024
Peer Reviewed verified by ORBi

Souberbielle, J.-C., CAVALIER, E., DELANAYE, P., Massart, C., Brailly-Tabard, S., Cormier, C., Borderie, D., Benachi, A., & Chanson, P. (07 December 2015). Serum calcitriol concentrations measured with a new direct automated assay in a large population of adult healthy subjects and in various clinical situations. Clinica Chimica Acta, 451 (Pt B), 149-53. doi:10.1016/j.cca.2015.09.021
Peer Reviewed verified by ORBi

DELANAYE, P., CAVALIER, E., BOUQUEGNEAU, A., & Khwaja, A. (December 2015). Sclerostin levels in CKD patients : an important, but not definitive, step on the way to clinical use. Kidney International, 88 (6), 1221-1223. doi:10.1038/ki.2015.258
Peer Reviewed verified by ORBi

Cavalier, E., Plebani, M., DELANAYE, P., & Souberbielle, J.-C. (November 2015). Considerations in parathyroid hormone testing. Clinical Chemistry and Laboratory Medicine, 53 (12), 1913-9. doi:10.1515/cclm-2015-0314
Peer Reviewed verified by ORBi

DELANAYE, P., Liabeuf, S., BOUQUEGNEAU, A., CAVALIER, E., & Massy, Z. (July 2015). L'éveil de la matrix-gla-protéine sonnera le glas des calcifications vasculaires. Néphrologie et Thérapeutique, 11 (4), 191-200. doi:10.1016/j.nephro.2014.12.003
Peer Reviewed verified by ORBi

Liabeuf, S., DELANAYE, P., Cavalier, E., Guerin, A., Kamel, S., & Massy, Z. A. (June 2015). Inhibiteurs des calcifications cardiovasculaires. Annales de Biologie Clinique, 73 (3), 315-22. doi:10.1684/abc.2015.1047
Peer Reviewed verified by ORBi

Pelletier, S., Jean, G., Fouque, D., CAVALIER, E., DELANAYE, P., Souberbielle, J.-C., Zaoui, P., Cristol, J. P., Urena-Torres, P., Boutten, A., Hannedouche, T., Brunet, P., Jean, G., Pieroni, L., Mercadal, L., Lafage-Proust, M.-H., Guérin, A., Prié, D., Kamel, S., ... Arnaud, J. (May 2015). La sclérostine: un nouveau biomarqueur d'intérêt en néprhologie. Annales de Biologie Clinique, 73 (3), 305-13. doi:10.1684/abc.2015.1049
Peer Reviewed verified by ORBi

CAVALIER, E., DELANAYE, P., Nyssen, L., & Souberbielle, J.-C. (May 2015). Problems with the PTH assays. Annales d'Endocrinologie, 76 (2), 128-133. doi:10.1016/j.ando.2015.03.018
Peer Reviewed verified by ORBi

BOUQUEGNEAU, A., KRZESINSKI, J.-M., DELANAYE, P., & CAVALIER, E. (30 March 2015). Biomarkers and physiolpathology in the cardiorenal syndrome. Clinica Chimica Acta, 443, 100-107.
Peer Reviewed verified by ORBi

DELANAYE, P., BOUQUEGNEAU, A., KRZESINSKI, J.-M., CAVALIER, E., Jean, G., Urena-Torres, P., & Souberbielle, J.-C. (February 2015). Place de la vitamine D native en dialyse. Néphrologie et Thérapeutique, 11 (1), 5-15. doi:10.1016/j.nephro.2014.10.004
Peer Reviewed verified by ORBi

Yayo, E., Konan, J., Aye, M., Amième, A., Gnionsahé, A., Gbago, G., Monnet, D., CAVALIER, E., & DELANAYE, P. (2015). Evaluation du débit de filtration glomérulaire en population générale : résultats en Côte d’Ivoire E [Poster presentation]. XVII réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lyon, France.

Ebert, N., DELANAYE, P., Jakob, O., Mariat, C., Shlipak, M., & Schaeffner, E. (2015). Absolute versus BSA-adjusted estimated GFR compared to measured GFR – what to bear in mind when dosing drugs in elderly individuals [Poster presentation]. LII Congress of ERA-EDTA, London, United Kingdom.

DELANAYE, P. (2015). Guidelines about CKD classification: a provocative point of view [Paper presentation]. XXI IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, Paris, France.

DELANAYE, P. (2015). Place de la vitamine D native dans le traitement des patients dialysés [Paper presentation]. 21èmes édition du symposium belge de Dialyse, Hargimont, Belgium.

DELANAYE, P., & Glassock, R. (2015). Glomerular Filtration Rate and Aging: Another Longitudinal Study--A Long Time Coming! Nephron journals, 131 (1), 1-4. doi:10.1159/000439147
Peer Reviewed verified by ORBi

Pottel, H., Dubourg, L., Ebert, N., Schaeffner, E., Eriksen, B., Lamb, E., Rule, A., Glassock, R., de Souza, V., Mariat, C., Sellistre, L., & DELANAYE, P. (2015). L’équation FAS : Une nouvelle équation pour estimer le débit de filtration glomérulaire applicable quel que soit l’âge [Paper presentation]. XVII réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lyon, France.

DELANAYE, P., DUBOIS, B., LUKAS, P., PETERS, P., KRZESINSKI, J.-M., Pottel, H., & CAVALIER, E. (2015). impact of stopping vitamin K antagonist therapy on concentrations of dephospho-uncarboxylated Matrix Gla protein [letter to the editor]. Clinical Chemistry and Laboratory Medicine, 53 (8), 191-193. doi:10.1515/cclm-2015-0073
Peer Reviewed verified by ORBi

Maillard, N., DELANAYE, P., & Mariat, C. (2015). Exploration de la fonction glomérulaire rénale : estimation du débit de filtration glomérulaire. Néphrologie et Thérapeutique, 11 (1), 54-67. doi:10.1016/j.nephro.2015.01.002
Peer Reviewed verified by ORBi

DELANAYE, P., El-Nahas, M., & Glassock, R. (2015). The myth of the future burden of CKD in United States [letter to the editor]. American Journal of Kidney Diseases, 66 (1), 171-172. doi:10.1053/j.ajkd.2015.01.035
Peer Reviewed verified by ORBi

DELANAYE, P., & CAVALIER, E. (2015). Vitamine D et maladie rénale chronique. In C. Benhamou & J. Souberbielle, La vitamine D chez l’adulte. Sauramps Medical.
Peer reviewed

DELANAYE, P., & Glassock, R. (2015). Lifetime Risk of CKD: What Does It Really Mean? Clinical Journal of the American Society of Nephrology, 10 (9), 1504-1506. doi:10.2215/CJN.07860715
Peer Reviewed verified by ORBi

Moranne, O., Vidal-Petiot, E., Fafin, C., DELANAYE, P., & Flamant, M. (2015). Accuracy of serum creatinine and glomerular filtration rate estimation for adjusting metformin prescription in European type 2 diabetics [Poster presentation]. LII Congress of ERA-EDTA, London, United Kingdom.

BOUQUEGNEAU, A., Vidal-Petiot, E., Vrtovsnik, F., Moranne, O., Flamant, M., & DELANAYE, P. (2015). Equations basées sur la créatinine pour l’adaptation posologique des médicaments dans une population de patients obèses [Poster presentation]. XVII réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lyon, France.

EVRARD, S., DELANAYE, P., Kamel, S., Cristol, J., & CAVALIER, E. (January 2015). Vascular calcification: from pathophysiology to biomarkers. Clinica Chimica Acta, 438, 401-14. doi:10.1016/j.cca.2014.08.034
Peer Reviewed verified by ORBi

DELANAYE, P. (2015). Renal function assessment. Techniques, clinical applications, populations, limitations [Paper presentation]. Core Curriculum Course Nephrology 2015, Bruxelles, Belgium.

DELANAYE, P., Warling, X., Moonen, M., Smelten, N., KRZESINSKI, J.-M., Pottel, H., & CAVALIER, E. (2015). Variation of PTH and bone biomarkers in hemodialysis patients [Poster presentation]. ASN Kidney Week, San Diego, United States - California.

Moranne, O., Fafin, C., DELANAYE, P., & Flamant, M. (2015). Accuracy of Serum Creatinine and Glomerular Filtration Rate Estimation for Adjusting Metformin Prescription in European Type 2 Diabetics [Poster presentation]. ASN Kidney Week, San Diego, United States - California.

DELANAYE, P., Warling, Moonen, M., Smelten, N., KRZESINSKI, J.-M., Moranne, O., Pottel, H., & CAVALIER, E. (2015). Variation de la parathormone et de différents biomarqueurs osseux chez le patient hémodialysé [Poster presentation]. XVII réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lyon, France.

DELANAYE, P., Pottel, H., & Mariat, C. (2015). Quelle formule pour l’adaptation posologique des medicaments ? Une simulation mathématique illustrative [Poster presentation]. XVII réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lyon, France.

DELANAYE, P., LAMBERMONT, B., MORIMONT, P., KRZESINSKI, J.-M., Maillard, N., Claisse, G., Mariat, C., & CAVALIER, E. (2015). Discrepancies between urinary and plasma NGAL concentrations in patients adlmitted to the medical intensive care [Poster presentation]. LII Congress of ERA-EDTA, London, United Kingdom.

VON FRENCKELL, C., & DELANAYE, P. (2015). Rituximab (MabThera®) : nouveau médicament dans les vascularites associées à ANCA. Revue Médicale de Liège, 70 (2), 92-100.

Masson, I., Maillard, N., CAVALIER, E., Alamartine, E., Mariat, C., & DELANAYE, P. (2015). KDIGO Guidelines and Kidney Transplantation: Is the cystatin-C Based Recommendation relevant? American Journal of Transplantation, 15 (8), 2211-4. doi:10.1111/ajt.13258
Peer Reviewed verified by ORBi

Pottel, H., Hoste, L., & DELANAYE, P. (2015). Abnormal glomerular filtration rate in children, adolescents and young adults starts below 75 mL/min/1.73 m2. Pediatric Nephrology, 30 (5), 821-828. doi:10.1007/s00467-014-3002-5
Peer Reviewed verified by ORBi

Glassock, R., DELANAYE, P., & El-Nahas, M. (2015). An Age-Calibrated Classification of Chronic Kidney Disease. JAMA: Journal of the American Medical Association, 314 (6), 559-560. doi:10.1001/jama.2015.6731
Peer Reviewed verified by ORBi

DELANAYE, P. (2015). Pourquoi et comment corriger les anomalies de la PTH ? [Paper presentation]. 4èmes assises renal pharma (Division médicament de Fresenius Medical Care) : Métabolisme minéral et osseux : Quoi de neuf en 2015 ?, Paris, France.

DELANAYE, P. (2015). Evaluation de la fonction rénale [Paper presentation]. 9ème réunion, Prise en charge précoce de la maladie rénale chronique, « Rein et obésité », Lyon, France.

Claisse, G., Hougardy, J., Alamartine, E., DELANAYE, P., Maillard, N., Morel, J., & Mariat, C. (2015). Evaluation d’un nouvel estimateur du Débit de Filtration Glomérulaire cinétique (KeGFR) pour prédire la survenue d’une insuffisance rénale aiguë après chirurgie cardiaque : étude AKInetic [Poster presentation]. XVII réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lyon, France.

DELANAYE, P., Mariat, C., & Glassock, R. (2015). Safety of living kidney donation: another brick in the wall…and a solid (physiologic) one. American Journal of Kidney Diseases, 66 (1), 1-3. doi:10.1053/j.ajkd.2015.04.005
Peer Reviewed verified by ORBi

ROUSSEAU, A.-F., DAMAS, P., JANSSENS, M., KALIN, S., LEDOUX, D., LE GOFF, C., GADISSEUR, R., DELANAYE, P., & CAVALIER, E. (November 2014). Critical care and vitamin D status assessment: What about immunoassays and calculated free 25OH-D? Clinica Chimica Acta, 437, 43-47. doi:10.1016/j.cca.2014.07.007
Peer Reviewed verified by ORBi

CAVALIER, E., DUBOIS, B., Urena, P., Smelten, N., & DELANAYE, P. (November 2014). Impact of the dialysis membrane on the Vitamin D metabolims markers [Poster presentation]. Kidney week, Philadelphia, United States.

Ebert, N., DELANAYE, P., Martus, P., Jakob, O., Bartel, J., Schuchardt, M., CAVALIER, E., & Schaeffner, E. (November 2014). Systematic Analysis of two cystatin C assays using samples of 2057 older adults - The Berlin initiative study [Poster presentation]. Kidney Week, Philadelphia, United States.

CAVALIER, E., BEKAERT, A.-C., LUKAS, P., PEETERS, S., GADISSEUR, R., LE GOFF, C., & DELANAYE, P. (October 2014). Les résultats des formules de calcul de la 25(OH)-vitamine D libre varient en fonction des méthodes de dosage de la 25(OH)D [Poster presentation]. 16ème Réunion commune - Société de néphrologie - Société de dialyse, Saint-Etienne, France.

CAVALIER, E., DUBOIS, B., BEKAERT, A.-C., LUKAS, P., PEETERS, S., GADISSEUR, R., LE GOFF, C., KRZESINSKI, J.-M., & DELANAYE, P. (October 2014). La membrane de dialyse peut-elle avoir une influence sur le statut en vitamine D du patient? [Poster presentation]. 16ème réunion commune - Société de néphrologie - Société de dialyse, Saint Etienne, France.

DELANAYE, P., CAVALIER, E., Cristol, J.-P., & Delanghe, J. (October 2014). Calibration and precision of serum creatinine and plasma cystatin C measurement: impact on the estimation of glomerular filtration rate. Journal of Nephrology, 27 (5), 467-75. doi:10.1007/s40620-014-0087-7
Peer Reviewed verified by ORBi

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Moonen, M., Smelten, N., Médart, Pottel, H., & CAVALIER, E. (September 2014). Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrology, 15, 145. doi:10.1186/1471-2369-15-145
Peer Reviewed verified by ORBi

CAVALIER, E., Souberbielle, J.-C., GADISSEUR, R., DUBOIS, B., KRZESINSKI, J.-M., & DELANAYE, P. (September 2014). Inter-method variability in bone alkaline phosphatase measurement : clinical impact on the management of dialysis patients. Clinical Biochemistry, 47 (13-14), 1227-30. doi:10.1016/j.clinbiochem.2014.04.007
Peer Reviewed verified by ORBi

CAVALIER, E., DELANAYE, P., LUKAS, P., CARLISI, I., GADISSEUR, R., & Souberbielle, J.-C. (01 August 2014). Standardization of DiaSorin and Roche automated third generation PTH assays with an international standard: impact on clinical populations. Clinical Chemistry and Laboratory Medicine, 52 (8), 1137-41. doi:10.1515/cclm-2013-1027
Peer Reviewed verified by ORBi

KRZESINSKI, J.-M., & DELANAYE, P. (June 2014). Altération de la fonction rénale chez le patient âgé, comment gérer? Revue Médicale de Liège, 69 (5-6), 287-293.
Peer reviewed

DELANAYE, P., Souberbielle, J.-C., Lafage-Proust, M.-H., Jean, G., & CAVALIER, E. (May 2014). Can we use circulating biomarkers to monitor bone turnover in CKD haemodialysis patients? Hypotheses and facts. Nephrology Dialysis Transplantation, 29 (5), 997-1004. doi:10.1093/ndt/gft275
Peer Reviewed verified by ORBi

CAVALIER, E., LUKAS, P., CRINE, Y., PEETERS, S., CARLISI, I., LE GOFF, C., GADISSEUR, R., DELANAYE, P., & Souberbielle, J.-C. (20 April 2014). Evaluation of automated immunoassays for 25 (OH)-vitamin D determination in different critical populations before and after standardization of the assays. Clinica Chimica Acta, 431, 60-5. doi:10.1016/j.cca.2014.01.026
Peer Reviewed verified by ORBi

CAVALIER, E., LUKAS, P., CRINE, Y., PEETERS, S., CARLISI, I., LE GOFF, C., GADISSEUR, R., DELANAYE, P., & Souberbielle, J.-C. (April 2014). Standardization of 25-hydroxyvitamin D assays: impact of vitamin-D binding protein concentrations and uremic media on the re-standardization of six different 25(OH) vitamin D immunoassays [Poster presentation]. WCO-IOF-ESCEO Seville 2014 : World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases, Séville, Spain.

CAVALIER, E., BETEA, D., SCHLECK, M.-L., GADISSEUR, R., VROONEN, L., DELANAYE, P., Daly, A., & BECKERS, A. (March 2014). The Third/Second Generation PTH Assay Ratio as a Marker for Parathyroid Carcinoma: Evaluation Using an Automated Platform. Journal of Clinical Endocrinology and Metabolism, 99 (3), 453-7. doi:10.1210/jc.2013-3730
Peer Reviewed verified by ORBi

DELANAYE, P., CAVALIER, E., Morel, J., Mehdi, M., Maillard, N., Claisse, G., LAMBERMONT, B., DUBOIS, B., DAMAS, P., KRZESINSKI, J.-M., Lautrette, A., & Mariat, C. (13 January 2014). Detection of decreased glomerular filtration rate in intensive care units: serum cystatin C versus serum creatinine. BMC Nephrology, 15 (9), 1471-2369. doi:10.1186/1471-2369-15-9
Peer Reviewed verified by ORBi

DELANAYE, P., & Rule, A. (2014). Assessing kidney function. In P. Kimmel & M. Rosenberg, Chronic Renal Disease. United States: Elsevier. doi:10.1016/B978-0-12-411602-3.00004-4
Peer reviewed

DELANAYE, P. (2014). Nephrology and Clinical Chemistry: the essential link [Paper presentation]. Lecture in the programme of “Internationalisation at home”, Kortrijk, Belgium.

DELANAYE, P. (2014). Creatinine-based GFR estimating equations in kidney transplant recipients [letter to the editor]. American Journal of Kidney Diseases, 64 (5), 818. doi:10.1053/j.ajkd.2014.05.027
Peer Reviewed verified by ORBi

BOUQUEGNEAU, A., Vidal-Petiot, E., Vrtovsnik, F., CAVALIER, E., KRZESINSKI, J.-M., Flamant, M., & DELANAYE, P. (2014). Accuracy of Cockcroft&Gault and CKD-EPI equations to estimate glomerular filtration rate in obese population [Poster presentation]. LI Congress of ERA-EDTA, Amsterdam, Netherlands.

BOUQUEGNEAU, A., Vidal-Petito, E., Vrtovsnik, F., CAVALIER, E., KRZESINSKI, J.-M., Flamant, M., & DELANAYE, P. (2014). Cockcroft&Gault and CKD-EPI equations: are these equations concordant to adjust drug dosage? [Poster presentation]. LI Congress of ERA-EDTA, Amsterdam, Netherlands.

Kuster, N., Cristol, J.-P., CAVALIER, E., Bargnoux, A.-S., Halimi, J.-M., Froissart, M., Piéroni, L., & DELANAYE, P. (January 2014). Enzymatic creatinine assays allowestimation of glomerular filtration rate in stages 1 and 2 chronic kidney disease using CKD-EPI equation. Clinica Chimica Acta, 428, 89-95. doi:10.1016/j.cca.2013.11.002
Peer Reviewed verified by ORBi

Mariat, C., Guerber, F., Pottel, H., & DELANAYE, P. (2014). Estimation du DFG et adaptation posologique : la formule de Cockcroft-Gault et l’équation CKD-EPI désindexée sont-elles interchangeables ? [Poster presentation]. XVI réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Saint-Etienne, France.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Moonen, M., Smelten, N., Médart, M., Bruyère, O., REGINSTER, J.-Y., Pottel, H., & CAVALIER, E. (2014). Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients. Nephron. Clinical Practice, 128, 127-134. doi:10.1159/000366449
Peer Reviewed verified by ORBi

Hougardy, J.-M., DELANAYE, P., Le Moine, A., & Nortier, J. (2014). L'Estimation de la filtration glomérulaire en 2014: Intérêts et limites des tests et formules. Revue Médicale de Bruxelles, 35 (4), 250-257.

DELANAYE, P., LAMBERMONT, B., MORIMONT, P., KRZESINSKI, J.-M., Maillard, N., Claisse, M., Mariat, C., & CAVALIER, E. (2014). Mesure du NGAL dans le sang et les urines : comparaison des méthodes de mesure et éventuel impact sur la décision clinique [Poster presentation]. XVI réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Saint-Etienne, France.

DELANAYE, P., Souberbielle, J.-C., GADISSEUR, R., DUBOIS, B., Krzesinski, J.-M., & CAVALIER, E. (2014). Inter-method variability in bone alkaline phosphatase measurement: clinical impact on the management of dialysis patients [Poster presentation]. LI Congress of ERA-EDTA, Amsterdam, Netherlands.

DELANAYE, P., & Krzesinski, J.-M. (2014). Estimation du débit de filtration glomérulaire en 2014. Revue Médicale de Liège, 69, 47-52.
Peer reviewed

DELANAYE, P., & SCHEEN, A. (2014). Comment on Tsuda et al. Poor glycemic control is a major factor in the overestimation of glomerular filtration rate in diabetic patients. Diabetes care 2014;37:596-603 [letter to the editor]. Diabetes Care, 37 (4), 83. doi:10.2337/dc13-2703
Peer Reviewed verified by ORBi

DELANAYE, P., WEEKERS, L., Warling, X., Moonen, M., Smelten, N., KRZESINSKI, J.-M., & CAVALIER, E. (2014). Effet de la vitamine D native sur la concentration de parathormone chez le patient hémodialysé : y a-t-il un intérêt au dosage de la parathormone non oxydée ? [Poster presentation]. XVI réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Saint-Etienne, France.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Moonen, M., Smelten, N., Médart, L., Pottel, H., & CAVALIER, E. (2014). Sclerostin concentration is not predictive of mortality in hemodialysis patients [Poster presentation]. LI Congress of ERA-EDTA, Amsterdam, Netherlands.

DELANAYE, P., DUBOIS, B., LUKAS, P., PETERS, P., KRZESINSKI, J.-M., & CAVALIER, E. (2014). Impact of the stopping of vitamin K antagonist treatment on concentrations of Dephosphorylated and uncarboxylated Matrix Gla protein [Poster presentation]. ASN Kidney Week, Philadelphia, United States - Pennsylvania.

DELANAYE, P. (2014). Peut-on approcher l’ostéoporose de l’insuffisant rénal chronique par les biomarqueurs ? [Paper presentation]. 4èmes rencontres interrégionales : actualités sur l’anémie et l’os dans l’insuffisance rénale chronique, Amiens, France.

DELANAYE, P. (2014). Estimation du DFG en 2014 : le CKD-EPI (en autres choses…) [Paper presentation]. 14ème journées de de la société marocaine de chimie clinique, Rabbat, Morocco.

DELANAYE, P. (2014). Evaluation de la fonction rénale [Paper presentation]. Réunion de consensus : l’usage rationnel des médicaments en cas d’insuffisance rénale, Bruxelles, Belgium.

DELANAYE, P., BECKERS, C., & HUSTINX, R. (2014). Le néphrogramme isotopique (méthode de “Gates”) permet-il une estimation correcte du débit de filtration glomérulaire ? Revue de la littérature [Poster presentation]. XVI réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Saint-Etienne, France.

Gagneux-Brunon, A., DELANAYE, P., Fafin, C., Mariat, C., Fresard, A., Lucht, F., & Moranne, O. (2014). Estimateurs du débit de filtration glomérulaire : impact sur la prescription des antirétroviraux chez les sujets infectés par le VIH [Poster presentation]. Estimateurs du débit de filtration glomérulaire : impact sur la prescription des antirétroviraux chez les sujets infectés par le VIH, Saint-Etienne, France.

CAVALIER, E., & DELANAYE, P. (08 November 2013). Analytical performance of a new bone specific ALP automated immunoassay [Poster presentation]. ASN Kidney week, Atlanta, United States.

CAVALIER, E., & DELANAYE, P. (08 November 2013). PINP in renal impaired patients: the assay matters [Poster presentation]. ASN Kidney week, Atlanta, United States.

CAVALIER, E., & DELANAYE, P. (08 November 2013). Performance of a novel fully automated method for the detection of dephospho-uncarboxylated matrix gla ptrotein (dp-ucMGP) [Poster presentation]. ASN Kidney week, Atlanta, United States.

CAVALIER, E., & DELANAYE, P. (08 November 2013). Inter-method variability for the measurement of bone alkaline phosphatase: Implication for the monitoring of CKD-MBD [Poster presentation]. ASN Kidney week, Atlanta, United States.

BOUQUEGNEAU, A., Vidal-Petiot, E., Vrtovsnik, F., CAVALIER, E., RORIVE, M., KRZESINSKI, J.-M., DELANAYE, P., & Flamant, M. (November 2013). Modification of diet in renal disease versus chronic kidney disease epidemiology collaboration equation to estimate glomerular filtration rate in obese patients. Nephrology Dialysis Transplantation, 28 (4), 122-130. doi:10.1093/ndt/gft329
Peer Reviewed verified by ORBi

DELANAYE, P., & CAVALIER, E. (October 2013). Staging chronic kidney disease and estimating glomerular filtration rate: an opinion paper about the new international recommendations. Clinical Chemistry and Laboratory Medicine, 51 (10), 1911-1917. doi:10.1515/cclm-2013-0223
Peer Reviewed verified by ORBi

CAVALIER, E., LUKAS, P., CARLISI, I., GADISSEUR, R., & DELANAYE, P. (October 2013). Aminoterminal propeptide of type I procollagen (P1NP) in chronic kidney disease patients: the assay matters [letter to the editor]. Clinica Chimica Acta, 425, 117-118.
Peer Reviewed verified by ORBi

DELANAYE, P., & Mariat, C. (September 2013). The applicability of eGFR equations to different populations. Nature Reviews Nephrology, 9, 513-522. doi:10.1038/nrneph.2013.143
Peer Reviewed verified by ORBi

DELANAYE, P., WEEKERS, L., WARLING, X., MOONEN, M., Smelten, N., MEDART, L., KRZESINSKI, J.-M., & CAVALIER, E. (07 July 2013). Cholecalciferol in haemodialysis patients : a randomized, double-blind, proof-of-concept and safety study. Nephrology Dialysis Transplantation, 28 (7), 1779-1786. doi:10.1093/ndt/gft001
Peer Reviewed verified by ORBi

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Smelten, N., & CAVALIER, E. (July 2013). VITAMIN K ANTAGONISTS IN HEMODIALYSIS PATIENTS: IMPACT ON THE PLASMA LEVELS OF DEPHOSPHO-UNCARBOXYLATED MATRIX GLA-PROTEIN [Poster presentation]. AACC Annual meeting 2013, Houston, United States.

DELANAYE, P., Krzesinski, J.-M., & CAVALIER, E. (July 2013). EVOLVE: entre déception et optimisme. Néphrologie et Thérapeutique, 9 (4), 241-245. doi:10.1016/j.nephro.2013.04.001
Peer Reviewed verified by ORBi

DELANAYE, P., Pottel, H., & Botev, R. (June 2013). Con: Should we abandon the use of the MDRD equation in favour of the CKD-EPI equation? Nephrology Dialysis Transplantation, 28 (6), 1396-1403. doi:10.1093/ndt/gft006
Peer Reviewed verified by ORBi

CAVALIER, E., LE GOFF, C., CARLISI, I., BEKAERT, A.-C., FERRANTE, N., ROUSSELLE, O., DELANAYE, P., & Souberbielle, J.-C. (May 2013). Comparison of the total error obtained with six immuno-assays for 25-hydroxy vitamin D with the minimal, desirable and optimal total allowable errors calculated according to the biological variation. Biochimica Clinica, 37 (SS), 259.
Peer reviewed

DELANAYE, P., Bruyère, O., Moranne, O., LUTTERI, L., KRZESINSKI, J.-M., & CAVALIER, E. (May 2013). Creatinine-or cystatin C-based equations to estimate glomerular filtration: impact on the epidemiology of chronic kidney disease [Poster presentation]. 20th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab), Milan, Italy.

Masson, I., Flamant, M., Maillard, N., Rule, A., Vrtovsnik, F., Peraldi, M.-N., Thibaudin, L., CAVALIER, E., Vidal-Petiot, E., Bonneau, C., Moranne, O., Alamartine, E., Mariat, C., & DELANAYE, P. (May 2013). MDRD versus CKD-EPI equation to estimate glomerular filtration rate in kidney transplant recipients. Transplantation, 95 (10), 1211-1217. doi:10.1097/TP.0b013e318288caa6
Peer Reviewed verified by ORBi

DELANAYE, P., Cavalier, E., Moranne, O., Bruyère, O., LUTTERI, L., & Krzesinski, J.-M. (May 2013). Creatinine- or cystatin C-based equations to estimate glomerular filtration rate in the general population: impact on the epidemiology of chronic kidney disease [Poster presentation]. 50th ERA-EDTA Congress, Istanbul, Turkey.

CAVALIER, E., DELANAYE, P., & MORANNE, O. (May 2013). Variability of new bone mineral metabolism markers in patients treated with maintenance hemodialysis: implications for clinical decision making. American Journal of Kidney Diseases, 61 (5), 847-8. doi:10.1053/j.ajkd.2012.12.013
Peer Reviewed verified by ORBi

CAVALIER, E., GADISSEUR, R., LUKAS, P., CARLISI, I., & DELANAYE, P. (May 2013). Association of the circulating inactive form of matrix GLA protein (DP-UCMGP) levels and abdominal aortic calcification score (AACS) in haemodialysis patients. Biochimica Clinica, 37 (SS), 215.
Peer reviewed

CAVALIER, E., LUKAS, P., FERRANTE, N., ROUSSELLE, O., CARLISI, I., & DELANAYE, P. (May 2013). Difference between total and intact assays for N-Terminal propeptide of type I procollagen (P1NP) determination in renal impaired patients. Biochimica Clinica, 37 (SS), 498.
Peer reviewed

BOUQUEGNEAU, A., CAVALIER, E., Krzesinski, J.-M., & DELANAYE, P. (18 April 2013). MDRD VERSUS CKD-EPI EQUATIONS TO ESTIMATE GLOMERULAR FILTRATION RATE IN OBESE PATIENTS [Poster presentation]. 50th ERA-EDTA Congress, Istanbul, Turkey.

Boutten, A., Bargnoux, A.-S., Carlier, M.-C., DELANAYE, P., Rozet, E., Delatour, V., CAVALIER, E., Hanser, A.-M., Froissart, M., Cristol, J.-P., Piéroni, L., & Société Française de Biologie clinique. (April 2013). Enzymatic but not compensated Jaffe methods reach the desirable specifications of NKDEP at normal levels of creatinine. results of the French multicentric evaluation. Clinica Chimica Acta, 419, 132-135. doi:10.1016/j.cca.2013.01.021
Peer Reviewed verified by ORBi

DELANAYE, P., CAVALIER, E., Moranne, O., LUTTERI, L., KRZESINSKI, J.-M., & Bruyère, O. (12 March 2013). Creatinine - or cystatin C - based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease. BMC Nephrology, 14, 57. doi:10.1186/1471-2369-14-57
Peer Reviewed verified by ORBi

DELANAYE, P., DUBOIS, B., JOURET, F., KRZESINSKI, J.-M., MORANNE, O., & CAVALIER, E. (February 2013). Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients : Is it so simple? Clinica Chimica Acta, 417, 35-38. doi:10.1016/j.cca.2012.12.009
Peer Reviewed verified by ORBi

Gagneux-Brunon, A., DELANAYE, P., Maillard, N., Fresard, A., Basset, T., Alamartine, E., Lucht, F., Pottel, H., & Mariat, C. (2013). Performance of creatinine and cystatin C-based glomerular filtration rate estimating equations in a European HIV-positive cohort. AIDS. doi:10.1097/QAD.0b013e32835fac30
Peer Reviewed verified by ORBi

DELANAYE, P., Claisse, G., Mehdi, M., Maillard, N., LAMBERMONT, B., DUBOIS, B., DAMAS, P., KRZESINSKI, J.-M., Morel, J., Lautrette, A., CAVALIER, E., & Mariat, C. (2013). Déterminant physiologique du NGAL sanguin et discordance entre NGAL sanguin et urinaire [Poster presentation]. XLI congrès de la Société de Réanimation de Langue Française, Paris, France.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Smelten, N., & CAVALIER, E. (2013). La concentration de la Matrix Gla protéine décarboxylée déphosphorylée est prédictive du statut en vitamine K, mais pas des calcifications vasculaires, chez les patients hémodialysés chroniques [Paper presentation]. XV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Nantes, France.

Masson, I., Maillard, N., & DELANAYE, P. (2013). New K/DIGO guidelines and kidney transplantation: is the cystatin-C based recommendation relevant? [Paper presentation]. ASN Kidney Week, Atlanta, United States - Georgia.

DELANAYE, P., Claisse, G., Mehdi, M., Maillard, N., LAMBERMONT, B., DUBOIS, B., DAMAS, P., KRZESINSKI, J.-M., Morel, J., Lautrette, A., CAVALIER, E., & Mariat, C. (2013). Déterminant physiologique du NGAL sanguin et discordance entre NGAL sanguin et urinaire [Poster presentation]. XLI congrès de la Société de Réanimation de Langue Française, Paris, France.

DELANAYE, P., Moranne, O., KRZESINSKI, J.-M., Warling, X., Smelten, N., & Pottel, H. (2013). Clinical and biological variables associated with mortality in hemodialysis patients [Poster presentation]. L Congress of ERA-EDTA, Istanbul, Turkey.

DELANAYE, P., Vidal-Patiot, E., BOUQUEGNEAU, A., Vrtovsnik, F., CAVALIER, E., KRZESINSKI, J.-M., & Flamant, M. (2013). MDRD versus CKD-EPI equations to estimate glomerular filtration rate in obese patients [Poster presentation]. ASN Kidney Week, Atlanta, United States - Georgia.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Smelten, N., & CAVALIER, E. (2013). Determinants of sclerostin concentration in hemodialysis patients [Poster presentation]. ASN Kidney Week, Atlanta, United States - Georgia.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Smelten, N., & CAVALIER, E. (2013). Vitamin K antagonists in hemodialysis patients: impact on the levels of dephospho- uncarboxylated matrix gla-protein [Paper presentation]. L Congress of ERA-EDTA, Istanbul, Turkey.

Masson, I., Maillard, N., Alamartine, E., Mariat, C., & DELANAYE, P. (2013). New K/DIGO guidelines and kidney transplantation: is the cystatin C-based recommendation relevant? [Paper presentation]. L Congress of ERA-EDTA, Istanbul, Turkey.

DELANAYE, P., LAMBERMONT, B., CLAISSE, G., MEHDI, M., MAILLARD, N., DUBOIS, B., DAMAS, P., KRZESINSKI, J.-M., MOREL, J., LAUTRETTE, A., CAVALIER, E., & MARIAT, C. (January 2013). Le débit de filtration glomérulaire est-il un déterminant de la concentration plasmatique du NGAL aux soins intensifs ? [Paper presentation]. Congrès de la société de réanimation de langue française.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Smelten, N., & CAVALIER, E. (2013). Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and correlated with vascular calcification in hemodialysis patients [Poster presentation]. ASN Kidney Week, Atlanta, United States - Georgia.

Gagneux-Brunon, A., DELANAYE, P., Mariat, C., & Moranne, O. (2013). GFR estimation equations in HIV-infected patients: one patient, one GFR estimating equation [Poster presentation]. ASN Kidney Week, Atlanta, United States - Georgia.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Smelten, N., Pottel, H., & CAVALIER, E. (2013). Variables cliniques et biologiques associées à la mortalité du patient hémodialysé [Poster presentation]. XV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Nantes, France.

Masson, I., Maillard, N., Alamartine, E., Mariat, C., & DELANAYE, P. (2013). Nouvelles recommendations K/DIGO et transplantation rénale : quelle place pour la cystatine C ? [Paper presentation]. XV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Nantes, France.

Masson, I., Maillard, N., Tack, I., Thibaudin, L., Dubourg, L., DELANAYE, P., CAVALIER, E., Bonneau, C., Kamar, N., Morelon, E., Moranne, O., Alamartine, E., & Mariat, C. (2013). GFR Estimation Using Standardized Cystatin C in Kidney Transplant Recipients. American Journal of Kidney Diseases, 61 (2), 279-284. doi:10.1053/j.ajkd.2012.09.010
Peer Reviewed verified by ORBi

BOUQUEGNEAU, A., DELANAYE, P., CAVALIER, E., & Krzesinski, J.-M. (2013). Annual meeting of the SBN/BVN [Paper presentation]. Annual meeting of the SBN/BVN, Bruxelles, Belgium.

Vidal-Petiot, E., DELANAYE, P., BOUQUEGNEAU, A., Vrtovsnik, F., CAVALIER, E., & Flamant, M. (2013). Estimation du débit de filtration glomérulaire chez l’obèse : MDRD ou CKD-EPI ? [Poster presentation]. XV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Nantes, France.

Masson, I., Flamant, M., Maillard, N., CAVALIER, E., Moranne, O., Alamartine, E., Mariat, C., & DELANAYE, P. (2013). MDRD versus CKD-EPI equation to estimate glomerular filtration rate in kidney transplant recipients [Poster presentation]. L Congress of ERA-EDTA, Istanbul, Turkey.

DELANAYE, P., CAVALIER, E., Maillard, N., Mehdi, M., LAMBERMONT, B., DUBOIS, B., DAMAS, P., KRZESINSKI, J.-M., Morel, J., Lautrette, A., & Mariat, C. (2013). Intérêt de la cystatine C aux soins intensifs : validation par rappoert à une mesure de référence du débit de filtration glomérulaire [Paper presentation]. XLI congrès de la Société de Réanimation de Langue Française, Paris, France.

Gagneux-Brunon, A., DELANAYE, P., LEGRAND, D., CAVALIER, E., & Mariat, C. (December 2012). NGAL biomarqueur de lésion rénale. Néphrologie et Thérapeutique, 8 (7), 508-515. doi:10.1016/j.nephro.2012.03.006
Peer Reviewed verified by ORBi

COLSON, L., Vander Rest, C., Reginster, J.-Y., DELANAYE, P., CAVALIER, E., LE GOFF, C., Crielaard, J.-M., & Kaux, J.-F. (December 2012). Ostéomalacie hypophosphatémique hyperphosphaturique avec hypersécrétion de FGF-23. Lettre du Rhumatologue, 387, 26-29.
Peer reviewed

DETRY, O., JANSSEN, N., CHERAMY-BIEN, J.-P., Cavalier, E., Defraigne, J.-O., DELANAYE, P., & LAMBERMONT, B. (November 2012). Effects of Large-Pore Hemofiltration in a Swine Model of Fulminant Hepatic Failure. Artificial Organs, 36 (11), 981-987. doi:10.1111/j.1525-1594.2012.01506.x
Peer Reviewed verified by ORBi

Pottel, H., Hoste, L., DELANAYE, P., CAVALIER, E., & Martens, F. (October 2012). Demystifying ethnic/sex differences in kidney function: is the difference in (estimating) glomerular filtration rate or in serum creatinine concentration? Clinica Chimica Acta, 413 (19-20), 1612-17. doi:10.1016/j.cca.2012.04.034
Peer Reviewed verified by ORBi

HAMDI, E., DELANAYE, P., LUTTERI, L., CHAPELLE, J.-P., & CAVALIER, E. (18 July 2012). analytical and Clinical Validation of Beta-Trace Protein, a New Marker of Glomerular Filtration Rate [Poster presentation]. AACC 2012, Los Angeles, United States.

CAVALIER, E., DELANAYE, P., CARLISI, I., BEKAERT, A.-C., FERRANTE, N., ROUSSELLE, O., & MORANNE, O. (17 July 2012). Variability of Different Markers of Bone mineral Metabolism in Hemodialysis PAtients: Implication on the Evaluation of the Critical Difference between two Measurements [Poster presentation]. AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., FERRANTE, N., ROUSSELLE, O., CHAPELLE, J.-P., & DELANAYE, P. (17 July 2012). Evaluation of Sclerostin levels in patients suffering from Chronic Kidney Diseases [Poster presentation]. AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., ROUSSELLE, O., & DELANAYE, P. (17 July 2012). Comparison of two automated 3rd generation PTH assays in different clinical populations [Poster presentation]. AACC 2012, Los Angeles, United States.

DELANAYE, P., Schaeffner, E., Ebert, N., CAVALIER, E., Mariat, C., KRZESINSKI, J.-M., & Moranne, O. (July 2012). Normal reference values for glomerular filtration rate: what do we really know? Nephrology Dialysis Transplantation, 27 (7), 2664-72. doi:10.1093/ndt/gfs265
Peer Reviewed verified by ORBi

CAVALIER, E., & DELANAYE, P. (03 May 2012). KDIGO Guidelines on « renal osteodystrophy»: A Critical review. Focus on the hemodialysis patient and on the lab [Paper presentation]. Annual Symposium of the Royal Belgian Society for Clinical Chemistry, Brussels, Belgium.

DELANAYE, P., Thibaudin, L., Souvignet, M., Maillard, N., Alamartine, E., Rozet, E., CAVALIER, E., & Mariat, C. (22 March 2012). Comparison of acid and enzymatic methods for insulin dosage: Analytical performances and impact on glomerular filtration rate evaluation. Clinica Chimica Acta, 413 (5-6), 556-560.
Peer Reviewed verified by ORBi

CAVALIER, E., CARLISI, I., ROUSSELLE, O., FERRANTE, N., & DELANAYE, P. (March 2012). Difference between total and intact assays for N-terminal propeptide of type I procollagen in renal impaired patients. Osteoporosis International, 23 (Supplement 2), 339.
Peer Reviewed verified by ORBi

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., Chapelle, J.-P., & DELANAYE, P. (18 January 2012). New insights on the stability of the Parathyroid hormone as assayed by an automated 3rd generation PTH assay. Clinica Chimica Acta, 413 (1-2), 353-4. doi:10.1016/j.cca.2011.09.034
Peer Reviewed verified by ORBi

Gagneux-Brunon, A., Mariat, C., & DELANAYE, P. (2012). Cystatin C in HIV-infected patients: promising but not yet ready for prime time. Nephrology Dialysis Transplantation, 27 (4), 1305-1313. doi:10.1093/ndt/gfs001
Peer Reviewed verified by ORBi

DELANAYE, P., DUBOIS, B., KRZESINSKI, J.-M., & CAVALIER, E. (2012). Compliance of the hemodialysis patient to the native vitamin D therapy [Poster presentation]. XLIX Congress of ERA-EDTA, Paris, France.

DELANAYE, P., Vidal-Petiot, E., & Flamant, M. (2012). Creatinine: Production, Physiology and Diagnostic Use in Kidney Diseases. In Perkins (Ed.), Creatinine: Production, Diagnostic Uses and role in Renal Disease. NovaPublisher.

DELANAYE, P. (2012). How measuring glomerular filtration rate? Comparison of reference methods. In M. Sahay (Ed.), Basic Nephrology and Acute Kidney Injury. InTech.
Peer reviewed

DELANAYE, P. (Ed.). (2012). Nephrology and Clinical Chemistry: the essential link. Bentham. doi:10.2174/97816080533391120101

DELANAYE, P., CAVALIER, E., Masson, I., Mehdi, Maillard, N., LAMBERMONT, B., DAMAS, P., KRZESINSKI, J.-M., Morel, J., Lautrette, A., & Mariat, C. (2012). Detection of decreased glomerular filtration rate in intensive care units: interest of cystatin C [Poster presentation]. XLIX congress of ERA-EDTA, Paris, France.

DELANAYE, P., DUBOIS, B., JOURET, F., KRZESINSKI, J.-M., & Moranne, O. (2012). Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple? [Poster presentation]. American Society of Nephrology, San Diego, United States - California.

DELANAYE, P. (2012). Mesures et estimations de la fonction rénale. Contribution générale et étude de différentes populations à risque [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/183370

Schaeffner, E., Ebert, N., DELANAYE, P., Frei, U., Gaedeke, J., Jakob, O., Kuhlmann, K., Schuchardt, M., Tölle, M., Ziebig, R., van der Giet, M., & Martus, P. (2012). Two novel equations to estimate kidney function in persons aged 70 years or older [Poster presentation]. American Society of Nephrology, San Diego, United States - California.

DELANAYE, P., Mariat, C., Moranne, O., CAVALIER, E., & Flamant, M. (2012). L'estimation du débit de filtration glomérulaire en 2012: quelle valeur ajoutée pour la nouvelle équation CKD-EPI. Néphrologie et Thérapeutique, 8, 199-205. doi:10.1016/j.nephro.2012.03.002
Peer Reviewed verified by ORBi

BOUQUEGNEAU, A., DUBOIS, B., Krzesinski, J.-M., & DELANAYE, P. (2012). Anorexia Nervosa and the Kidney. American Journal of Kidney Diseases, 60 (2), 299-307. doi:10.1053/j.ajkd.2012.03.019
Peer Reviewed verified by ORBi

DELANAYE, P. (2012). How Measuring Glomerular Filtration Rate? Comparison of reference methods. In M. Sahay (Ed.), Basic Nephrology and Acute Kidney injury. Croatia: InTech.

DELANAYE, P., BOUQUEGNEAU, A., DUBOIS, B., & ANDRE, B. (2012). Le médicament du mois : Fébuxostat (Adenuric®). Revue Médicale de Liège, 67 (4), 202-209.

DELANAYE, P., & Ebert, N. (2012). Assessment of kidney function: estimating GFR in children. Nature Reviews Nephrology, 8 (9), 503-504. doi:10.1038/nrneph.2012.163
Peer Reviewed verified by ORBi

Gagneux-Brunon, A., DELANAYE, P., Fresard, A., Lucht, F., & Mariat, C. (2012). Creatinine and/or cystatin C-based GFR estimation in HIV-infected patients [Poster presentation]. XLIX Congress of ERA-EDTA, Paris, France.

Masson, I., Maillard, N., Kamar, K., DELANAYE, P., & Mariat, C. (2012). CKD-EPI GFR estimating equations in kidney transplantation: which added value for the new cystatin C based equations? [Poster presentation]. American Society of Nephrology, San Diego, United States - California.

Gagneux-Brunon, A., DELANAYE, P., Delavenne, X., Basset, T., Lucht, F., & Mariat, C. (2012). Creatinine and/or cystatin C-based GFR estimation in HIV-infected patients [Poster presentation]. American Society of Nephrology, San Diego, United States - California.

DELANAYE, P., CAVALIER, E., Mehdi, M., Maillard, N., LAMBERMONT, B., DUBOIS, B., DAMAS, P., KRZESINSKI, J.-M., Morel, L., Lautrette, A., & Mariat, C. (2012). Intérêt de la cystatine C aux soins intensifs : validation par rapport à une mesure de référence du débit de filtration glomérulaire [Paper presentation]. XIV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Genève, Switzerland.

DELANAYE, P. (2012). Estimating GFR in 2012: the creatinine-based equations [Paper presentation]. Second EFCC-UEMS congress, Dubrovnik, Croatia.

DELANAYE, P., CAVALIER, E., DUBOIS, B., & KRZESINSKI, J.-M. (2012). Adhésion thérapeutique du patient hémodialysé [Poster presentation]. XIV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Genève, Switzerland.

DELANAYE, P., CARLISI, I., ROUSSELLE, O., FERRANTE, N., KRZESINSKI, J.-M., & CAVALIER, E. (2012). Utilisation du propeptide N-terminal du procollagène de type 1 (P1NP) comme marqueur de formation osseuse chez le patient insuffisant rénal : différence entre le dosage total et le dosage « intact » [Poster presentation]. XIV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Genève, Switzerland.

DELANAYE, P., Claisse, G., Mehdi, M., Maillard, N., LAMBERMONT, B., DUBOIS, B., DAMAS, P., KRZESINSKI, J.-M., Morel, J., Lautrette, A., & Mariat, C. (2012). Le débit de filtration glomérulaire est-il un déterminant de la concentration plasmatique du NGAL aux soins intensifs ? [Poster presentation]. XIV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Genève, Switzerland.

Bargnoux, A.-S., Morena, M., Dupuy, A.-M., CAVALIER, E., Mourad, G., DELANAYE, P., Canaud, B., & Cristol, J.-P. (2012). Vascular calcifications in chronic kidney disease: can the Biologist be of some help? In P. DELANAYE (Ed.), Clinical Chemistry and Nephrology: the essential link. Bentham Science Publishers. doi:10.2174/978160805333911201010122

DELANAYE, P., WEEKERS, L., DUBOIS, B., CAVALIER, E., DETRY, O., SQUIFFLET, J.-P., & KRZESINSKI, J.-M. (January 2012). Outcome of the living kidney donor. Nephrology Dialysis Transplantation, 27 (1), 41-50. doi:10.1093/ndt/gfr669
Peer Reviewed verified by ORBi

Schaeffner, E., Ebert, N., DELANAYE, P., Frei, U., Gaedeke, J., Jakob, O., Kuhlmann, K., Schuchardt, M., Tolle, M., Ziebig, R., van der Giet, M., & Martus, P. (2012). Two novel equations to estimate kidney function in persons aged 70 years or older. Annals of Internal Medicine, 157 (7), 471-481. doi:10.7326/0003-4819-157-7-201210020-00003
Peer Reviewed verified by ORBi

DELANAYE, P., WEEKERS, L., Warling, X., Moonen, M., Smelten, N., Médart, L., KRZESINSKI, J.-M., & CAVALIER, E. (2012). Vitamine D native chez le patient hémodialysé: efficacité et profil de sécurité. Une étude multicentrique, prospective et randomisée contre placebo sur un an [Poster presentation]. XIV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Genève, Switzerland.

CAVALIER, E., DELANAYE, P., VRANKEN, L., BEKAERT, A.-C., CARLISI, I., Chapelle, J.-P., & SOUBERBIELLE, J.-C. (2012). Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values. Nephrology Dialysis Transplantation, 27, 1950-56. doi:10.1093/ndt/gfr535
Peer Reviewed verified by ORBi

Masson, I., Maillard, N., Tack, I., Jaafar, A., Thibaudin, L., Hadj-Aissa, A., Dubourg, L., DELANAYE, P., CAVALIER, E., Rostaing, L., Kamar, N., Morelon, E., Alamartine, E., & Mariat, C. (2012). Performance, limitations and utility of cystatin C as an endogenous GFR marker in renal transplantation [Poster presentation]. XLIX Congress of ERA-EDTA, Paris, France.

DELANAYE, P., & Krzesinski, J.-M. (2012). Estimating Glomerular Filtration Rate in 2012 - Does the New Chronic Kidney Disease Epidemiology Equation Fare Better than Older Equations? European Nephrology, 6 (1), 15-20.
Peer reviewed

CAVALIER, E., DELANAYE, P., & Souberbielle, J.-C. (October 2011). Maintenir la PTH entre 2 et 9 fois la valeur de référence supérieure du Laboratoire: d'accord, mais quelle valeur? Néphrologie et Thérapeutique, 7 (5), 411-447 (Pub 27.
Peer Reviewed verified by ORBi

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., GUADAGNI, A., ROUSSELLE, O., Chapelle, J.-P., & DELANAYE, P. (October 2011). New insights on the stability of the (1-84) PTH as determined with an automated 3rd generation PTH assay. Clinical Chemistry, 57 (S10), 190.
Peer Reviewed verified by ORBi

VAN DER REST, C., CAVALIER, E., KAUX, J.-F., KRZESINSKI, J.-M., HUSTINX, R., REGINSTER, J.-Y., & DELANAYE, P. (October 2011). Tumor-induced osteomalacia: The tumor may stay hidden! Clinical Biochemistry, 44 (14-15), 1264-6. doi:10.1016/j.clinbiochem.2011.07.013
Peer Reviewed verified by ORBi

CAVALIER, E., DELANAYE, P., VRANKEN, L., CARLISI, I., BEKAERT, A.-C., Chapelle, J.-P., & Souberbielle, J.-C. (October 2011). Impact of the use of the Manufacture's published reference range for PTH vs. the reference range established in the Laboratory for the classification of the haemodialyzed patients with the KDIGO Guidelines. Clinical Chemistry, 57 (S10), 191.
Peer Reviewed verified by ORBi

DELANAYE, P., CAVALIER, E., Mariat, C., KRZESINSKI, J.-M., & Rule, A. (September 2011). Estimating glomerular filtration rate in Asian subjects: where do we stand? Kidney International, 80 (5), 439-440. doi:10.1038/ki.2011.197
Peer Reviewed verified by ORBi

CAVALIER, E., DELANAYE, P., Souberbielle, J.-C., & RADERMECKER, R. (September 2011). Vitamin D and type 2 diabetes mellitus: Where do we stand? Diabetes and Metabolism, 37 (4), 265-72. doi:10.1016/j.diabet.2011.01.001
Peer Reviewed verified by ORBi

DELANAYE, P., CAVALIER, E., & KRZESINSKI, J.-M. (September 2011). Détection de la maladie rénale chronique dans la population générale: créatinine ou cystatine C? [Poster presentation]. 13e Réunion commune de la Société Francophone de Dialyse (SFD) et de la Société de Néphrologie (SN), Bordeaux, France.

DELANAYE, P., KRZESINSKI, J.-M., & CAVALIER, E. (September 2011). Suivi longitudinal des concentrations de PTH et de phosphatase alcaline osseuse chez le sujet hémodialysé: mesure-t-on la même chose? [Poster presentation]. 13e Réunion commune de la Société Francophone de Dialyse (SFD) et de la Société de Néphrologie (SN), Bordeaux, France.

DELANAYE, P., CAVALIER, E., Mariat, C., Maillard, N., KRZESINSKI, J.-M., & White, C. (September 2011). Trimethoprim, creatinine and creatinine-based equations. Kidney International, 80 (5), 439-40. doi:10.1159/000328911
Peer Reviewed verified by ORBi

CAVALIER, E., & DELANAYE, P. (September 2011). Nouveautés sur la stabilité de la parathormone telle que mesurée à l'aide d'un kit de troisième génération: impact sur la pratique quotidienne. Néphrologie et Thérapeutique, 7 (5), 284-85.
Peer Reviewed verified by ORBi

Masson, I., Maillard, N., Jaafar, A., Thibaudin, L., Dubourg, L., DELANAYE, P., CAVALIER, E., Bonneau, F., Kamar, N., Morelon, E., Alarmatine, E., & Mariat, C. (September 2011). Estimation du débit de filtration glomérulaire en transplantation rénale: étude multicentrique d'évaluation de la performance de la cystatine C [Poster presentation]. 13e Réunion commune de la Société Francophone de Dialyse (SFD) et de la Société de Néphrologie (SN), Bordeaux, France.

DELANAYE, P., CAVALIER, E., & KRZESINSKI, J.-M. (September 2011). Définition d'un débit de filtration "normal" fixe ou adapté à l'âge et au genre: impact sur l'épidémiologie de la maladie rénale chronique [Poster presentation]. 13e Réunion commune de la Société Francophone de Dialyse (SFD) et de la Société de Néphrologie (SN), Bordeaux, France.

DELANAYE, P., KRZESINSKI, J.-M., & CAVALIER, E. (September 2011). Suivi à court et à long terme de la concentration de parathormone chez le patient hémodialysé: dosage de seconde et troisième génération [Poster presentation]. 13e Réunion commune de la Société Francophone de Dialyse (SFD) et de la Société de Néphrologie (SN), Bordeaux, France.

VAN DER REST, C., CAVALIER, E., COLSON, L., KAUX, J.-F., KRZESINSKI, J.-M., REGINSTER, J.-Y., HUSTINX, R., & DELANAYE, P. (August 2011). Hypophosphatémie et ostéomalacie oncogénique. Revue Médicale Suisse, 7, 1630-3.
Peer Reviewed verified by ORBi

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., GUADAGNI, A., ROUSSELLE, O., CHAPELLE, J.-P., & DELANAYE, P. (28 July 2011). New insights on the stability of the (1-84) PTH as determined with an automated 3rd generation PTH assay [Poster presentation]. AACC, Atlanta, United States.

CAVALIER, E., DELANAYE, P., Vranken, L., CARLISI, I., BEKAERT, A.-C., CHAPELLE, J.-P., & Souberbielle, J.-C. (28 July 2011). Impact of the use of the Manufacturer's published reference range for PTH vs. the reference range established in the Laboratory for the classification of the haemodialyzed patients with the KDIGO Guidelines [Poster presentation]. AACC, Atlanta, United States.

WEEKERS, L., Warling, X., Moonen, M., Smelten, N., Medart, L., Krzesinski, J.-M., CAVALIER, E., & DELANAYE, P. (25 June 2011). Native vitamin D in dialysis patients : safety and biological effects [Paper presentation]. XLVIII ERA-EDTA, Prague, Czechia.

CAVALIER, E., CARLISI, I., & DELANAYE, P. (May 2011). Human anti-animal antibodies: even today, it is still a problem in routine practice: illustration with 4 clinical cases. Clinical Chemistry and Laboratory Medicine, 49 (s1), 409.
Peer Reviewed verified by ORBi

DELANAYE, P., MARIAT, C., MAILLARD, N., KRZESINSKI, J.-M., & CAVALIER, E. (April 2011). Are the creatinine-based equations accurate to estimate glomerular filtration rate in african american populations ? Clinical Journal of the American Society of Nephrology, 6, 906-912. doi:10.2215/CJN.10931210
Peer Reviewed verified by ORBi

DELANAYE, P., MARIAT, C., KRZESINSKI, J.-M., & CAVALIER, E. (19 February 2011). Paricalcitol for reduction of albuminuria in diabetes [letter to the editor]. The Journal-Lancet, 377, 635. doi:10.1016/S0140-6736(11)60223-7
Peer Reviewed verified by ORBi

Bargnoux, A. S., Cavalier, E., Cristol, J. P., Simon, N., Dupuy, A. M., Garrigue, V., Delanaye, P., & Mourad, G. (February 2011). Cystatin C is a reliable marker for estimation of glomerular filtration rate in renal transplantation: validation of a new turbidimetric assay using monospecific sheep antibodies. Clinical Chemistry and Laboratory Medicine, 49 (2), 265-70. doi:10.1515/CCLM.2011.043
Peer Reviewed verified by ORBi

DETRY, O., JANSSEN, N., CHERAMY-BIEN, J.-P., Defraigne, J.-O., DELANAYE, P., & LAMBERMONT, B. (February 2011). EFFECTS OF LARGE PORE HEMOFILTRATION IN A SWINE MODEL OF FULMINANT HEPATIC FAILURE. Transplant International, 24 (1), 10-10.
Peer Reviewed verified by ORBi

WIESEN, P., VAN OVERMEIRE, L., DELANAYE, P., DUBOIS, B., & PREISER, J.-C. (2011). Nutritional disorders during acute renal failure and renal replacement therapy. JPEN Journal of Parenteral and Eternal Nutrition, 35, 217-222. doi:10.1177/0148607110377205
Peer Reviewed verified by ORBi

Gagneux-Brunon, A., Mariat, C., & DELANAYE, P. (2011). Cystatin C in HIV Patients: More than just a GFR marker ? In J. B. Cohen & L. P. Ryseck (Eds.), Cystatins: Protease Inhibitors, Biomarkers and Immunomodulators. New York, United States - New York: Nova Science Publisher.

Masson, I., Mariat, C., & DELANAYE, P. (2011). Cystatin C as a GFR Marker in Renal Transplantation: Promises and Challenges. In J. B. Cohen & L. P. Ryseck (Eds.), Cystatins: Protease Inhibitors, Biomarkers and Immunomodulators. New York, United States - New York: Nova Science Publisher.

DELANAYE, P. (2011). Vascular calcifications in hemodialyzed patients [Paper presentation]. Annual Symposium of the Royal Belgian Society of Clinical Chemistry, Groot Bijgaard, Belgium.

Pieroni, L., DELANAYE, P., Boutten, A., Bargnoux, A.-S., Rozet, E., Delatour, V., Carlier, M.-C., Hanser, A.-M., CAVALIER, E., Froissart, M., & Cristol, J.-P. (2011). A multicentric evaluation of IDMS-traceable creatinine enzymatic assays. Clinica Chimica Acta, 412, 2070-2075. doi:10.1016/j.cca.2011.07.012
Peer Reviewed verified by ORBi

Delanaye, P., Rozet, E., Krzesinski, J.-M., & Cavalier, E. (2011). Urinary NGAL measurement : Biological variation and ratio to creatinine. Clinica Chimica Acta, 412 (3-4), 390. doi:10.1016/j.cca.2010.10.011
Peer Reviewed verified by ORBi

Cavalier, E., Bekaert, A.-C., Carlisi, I., Legrand, D., Krzesinski, J.-M., & Delanaye, P. (2011). Neutrophil gelatinase-associated lipocalin (NGAL) determined in urine with the Abbott Architect or in plasma with the Biosite Triage? The laboratory's point of view. Clinical Chemistry and Laboratory Medicine, 49 (2), 339-341. doi:10.1515/CCLM.2011.044
Peer Reviewed verified by ORBi

DELANAYE, P., Souvignet, M., Dubourg, L., Thibaudin, L., Maillard, N., KRZESINSKI, J.-M., CAVALIER, E., & Mariat, C. (2011). Le dosage de l'inuline: mise au point. Annales de Biologie Clinique, 69 (3), 273-84. doi:10.1684/abc.2011.0580
Peer Reviewed verified by ORBi

Bargnoux, A.-S., Boutten, A., Cambillau, M., Carlier, M.-C., CAVALIER, E., Cristol, J.-P., Hanser, A.-M., Piéroni, L., DELANAYE, P., Frimat, L., & Froissart, M. (January 2011). Recommandations pour le choix et l'harmonisation des techniques de dosage de la créatinine. Annales de Biologie Clinique, 69 (1), 9-16.
Peer Reviewed verified by ORBi

Cavalier, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Chapelle, J.-P., & Delanaye, P. (2011). Analytical validation of the Liaison Calcitonin_II-Gen (DiaSorin). Clinical Chemistry and Laboratory Medicine, 49 (2), 271-275. doi:10.1515/CCLM.2011.036
Peer Reviewed verified by ORBi

CAVALIER, E., WALLACE, A. M., CARLISI, I., CHAPELLE, J.-P., DELANAYE, P., & SOUBERBIELLE, J.-C. (2011). Cross-reactivity of 25-hydroxy vitamin D2 from different commercial immunoassays for 25-hydroxy vitamin D: an evaluation without spiked samples. Clinical Chemistry and Laboratory Medicine, 49 (3), 555-8. doi:10.1515/CCLM.2011.072
Peer Reviewed verified by ORBi

DELANAYE, P., Maillard, N., Thibaudin, L., & Mariat, C. (2011). Exploration de la fonction glomérulaire rénale (I). Méthodes de référence et créatinine sérique. Paris, France: EMC, Elsevier Masson SAS.

DELANAYE, P., & KRZESINSKI, J.-M. (2011). Indexing of renal function parameters by body surface area: intelligence or folly? Nephron. Clinical Practice, 119 (4), 289-92. doi:10.1159/000330276
Peer Reviewed verified by ORBi

DELANAYE, P. (2011). How to measure GFR in the year 2011? [Paper presentation]. CME Course 3, XLVIII Congress of ERA-EDTA, Prague, Czechia.

Delanaye, P., & Krzesinski, J.-M. (10 October 2010). Points forts de la SFN (Société Française de Néphrologie) [Paper presentation]. Réunion scientifique, Liège, Belgium.

Delanaye, P., & Cavalier, E. (2010). Vascular calcifications in dialysis patients.

Cavalier, E., Daly, A., Betea, D., Stubbs, P., DELANAYE, P., Bradwell, A., Chapelle, J., & Beckers, A. (September 2010). Un nouveau marqueur tumoral pour le carcinome parathyroïdien? Résultats observés chez 24 patients. Annales d'Endocrinologie, 71 (5), 350-351.
Peer Reviewed verified by ORBi

Cavalier, E., Carlisi, I., Delanaye, P., Beckers, A., & Souberbielle, J.-C. (2010). Dosage de la 25-OH vitamine D: attention aux erreurs analytiques! Congrès de la Société Française d'Endocrinologie.
Peer reviewed

Cavalier, E., Barguil, Y., Bourgeois, A. M., Boutten, A., Delanaye, P., Desch, G., Duvillard, L., Fellahi, S., Froissart, M., Piéroni, L., Rozet, E., & Cristol, J. P. (September 2010). Evaluation analytique de la cystatine C: résultats de l'étude multicentrique SN/SFBC. Néphrologie et Thérapeutique, 6 (5), 314.
Peer Reviewed verified by ORBi

Cavalier, E., Jean, G., Delanaye, P., & Souberbielle, J.-C. (September 2010). Les cibles thérapeutiques pour la PTH dans les nouvelles recommandations du KDIGO: la fin d'un cauchemar? Néphrologie et Thérapeutique, 6 (5), 424.
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., & Beckers, A. (2010). Détection précoce de l'hyperparathyroïdie secondaire : impact de l'établissement des valeurs de références de la parathormone. In 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010.
Peer reviewed

Cavalier, E., Krzesinski, J.-M., & Delanaye, P. (September 2010). Mesure de la PTH chez le patient hémodialysé avec une trousse de 2è ou de 3è génération: impact pour le clinicien. Néphrologie et Thérapeutique, 6 (5), 397.
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Mariat, C., Lambermont, B., Wiesen, P., Damas, P., & Krzesinski, J.-M. (September 2010). Intérêt de la cystatine C plasmatique pour la détection d'une insuffisance rénale chez le patient hospitalisé aux soins intensifs : résultats préliminaires [Poster presentation]. 12è Réunion commune de la Société de Néphrologie (SN) et de la Société Francophone de Dialyse (SFD), Bruxelles, Belgium.

Delanaye, P., Warling, X., Moonen, M., Smelten, N., Rozet, E., Médart, L., Weekers, L., Krzesinski, J.-M., & Cavalier, E. (September 2010). Quels paramètres cliniques et biologiques peuvent être considérés comme prédictifs des calcifications vasculaires chez le patient hémodialysé? [Poster presentation]. 12è Réunion commune de la Société de Néphrologie (SN) et de la Société Francophone de Dialyse (SFD), Bruxelles, Belgium.

Thibaudin, L., Delanaye, P., Maillard, N., Cavalier, E., Rozet, E., Alamartine, E., & Mariat, C. (September 2010). Comparaison d'une méthode "acide" et enzymatique pour le dosage de l'inuline [Poster presentation]. 12è Réunion commune de la Société de Néphrologie (SN) et de la Société Francophone de Dialyse (SFD), Bruxelles, Belgium.

Cavalier, E., Delanaye, P., & Beckers, A. (2010). Les anticorps hétérophiles : une cause souvent méconnue d'erreurs de diagnostic. In 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010.
Peer reviewed

Cavalier, E., Rozet, E., Bekaert, A.-C., Legrand, D., Krzesinski, J.-M., & Delanaye, P. (September 2010). Le dosage urinaire et plasmatique du NGAL: étude analytique et implications pratiques pour le clinicien. Néphrologie et Thérapeutique, 6 (5), 350.
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., & Beckers, A. (September 2010). Détection précoce de l'hyperparathyroïdie secondaire : impact de l'établissement des valeurs de référence de la parathormone. Annales d'Endocrinologie, 71 (5), 364.
Peer Reviewed verified by ORBi

Cavalier, E., Carlisi, A., Delanaye, P., & Beckers, A. (September 2010). Les anticorps hétérophiles : une cause souvent méconnue d'erreurs de diagnostic. Annales d'Endocrinologie, 71 (5), 367-68.
Peer Reviewed verified by ORBi

Cavalier, E., Carlisi, A., Delanaye, P., Beckers, A., & Souberbielle, J.-C. (September 2010). Dosage de la vitamine D : attention aux erreurs analytiques! Annales d'Endocrinologie, 71 (5), 368.
Peer Reviewed verified by ORBi

Cavalier, E., Daly, A., Betea, D., Pruteanu-Apetrii, P. N., Delanaye, P., Stubbs, P., Bradwell, A. R., Chapelle, J.-P., & Beckers, A. (August 2010). The Ratio of Parathyroid Hormone as Measured by Third- and Second-Generation Assays as a Marker for Parathyroid Carcinoma. Journal of Clinical Endocrinology and Metabolism, 95, 3745-9. doi:10.1210/jc.2009-2791
Peer Reviewed verified by ORBi

Cavalier, E., Saarbach, D., Bekaert, A.-C., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (June 2010). Analytical validation of the Abbott Architect urine NGAL. Clinical Chemistry, 56 (S6), 96.
Peer Reviewed verified by ORBi

Cavalier, E., Rousselle, O., Bekaert, A.-C., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (June 2010). Evaluation of the DiaSorin Liaison 1-84 PTH Assay, a new automated immunoassay for the determination of the 3rd Generation PTH. Clinical Chemistry, 56 (S6), 56.
Peer Reviewed verified by ORBi

Cavalier, E., Daly, A., Betea, D., Pruteanu Apetrii, P., Delanaye, P., Stubbs, P., Bradwell, A. R., Chapelle, J.-P., & Beckers, A. (June 2010). The ratio of PTH as measured by third and second generation assays as a marker for parathyroid carcinoma. Clinical Chemistry, 56 (S6), 188.
Peer Reviewed verified by ORBi

Cavalier, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Delanaye, P., & Chapelle, J.-P. (June 2010). Evaluation of Liaison Calcitonin II Gen, a new kit for Calcitonin determination. Clinical Chemistry, 56 (S6), 188.
Peer Reviewed verified by ORBi

Detry, O., Janssen, N., Cheramy-Bien, J.-P., Cavalier, E., Defraigne, J.-O., Delanaye, P., & Lambermont, B. (April 2010). Effects of large pore hemofiltration in a swine model of fulminant hepatic failure. Acta Chirurgica Belgica, 110, 86. FP45.
Peer Reviewed verified by ORBi

Delanaye, P., Maillard, N., Rozet, E., Cavalier, E., Krzesinski, J.-M., Alamartine, E., & Mariat, C. (April 2010). Donor-Estimated Glomerular Filtration Rate as a Criterion for Allocation of Expended Criteria Donors Kidney into Single or Dual Transplantation : The Choice of the Estimating Equation Matters [Poster presentation]. American Society of Transplantation, San Diego, United States - California.

Cavalier, E., & Delanaye, P. (25 March 2010). First experience with Architect urine NGAL [Paper presentation]. 5th Annual Abbott European Laboratory Symposium, Wiesbaden, Germany.

Cavalier, E., Rozet, E., Gadisseur, R., Carlisi, I., Monge, M., Chapelle, J.-P., Hubert, P., Souberbielle, J.-C., & Delanaye, P. (2010). Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs. Osteoporosis International, 21, 1047-1051. doi:10.1007/s00198-009-1052-5
Peer Reviewed verified by ORBi

Delanaye, P., & Scheen, A. (2010). Effects of fibrates on cardiovascular outcomes [letter to the editor]. The Lancet, 376 (9746), 1051. doi:10.1016/S0140-6736(10)61481-X
Peer Reviewed verified by ORBi

Cavalier, E., Bekaert, A.-C., Legrand, D., Rozet, E., Krzesinski, J.-M., & Delanaye, P. (2010). Urinary NGAL: Use of absolute value or ratio to creatinine? Acta Clinica Belgica, 65-3, 13.
Peer Reviewed verified by ORBi

Cavalier, E., Daly, A., Chapelle, J.-P., Betea, D., Bradwell, A., Stubbs, P., Delanaye, P., & Beckers, A. (2010). The ratio of PTH as measured by third and second generation assays as a marker for parathyroid carcinoma. In 12th European Congress of Endocrinology - ICE 2010.
Peer reviewed

Cavalier, E., Delanaye, P., Cormier, C., & Souberbielle, J.-C. (2010). Measurement uncertainty for the analysis of serum 25-hydroxyvitamin D: response to Stepman and Thienpont [letter to the editor]. Osteoporosis International, 21, 1055-1056. doi:10.1007/s00198-009-1098-4
Peer Reviewed verified by ORBi

Cavalier, E., & Delanaye, P. (2010). Evaluation meets Precision. Sciencebook Europe, 1, 5.

Cavalier, E., Krzesinski, J.-M., & Delanaye, P. (2010). Mesure de la PTH chez le patient hémodialysé avec une trousse de 2ème ou de 3ème génération: impact pour le clinicien. Néphrologie et Thérapeutique.
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., & Krzesinski, J.-M. (2010). PTH reference target for the follow-up of hemodialyzed patients and new KDIGO guidelines: the end of a nightmare? Acta Clinica Belgica.
Peer Reviewed verified by ORBi

Cavalier, E., Saarbach, D., Bekaert, A.-C., Legrand, D., Krzesinski, J.-M., & Delanaye, P. (2010). Urinary or plasma NGAL?: Analytical point of view. Acta Clinica Belgica.
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Maillard, N., Krzesinski, J.-M., Mariat, C., Cristol, J.-P., & Pieroni, L. (2010). La creatinine : d'hier a aujourd'hui. Annales de Biologie Clinique, 68 (5), 531-43. doi:10.1684/abc.2010.0479
Peer Reviewed verified by ORBi

Detry, O., Janssen, N., Cavalier, E., Delanaye, P., Cheramy-Bien, J.-P., Honore, P., Defraigne, J.-O., & Lambermont, B. (2010). Effects of large pore hemofiltration in a swine model of fulminant hepatic failure. Acta Gastro-Enterologica Belgica, 73 (1), 35.
Peer Reviewed verified by ORBi

Delanaye, P., Rozet, E., Maillard, N., & Mariat, C. (2010). Allocation of ECD Kidneys Based on Donor GFR: The Choice of the Estimating Equation Matters [letter to the editor]. American Journal of Transplantation, 10 (6), 1493-1494. doi:10.1111/j.1600-6143.2010.03045.x
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Krzesinski, J.-M., & Mariat. (2010). Can creatinine clearance in children clear the indexing GFR with BSA from the charge of errors? [letter to the editor]. Nephrology Dialysis Transplantation, 25, 2381-2386. doi:10.1093/ndt/gfq235
Peer Reviewed verified by ORBi

Cavalier, E., Jean, G., Delanaye, P., & Souberbielle, J.-C. (2010). Les cibles thérapeutiques pour la PTH dans les nouvelles recommandations du KDIGO: la fin d'un cauchemar? Néphrologie et Thérapeutique.
Peer Reviewed verified by ORBi

Cavalier, E., Rozet, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Hubert, P., Chapelle, J.-P., & Delanaye, P. (January 2010). Analytical validation of the BAP OSTASE on Liaison (DiaSorin). Clinical Chemistry and Laboratory Medicine, 48 (1), 67-72. doi:10.1515/CCLM.2010.019
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Mariat, C., Maillard, N., & Krzesinski, J.-M. (2010). MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant? BMC Nephrology, 11 (8). doi:10.1186/1471-2369-11-8
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Hubert, P., Krzesinski, J.-M., Chapelle, J.-P., & Rozet, E. (December 2009). Estimation of the Stability of Parathyroid Hormone when Stored at -80°C for a Long Period. Clinical Journal of the American Society of Nephrology, 4 (12), 1988-92. doi:10.2215/CJN.03970609
Peer Reviewed verified by ORBi

Mariat, C., Cavalier, E., Maillard, N., Krzesinski, J.-M., & Delanaye, P. (October 2009). Prevalence of Chronic Kidney Disease in an Elderly Population: Impact of the Choice of the Equation Used for Estimating GFR [Poster presentation]. American Society of Nephrology, San Diego, United States.

Cavalier, E., & Delanaye, P. (September 2009). Defining a "reference population": no easy task [letter to the editor]. Journal of Bone and Mineral Research, 24 (9), 1638. doi:10.1359/jbmr.090322
Peer Reviewed verified by ORBi

Cavalier, E., Rozet, E., Carlisi, I., Bekaert, A.-C., Chapelle, J.-P., & Delanaye, P. (June 2009). ANALYTICAL PERFORMANCE OF THE C-TERMINAL FGF-23 (IMMUTOPICS). Clinical Chemistry and Laboratory Medicine, 47 (M-A032).
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Bekaert, A.-C., Carlisi, I., & Chapelle, J.-P. (June 2009). Establishment of a reference range for the Bone Alkaline Phosphatase (BAP) with Diasorin Liaison in a biologically well-designed population. Clinical Chemistry, 55 (S6), 178.
Peer Reviewed verified by ORBi

LECLERCQ, P., LOLY, C., DELANAYE, P., GARWEG, C., & LAMBERMONT, B. (2009). Green Urine. The Lancet. doi:10.1016/S0140-6736(09)60309-3
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Mariat, C., Maillard, N., Dubois, B., & Krzesinski, J.-M. (February 2009). Détection et estimation du niveau de la maladie rénale chronique. Revue Médicale de Liège, 64 (2), 73-78.
Peer reviewed

Cavalier, E., Carlisi, I., Chapelle, J.-P., Orfanos, P., Uzan, M., Falque, V., Delanaye, P., & Hachicha, M. (2009). Human anti-mouse antibodies interferences in Elecsys PTH assay after OKT3 treatment. Transplantation, 87 (3), 451-2. doi:10.1097/TP.0b013e31819575a1
Peer Reviewed verified by ORBi

Delanaye, P., Mariat, C., Cavalier, E., & Krzesinski, J.-M. (2009). Errors induced by indexing glomerular filtration rate for body surface area: reductio ad absurdum. Nephrology Dialysis Transplantation, 24 (12), 3593-6. doi:10.1093/ndt/gfp431
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Radermecker, R., Paquot, N., Depas, G., Chapelle, J.-P., Scheen, A., & Krzesinski, J.-M. (2009). Estimation of GFR by different creatinine- and cystatin-C-based equations in anorexia nervosa. Clinical Nephrology, 71 (5), 482-91. doi:10.5414/CNP71482
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Chapelle, J.-P., & Souberbielle, J.-C. (2009). Vitamin D: current status and perspectives. Clinical Chemistry and Laboratory Medicine, 47 (2), 120-127. doi:10.1515/CCLM.2009.036
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (2009). Low prevalence of chronic kidney disease in Far-East Asian populations: impact of the ethnicity factor? [letter to the editor]. Nephrology Dialysis Transplantation, 24 (9), 2952-3. doi:10.1093/ndt/gfp279
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Lambermont, B., Canivet, J.-L., Preiser, J.-C., Garweg, C., Dubois, B., Morimont, P., Wiesen, P., Bataille, Y., Damas, P., & Krzesinski, J.-M. (2009). Mesure du débit de filtration glomérulaire aux soins intensifs basée sur l’iohexol : clairance plasmatique ou urinaire ? [Poster presentation]. 37ème congrès de la Société de Réanimation de Langue Française, Paris, France.

Maillard, N., Alamartine, E., Berthoux, F., Delanaye, P., & Mariat, C. (2009). On the demanding necessity of properly evaluating renal graft function in clinical trials [letter to the editor]. Transplant International, 22 (2), 247-8. doi:10.1111/j.1432-2277.2008.00753.x
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Rorive, M., Radermecker, R., Scheen, A., & Krzesinski, J.-M. (2009). Indexing glomerular filtration for body surface area is misleading in obese subjects: reductio ad absurdum [Poster presentation]. World Congress of Nephrology, Milano, Italy.

Delanaye, P., Cavalier, E., Saint-Remy, A., Lutteri, L., & Krzesinski, J.-M. (2009). Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population. Scandinavian Journal of Clinical and Laboratory Investigation, 69 (3), 344-9. doi:10.1080/00365510802609856
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Rorive, M., Radermecker, R., Paquot, N., Scheen, A., & Krzesinski, J.-M. (2009). Estimation du debit de filtration glomérulaire chez le patient obese: performances des équations basées sur la créatinine et la cystatine C [Paper presentation]. réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Toulouse, France.

Delanaye, P., Janssen, N., Dogné, J.-M., Dubois, B., Ghuysen, A., Kolh, P., D'Orio, V., Desaive, T., Krzesinski, J.-M., & Lambermont, B. (2009). Influence de la largeur des pores des membranes utilisées au cours de l’hémofiltration et du débit d’ultrafiltration sur la clairance plasmatique de l’interleukine 6 dans un modèle porcin de choc septique [Poster presentation]. 37ème congrès de la Société de Réanimation de Langue Française, Paris, France.

WIESEN, P., VAN OVERMEIRE, L., DELANAYE, P., & PREISER, J.-C. (2009). Pertes de nutriments lors de procédures d’épuration extrarénale. Réanimation, 18, 518-523. doi:10.1016/j.reaurg.2009.06.008
Peer Reviewed verified by ORBi

Sumaili, E. K., Krzesinski, J.-M., Zinga, C. V., Cohen, E. P., Delanaye, P., Munyanga, S. M., & Nseka, N. M. (2009). Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo. Nephrology Dialysis Transplantation, 24 (1), 117-122. doi:10.1093/ndt/gfn469
Peer Reviewed verified by ORBi

Delanaye, P., Mariat, C., Cavalier, E., & Krzesinski, J.-M. (2009). Indexation du debit de filtration glomerulaire par la surface corporelle : mythe et realite. Néphrologie et Thérapeutique, 5 (7), 614-22. doi:10.1016/j.nephro.2009.04.002
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Carlisi, I., Chapelle, J.-P., & Collette, J. (2009). An unusual interference in parathormone assay caused by anti-goat IgG: a case report. Clinical Chemistry and Laboratory Medicine, 47 (1), 118. doi:10.1515/CCLM.2009.015
Peer Reviewed verified by ORBi

DELANAYE, P., Mariat, C., CAVALIER, E., & KRZESINSKI, J.-M. (2009). Indexing Glomerular Filtration Rate for Body Surface Area: Myth and Reality. In E. Krüger & K. Hahn (Eds.), Nephrology Dialysis Transplantation (pp. 33-53). New York, United States - New York: Nova Science Publisher.

DELANAYE, P., Cavalier, E., RORIVE, M., Paquot, N., SCHEEN, A., & KRZESINSKI, J.-M. (2009). Estimation de filtration glomérulaire chez le patient obese: performances des équations basées sur la créatinine et la cystatine C [Poster presentation]. 11e reunion commune de la Société Francophone de Dialyse (SFD) et de la société de Néphrologie (SN), Toulouse, France.

Delanaye, P., Cavalier, E., Maillard, N., Mariat, C., & Krzesinski, J.-M. (2009). Prévalence de la maladie rénale chronique par l’estimation du DFG dans une population de plus de 50 ans selon la formule MDRD versus la nouvelle formule CKD-EPI [Poster presentation]. XI réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Toulouse, France.

Cavalier, E., Péroni, L., Abshoff, C., Lutteri, L., Chapelle, J.-P., Krzesinski, J.-M., & Delanaye, P. (November 2008). Etude analytique des trois trousses de cystatine C et impact sur les formules basées sur la cystatine pour l'estimation du DFG. Néphrologie et Thérapeutique, 4 (6), 399-400.
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Carlisi, I., & Chapelle, J.-P. (September 2008). Analytical Validation of Diasorin Liaison and Roche Elecsys Methods for the Determination of Osteocalcin. Journal of Bone and Mineral Research, 23, 191.
Peer Reviewed verified by ORBi

Krzesinski, J.-M., DELANAYE, P., Smelten, N., Bovy, P., & moonen, M. (13 March 2008). L'insuffisance rénale et sa prise en charge [Paper presentation]. Journée Mondiale du Rein, Liège, Belgium.

Delanaye, P. (2008). Indexation du DFG pour la surface corporelle: mythe et réalité [Paper presentation]. Réunion du service de Néphrologie, Hôpital Nord, Université de Saint-Etienne, Saint-Etienne, France.

Delanaye, P., Cavalier, E., Saint-Remy, A., Dechenne, C., & Krzesinski, J.-M. (2008). Prevalence of chronic kidney disease in Province of Liège: critical comparison with the American NHANES study? [Paper presentation]. Réunion de la Société Belge de Néphrologie, Leuven, Belgium.

Delanaye, P., Cavalier, E., Krzesinski, J.-M., & Mariat, C. (2008). Cystatin C-based equations: don't repeat the same errors with analytical considerations [letter to the editor]. Nephrology Dialysis Transplantation, 23 (3), 1065; author reply 1065-6. doi:10.1093/ndt/gfm832
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Maillard, N., Krzesinski, J.-M., & Mariat, C. (2008). Creatinine calibration in NHANES: is a revised MDRD study formula needed? [letter to the editor]. American Journal of Kidney Diseases, 51 (4), 709; author reply 709-10. doi:10.1053/j.ajkd.2007.12.041
Peer Reviewed verified by ORBi

Delanaye, P., Krzesinski, J.-M., & Cavalier, E. (2008). Vitamin D treatment in chronic kidney disease: what we really need to know [letter to the editor]. Archives of Internal Medicine, 168 (18), 2045; author reply 2046. doi:10.1001/archinte.168.18.2045-a
Peer Reviewed verified by ORBi

Delanaye, P., Pieroni, L., Abshoff, C., Lutteri, L., Chapelle, J.-P., Krzesinski, J.-M., Hainque, B., & Cavalier, E. (2008). Analytical study of three cystatin C assays and their impact on cystatin C-based GFR-prediction equations. Clinica Chimica Acta, 398 (1-2), 118-24. doi:10.1016/j.cca.2008.09.001
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Saint-Remy, A., Lutteri, L., Chapelle, J.-P., & Krzesinski, J.-M. (2008). Prévalence de la maladie rénale chronique par l’estimation du DFG avec une formule basée sur la créatinine versus la cystatine C [Poster presentation]. 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

Delanaye, P., Cavalier, E., Radermecker, R., Paquot, N., Depas, G., Chapelle, J.-P., Scheen, A., & Krzesinski, J.-M. (2008). Cystatin C or Creatinine for Detection of Stage 3 Chronic Kidney Disease in Anorexia Nervosa. Nephron. Clinical Practice, 110 (3), 158-c163. doi:10.1159/000166607
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Morreale, A., Carlisi, I., Mourad, I., Chapelle, J.-P., & Emonts, P. (2008). La carence en vitamine d chez les femmes enceintes en region liegeoise: un probleme meconnu. Revue Médicale de Liège, 63 (2), 87-91.
Peer reviewed

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (2008). Chronic kidney disease in Taiwan [letter to the editor]. The Lancet, 372 (9654), 1950; author reply 1950-1. doi:10.1016/S0140-6736(08)61836-X
Peer Reviewed verified by ORBi

Froissart, M., Delanaye, P., Seronie-Vivien, S., & Cristol, J.-P. (2008). Evaluation de la fonction renale: une actualisation. Annales de Biologie Clinique, 66 (3), 269-75. doi:10.1684/abc.2008.0228
Peer Reviewed verified by ORBi

Monfort, M., Delanaye, P., Chapelle, J.-P., & Cavalier, E. (2008). Calcium chez les patients hemodialyses : calcemie totale ou calcium ionise ? Le laboratoire doit-il systematiquement fournir au clinicien une valeur de calcemie totale corrigee obtenue par calcul ? Annales de Biologie Clinique, 66 (5), 573-6. doi:10.1684/abc.2008.0264
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (2008). Cystatin C, renal function, and cardiovascular risk [letter to the editor]. Annals of Internal Medicine, 148 (4), 323. doi:10.7326/0003-4819-148-4-200802190-00023
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Froissart, M., & Krzesinski, J.-M. (2008). Reproducibility of GFR measured by chromium-51-EDTA and iohexol [letter to the editor]. Nephrology Dialysis Transplantation, 23 (12), 4077-8; author reply 4078. doi:10.1093/ndt/gfn496
Peer Reviewed verified by ORBi

Séronie-Vivien, S., Delanaye, P., Piéroni, L., Mariat, C., Froissart, M., & Cristol, J.-P. (2008). Cystatin C: current position and future prospects. Clinical Chemistry and Laboratory Medicine, 46 (12), 1664-1686. doi:10.1515/CCLM.2008.336
Peer Reviewed verified by ORBi

Cavalier, E., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (2008). Analytical quality of calcitonin determination and its effect on the adequacy of screening for medullary carcinoma of the thyroid [letter to the editor]. Clinical Chemistry, 54 (5), 929-30. doi:10.1373/clinchem.2007.100636
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2008). New data on the intraindividual variation of cystatin C. Nephron. Clinical Practice, 108 (4), 246-8. doi:10.1159/000124327
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (2008). Determining prevalence of chronic kidney disease using estimated glomerular filtration rate [letter to the editor]. JAMA: Journal of the American Medical Association, 299 (6), 631. doi:10.1001/jama.299.6.631-a
Peer Reviewed verified by ORBi

Mistretta, V., Delanaye, P., Chapelle, J.-P., Souberbielle, J.-C., & Cavalier, E. (2008). Vitamine D2 ou vitamine D3? Revue de Médecine Interne, 29 (10), 815-20. doi:10.1016/j.revmed.2008.03.003
Peer Reviewed verified by ORBi

Seronie-Vivien, S., Delanaye, P., Pieroni, L., Mariat, C., Froissart, M., & Cristol, J.-P. (2008). Cystatine C: point d'etape et perspectives. Annales de Biologie Clinique, 66 (3), 301-23. doi:10.1684/abc.2008.0227
Peer Reviewed verified by ORBi

Delanaye, P., & Cohen, E. P. (2008). Formula-based estimates of the GFR: equations variable and uncertain. Nephron. Clinical Practice, 110 (1), 48-53; discussion c54. doi:10.1159/000151436
Peer Reviewed verified by ORBi

Cavalier, E., Rozet, E., Dubois, N., Charlier, C., Hubert, P., Chapelle, J.-P., Krzesinski, J.-M., & Delanaye, P. (2008). Performance of iohexol determination in serum and urine by HPLC: validation, risk and uncertainty assessment. Clinica Chimica Acta, 396, 80-85. doi:10.1016/j.cca.2008.07.011
Peer Reviewed verified by ORBi

Cavalier, E., Carlisi, A., Chapelle, J.-P., & Delanaye, P. (January 2008). False positive PTH results: An easy strategy to test and detect analytical interferences in routine practice. Clinica Chimica Acta, 387 (1-2), 150-152. doi:10.1016/j.cca.2007.08.019
Peer Reviewed verified by ORBi

Delanaye, P. (2008). Les formules basées sur la créatinine :indiscutable ? [Paper presentation]. Réunion du Service de Néphrologie, Hôpital Nord, Université de Saint-Etienne, Saint-Etienne, France.

Delanaye, P., Cavalier, E., Saint-Remy, A., Dechenne, C., & Krzesinski, J.-M. (2008). Prévalence de la maladie rénale au stade 3 selon l’équation MDRD : comparaison critique des données liégeoises (Belgique) et américaines (étude NHANES) [Poster presentation]. 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

Piéroni, L., Delanaye, P., Abshoff, C., Lutteri, L., Chapelle, J.-P., Hainque, B., Krzesinski, J.-M., & Cavalier, E. (2008). Impact de la stabilité de la cystatine C sur la validité des mesures dans les études rétrospectives [Poster presentation]. 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

Lognard, M., Cavalier, E., Chapelle, J.-P., Lambermont, B., Krzesinski, J.-M., & Delanaye, P. (19 December 2007). Acetylcysteine and Enzymatic Creatinine: Beware of Laboratory Artefact! [letter to the editor]. Intensive Care Medicine, 34 (5), 973-974. doi:10.1007/s00134-007-0972-9
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (September 2007). Impact des conditions préanalytiques sur le dosage de la PTH. Néphrologie et Thérapeutique, 3 (5), 192.
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Carlisi, A., Krzesinski, J.-M., & Chapelle, J.-P. (August 2007). Stability of intact parathyroid hormone in samples from hemodialysis patients. Kidney International, 72 (3), 370-372. doi:10.1038/sj.ki.5002363
Peer Reviewed verified by ORBi

Delanaye, P., Dubois, B., Lambermont, B., & Krzesinski, J.-M. (July 2007). L'épuration extrarénale appliquée au patient hospitalisé aux soins intensifs. Néphrologie et Thérapeutique, 3 (4), 126-32. doi:10.1016/j.nephro.2007.03.007
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (June 2007). PTH stability : preanalytical conditios influences for Liaison (Diasorin). Clinical Chemistry and Laboratory Medicine, 45.
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (June 2007). Evaluation of heterophile antibodies interference on Liaison PTH (Diasorin). Clinical Chemistry and Laboratory Medicine, 45.
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (April 2007). Analytical variation in plasma renin activity: Implications for the screening of primary aldosteronism [letter to the editor]. Clinical Chemistry, 53 (4), 803-804. doi:10.1373/clinchem.2006.083600
Peer Reviewed verified by ORBi

Cavalier, E., & Delanaye, P. (24 March 2007). Equations for GFR estimation: application and limits [Paper presentation]. 3rd Euregio conference of clinical chemistry and laboratory medicine, Vaals, Netherlands.

Cavalier, E., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (23 March 2007). MDRD equation for GFR estimation : analytical limitations [Paper presentation]. 10th International Symposium of Nephrology at Montecatini, Montecatini Terme, Italy.

Delanaye, P., Krzesinski, J.-M., & Cavalier, E. (20 March 2007). Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction [letter to the editor]. Circulation, 115 (11), 333. doi:10.1161/CIRCULATIONAHA.106.677815
Peer Reviewed verified by ORBi

Delanaye, P., Nellessen, E., Cavalier, E., Depas, G., Grosch, S., Defraigne, J.-O., Chapelle, J.-P., Krzesinski, J.-M., & Lancellotti, P. (15 March 2007). Is cystatin C useful for the detection and the estimation of low glomerular filtration rate in heart transplant patients? Transplantation, 83 (5), 641-644. doi:10.1097/01.tp.0000253746.30273.cd
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Ferir, A.-M., Krzesinski, J.-M., & Chapelle, J.-P. (February 2007). Measurement uncertainty of creatinine in low values: Another good reason not to use the MDRD formula with low creatinine values. Clinical Biochemistry, 40 (3-4), 285-286. doi:10.1016/j.clinbiochem.2006.10.021
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (02 January 2007). Estimated glomerular filtration rate [letter to the editor]. Annals of Internal Medicine, 146 (1), 74-74. doi:10.7326/0003-4819-146-1-200701020-00020
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Carlisi, I., Rogister, C., Mourad, I., Krzesinski, J.-M., & Chapelle, J.-P. (2007). High prevalence of vitamin D deficiency in pregnant women and new mothers in the area of Liège, Belgium [Poster presentation]. 17th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Amsterdam, Netherlands.

Delanaye, P., Cavalier, E., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2007). Variabilité du débit de filtration glomérulaire, de la créatinine et de la cystatine C plasmatiques [Poster presentation]. 9ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lyon, France.

Delanaye, P., & Krzesinski, J.-M. (2007). Indexing glomerular filtration rate for body surface area : myth and reality [Paper presentation]. 10th International symposium of Nephrology at Montecatinin : Progression of chronic renal failure, the state of the art and an update, Montecatini, Italy.

Lognard, M., Cavalier, E., Chapelle, J.-P., Lambermont, B., Krzesinski, J.-M., & Delanaye, P. (2007). Acetylcysteine and enzymatic creatinine: take care for interference! Acta Clinica Belgica, 62 (6), 462-462.
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Carlisi, A., Krzesinski, J.-M., & Chapelle, J.-P. (2007). Analytical validation of the new version of the Liaison N-Tact PTH assay. Clinical Chemistry and Laboratory Medicine, 45 (1), 105-107. doi:10.1515/CCLM.2007.017
Peer Reviewed verified by ORBi

Delanaye, P., Van Overmeire, L., Dubois, B., & Krzesinski, J.-M. (2007). Nouveautés dans la prise en charge des anomalies du bilan phosphocalcique chez le patient dialysé. Revue Médicale de Liège, 62 (5-6, May-Jun), 360-5.
Peer reviewed

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (2007). Impact of creatinine calibration in the MDRD equation on the epidemiology of renal failure [Paper presentation]. Réunion de la Société Belge de Néphrologie, Bruxelles, Belgium.

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (2007). Stability of intact parathormone in hemodialyzed patients: a pragmatic study on Roche Elecsys assay [Poster presentation]. Réunion de la Société Belge de Néphrologie, Brussels, Belgium.

Delanaye, P., Krzesinski, J.-M., Cavalier, E., & Lambermont, B. (2007). The RIFLE criteria: are the foundations robust? [letter to the editor]. Critical Care Medicine, 35 (11), 2669; author reply 2669-70. doi:10.1097/01.CCM.0000288115.09689.3C
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Chapelle, J.-P., Krzesinski, J.-M., & Froissart, M. (November 2006). Renal extraction of cystatin C [letter to the editor]. Nephrology Dialysis Transplantation, 21 (11), 3333-3333. doi:10.1093/ndt/gfl324
Peer Reviewed verified by ORBi

Cavalier, E., Levaux, L., Carlisi, I., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (2006). VALIDATION ANALYTIQUE DE LA TROUSSE OCTEIA 25-HYDROXYVITAMINE D (IDS). Immuno-Analyse and Biologie Spécialisée.
Peer reviewed

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (2006). PTH oxidation after a session of hemodialyze: myth or reality? Immuno-Analyse and Biologie Spécialisée.
Peer reviewed

Delanaye, P., Lambermont, B., Dogné, J.-M., Dubois, B., Ghuysen, A., Janssen, N., Desaive, T., Kolh, P., D'Orio, V., & Krzesinski, J.-M. (October 2006). Confirmation of high cytokine clearance by hemofiltration with a cellulose triacetate membrane with large pores: an in vivo study. International Journal of Artificial Organs, 29 (10), 944-948. doi:10.1177/039139880602901004
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Collette, J., Krzesinski, J.-M., & Chapelle, J.-P. (September 2006). Evaluation of different bone markers in hemodialyzed patients. Clinica Chimica Acta, 371 (1-2), 107-111. doi:10.1016/j.cca.2006.02.029
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Krzesinski, J.-M., & Chapelle, J.-P. (August 2006). Why the MDRD equation should not be used in patients with normal renal function (and normal creatinine values)? [letter to the editor]. Clinical Nephrology, 66 (2), 147-148. doi:10.5414/cnp66147
Peer Reviewed verified by ORBi

Lambermont, B., Delanaye, P., Dogné, J.-M., Ghuysen, A., Janssen, N., Dubois, B., Desaive, T., Kolh, P., D'Orio, V., & Krzesinski, J.-M. (July 2006). Large-pore membrane hemofiltration increases cytokine clearance and improves right ventricular-vascular coupling during endotoxic shock in pigs. Artificial Organs, 30 (7), 560-564. doi:10.1111/j.1525-1594.2006.00260.x
Peer Reviewed verified by ORBi

Delanaye, P., Weekers, L., & Krzesinski, J.-M. (May 2006). Diarrhea induced by high doses of nicotinamide in dialysis patients [letter to the editor]. Kidney International, 69 (10), 1914-1914. doi:10.1038/sj.ki.5000381
Peer Reviewed verified by ORBi

Krzesinski, J.-M., Delanaye, P., Bovy, C., & Cavalier, E. (2006). Place de la Biologie Clinique dans l'évolution de l'insuffisance rénale et de ses complications [Paper presentation]. Formation continue en Biologie Clinique, Liège, Belgium.

Delanaye, P., Cavalier, E., Chapelle, J.-P., & Krzesinski, J.-M. (April 2006). Importance of the creatinine calibration in the estimation of GFR by MDRD equation [letter to the editor]. Nephrology Dialysis Transplantation, 21 (4), 1130-1130. doi:10.1093/ndt/gfl038
Peer Reviewed verified by ORBi

Delanaye, P., Depas, G., Radermecker, R., Rorive, M., & Krzesinski, J.-M. (March 2006). Indexing glomerular filtration rate for body surface area is useful in obese subjects - Reply [letter to the editor]. Nephrology Dialysis Transplantation, 21 (3), 821-822. doi:10.1093/ndt/gfi264
Peer Reviewed verified by ORBi

Delanaye, P., Lambermont, B., Dogné, J.-M., Dubois, B., Ghuysen, A., Janssen, N., Kolh, P., D'Orio, V., & Krzesinski, J.-M. (2006). Clairance plasmatique des cytokines IL6 et IL10 par hémofiltration avec un filtre à larges pores dans un modèle porcin de choc septique [Paper presentation]. 34ème congrès de la Société de Réanimation de Langue Française, Paris, France.

Delanaye, P., Cavalier, E., Radermecker, R., Paquot, N., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2006). Estimation du débit de filtration glomérulaire par les formules basées sur la créatinine et la cystatine C en cas d’anorexie mentale [Paper presentation]. 8éme réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lille, France.

Delanaye, P., Cavalier, E., Radermecker, R., Rorive, M., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2006). Plasma cystatin C for the detection of renal failure in obese patients [Poster presentation]. 43ème Congress of ERA-EDTA, Glasgow, United Kingdom.

RADERMECKER, R., DELANAYE, P., Warzee, F., SCHEEN, A., & LAMBERMONT, B. (2006). Exactitude de la mesure continue de la concentration de glucose par microdyalise sous cutanée chez les patients de soins intensifs [Poster presentation]. XXXIIIe Congrès de la Société de Réanimation de langue française. doi:10.1016/j.reaurg.2005.11.005

Delanaye, P., Nellessen, E., Grosch, S., Depas, G., Cavalier, E., Defraigne, J.-O., Chapelle, J.-P., Krzesinski, J.-M., & Lancellotti, P. (2006). Creatinine-based formulae for the estimation of glomerular filtration rate in heart transplant recipients. Clinical Transplantation, 20 (5, Sep-Oct), 596-603. doi:10.1111/j.1399-0012.2006.00523.x
Peer Reviewed verified by ORBi

Delanaye, P., Radermecker, R., Rorive, M., Depas, G., & Krzesinski, J.-M. (October 2005). Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example. Nephrology Dialysis Transplantation, 20 (10), 2024-2028. doi:10.1093/ndt/gfh983
Peer Reviewed verified by ORBi

Van Overmeire, L., Delanaye, P., & Krzesinski, J.-M. (24 August 2005). Nouveautés dans la prise en charge médicale des anomalies du bilan phosphocalcique chez le patient hémodialysé. Revue Médicale Suisse, 1 (30), 1960-5.
Peer Reviewed verified by ORBi

Delanaye, P., & Krzesinski, J.-M. (19 April 2005). The new Mayo clinic equation for estimating glomerular filtration rate [letter to the editor]. Annals of Internal Medicine, 142 (8), 679-680. doi:10.7326/0003-4819-142-8-200504190-00028
Peer Reviewed verified by ORBi

Bovy, C., Delanaye, P., Radermecker, R., Hamoir, E., Maweja, S., & Krzesinski, J.-M. (April 2005). Comment j'explore ... l'hypertension artérielle par excès de minéralocorticoides. Revue Médicale de Liège, 60 (4), 255-63.
Peer reviewed

Delanaye, P., & Krzesinski, J.-M. (March 2005). Nouveautés à propos du métabolisme du phosphore. Revue Médicale de Liège, 60 (3), 189-197.
Peer reviewed

Delanaye, P., & Krzesinski, J.-M. (January 2005). Massive renal and adrenal calcifications in a young dialysis patient with familial Mediterranean fever. Nephrology Dialysis Transplantation, 20 (1), 238-238. doi:10.1093/ndt/gfh481
Peer Reviewed verified by ORBi

Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (2005). Impact des différences dans les techniques de calibration de la créatinine sérique sur les résultats de la formule de Cockcroft et du MDRD [Poster presentation]. 7ème réunion commune de la Société de Néphrologie et de la société Française de Dialyse, Clermont-Ferrand, France.

Delanaye, P., Radermecker, R., Depas, G., Rorive, M., & Krzesinski, J.-M. (2005). Correction du debit de filtration glomérulaire par la surface corporelle : impact chez le patient obèse [Poster presentation]. 7ème réunion commune de la Société de Néphrologie et de la société Française de Dialyse, Clermont-Ferrand, France.

Cavalier, E., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (2005). Comparison of liaison N-tact PTH (diasorin) and N-tact PTH SPIRMA (diasorin) in hemodialyzed patients [letter to the editor]. Clinical Chemistry and Laboratory Medicine, 43 (8), 890-891. doi:10.1515/CCLM.2005.151
Peer Reviewed verified by ORBi

Cavalier, E., Carlisi, I., Delanaye, P., Pazzaglia, G., Krzesinski, J.-M., & Chapelle, J.-P. (October 2004). Comparaison of liaison N-tact PTH (Diasorin) and N-tact PTH SP IRMA (Diasorin) in hemodialyzed patients [Poster presentation]. 21ème Colloque CORATA, Paris, France.

Kotzampassakis, N., Delanaye, P., Masy, F., & Creemers, E. (July 2004). Endovascular stent-graft for thoracic aorta aneurysm caused by Salmonella. European Journal of Cardio-Thoracic Surgery, 26 (1), 225-227. doi:10.1016/j.ejcts.2004.02.035
Peer Reviewed verified by ORBi

Delanaye, P., Lambermont, B., Chapelle, J.-P., Gielen, J., Gérard, P., & Rorive, G. (May 2004). Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care units. Intensive Care Medicine, 30 (5), 980-983. doi:10.1007/s00134-004-2189-5
Peer Reviewed verified by ORBi

Delanaye, P., Radermecker, R., Rorive, M., Depas, G., Chapelle, J.-P., Gielen, J., & Krzesinski, J.-M. (2004). Detection of renal failure in overweight patients [Poster presentation]. Réunion de la Société Belge de Néphrologie, Liège, Belgium.

Delanaye, P., Rorive, M., Radermecker, R., & Krzesinski, J.-M. (2004). Which formula for the estimation of glomerular filtration rate in obese patients? [Poster presentation]. Congrès de la Société Belge de Médecine Interne, Bruxelles, Belgium.

Delanaye, P., Saint-Remy, A., Rorive, M., Radermecker, R., & Krzesinski, J.-M. (2004). Are MDRD formulas better than Cockcroft formula for the prediction of glomerular filtration rate in obese patients? [Poster presentation]. 41ème Congress of ERA-EDTA, Lisbonne, Portugal.

Delanaye, P., Bataille, Y., & Krzesinski, J.-M. (2004). Quel traitement pour les vascularites ANCA-positives ? Médecine et Hygiène, 62, 1607-1610.
Peer Reviewed verified by ORBi

Delanaye, P., Nellessen, E., Grosch, S., Depas, G., Chapelle, J.-P., Gielen, J., Foidart, J., Krzesinski, J.-M., & Lancellotti, P. (2004). Is plasme cystatin C better than creatinine to detect renal failure in heart transplant recipients? [Paper presentation]. 41ème Congress of ERA-EDTA, Lisbonne, Portugal.

Delanaye, P., Saint-Remy, A., Nellessen, E., Grosch, S., Depas, G., Chapelle, J.-P., Gielen, J., Krzesinski, J.-M., & Lancellotti, P. (2004). New methods for the detection and estimation of renal function in heart transplant recipients [Paper presentation]. Meeting of the Belgian Transplantation Society, Bruxelles, Belgium.

Rorive, M., Saint-Remy, A., Delanaye, P., Radermecker, R., & Krzesinski, J.-M. (2004). Estimation du débit de filtration glomérulaire chez le patient obèse [Poster presentation]. 5ème réunion commune de la Société de Néphrologie et de la Société Française de Dialyse, Nancy, France.

Delanaye, P., Demoulin, J.-C., Nellessen, E., Grosch, S., Saint-Remy, A., Foidart, J., Rorive, G., Lancellotti, P., & Krzesinski, J.-M. (2004). Intérêt de l’équation MDRD pour l’estimation du débit de filtration glomérulaire chez le patient greffé cardiaque [Poster presentation]. 5ème réunion commune de la Société de Néphrologie et de la Société Française de Dialyse, Nancy, France.

Delanaye, P., Radermecker, R., Saint-Remy, A., Chapelle, J.-P., Depas, G., Foidart, J., Gielen, J., Scheen, A., & Krzesinski, J.-M. (2004). Estimation de la fonction rénale chez le patient anorexique [Poster presentation]. Congrès annuel de l’ALFEDIAM, Nice, France.

Delanaye, P., Radermecker, R., Saint-Remy, A., Depas, G., Chapelle, J.-P., Gielen, J., Scheen, A., & Krzesinski, J.-M. (2004). Estimation of renal function in anorexia nervosa [Poster presentation]. Réunion de la Société Belge de Néphrologie, Liège, Belgium.

Delanaye, P., Bovy, C., de Leval, L., Fassotte, M.-F., Witvrouw, N., Dechenne, C., Tassin, F., & Krzesinski, J.-M. (2004). Back pain and renal failure. The Lancet, 364 (9449), 1992. doi:10.1016/S0140-6736(04)17484-9
Peer Reviewed verified by ORBi

Delanaye, P., Chapelle, J.-P., Ferir, A.-M., Gielen, J.-L., Krzesinski, J.-M., & Rorive, G. (February 2003). La mesure du débit de filtration glomérulaire en clinique quotidienne. Revue Médicale de Liège, 58 (2), 95-100.
Peer reviewed

Delanaye, P., Lambermont, B., Chapelle, J.-P., Gielen, J., & Rorive, G. (2003). Intérêt de la cystatine C dans l’évaluation de la fonction rénale chez le patient hospitalisé aux soins intensifs [Poster presentation]. 31ème congrès de la Société de Réanimation de Langue Française, Paris, France.

Delanaye, P., Chapelle, J.-P., Gielen, J., Krzesinski, J.-M., & Rorive, G. (2003). L'intérêt de la cystatine C dans l'évaluation de la fonction rénale. Nephrologie, 24 (8), 457-68.
Peer Reviewed verified by ORBi

Delanaye, P., De Fooz, G., NCHIMI LONGANG, A., Richardy, M., Pierard, L., & Lancellotti, P. (2003). L'image du mois. Hématome hépatique après une réanimation cardio-pulmonaire. Revue Médicale de Liège, 58 (7-8, Jul-Aug), 463-464.
Peer reviewed

Delanaye, P., Nikkels, A., Martalo, O., Dechenne, C., Arrese Estrada, J., Rorive, G., & Pierard, G. (2002). Comment j'explore ... le syndrome d'Alport par la biopsie cutanée. Quand la peau parle pour le rein. Revue Médicale de Liège, 57 (10), 670-1.
Peer reviewed

Delanaye, P., Dubois, C., Mendes, P., Bertholet, M., & Lambermont, B. (January 2002). Morsure de chien chez un patient splénectomisé. Revue Médicale de Liège, 57 (1), 40-4.
Peer reviewed

Belhocine, T., Kaye, O., Delanaye, P., Corman, V., Baghaie, M., Deprez, M., Daenen, F., De Barsy, C., Beckers, C., Gomez, P., Hustinx, R., Foidart-Willems, J., Demonty, J., Malaise, M., & Rigo, P. (2002). Maladie de Horton et atteintes arterielles extratemporales: utilite de la tomographie par emission de positons au 18FDG. A propos de trois observations et d'une revue de la litterature. Revue de Médecine Interne, 23 (7), 584-91. doi:10.1016/S0248-8663(02)00620-3
Peer Reviewed verified by ORBi

Delanaye, P., Lancellotti, P., Moonen, M., & Radermecker, M. (December 2001). Communication interventriculaire et infarctus récent du myocarde. Revue Médicale de Liège, 56 (12), 823-829.
Peer reviewed

Delanaye, P., Heymans, O., & Boverie, J. (November 2000). L'image du mois. Histiocytome fibreux malin. Revue Médicale de Liège, 55 (11), 969.
Peer reviewed

Delanaye, P., Nkoghe, D., & Demonty, J. (June 2000). La malaria: du diagnostic au traitement curatif. Revue Médicale de Liège, 55 (6), 510-5.
Peer reviewed

Delanaye, P., Nkoghe, D., & Demonty, J. (June 2000). Stratégies de prévention contre la malaria. Revue Médicale de Liège, 55 (6), 505-9.
Peer reviewed

Hubert, P., Greimers, R., Franzen-Detrooz, E., Sele, J., Delanaye, P., Boniver, J., & Delvenne, P. (October 1998). In Vitro Propagated Dendritic Cells from Patients with Human-Papilloma Virus-Associated Preneoplastic Lesions of the Uterine Cervix: Use of Flt3 Ligand. Cancer Immunology, Immunotherapy, 47 (2), 81-9. doi:10.1007/s002620050507
Peer Reviewed verified by ORBi

Contact ORBi